
<html lang="en"     class="pb-page"  data-request-id="d261027e-4e1c-4666-9769-7d5f8b9be065"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2017.60.issue-11;requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.7b00408;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate" /></meta><meta name="dc.Creator" content="Michael A.  Letavic" /></meta><meta name="dc.Creator" content="Brad M.  Savall" /></meta><meta name="dc.Creator" content="Brett D.  Allison" /></meta><meta name="dc.Creator" content="Leah  Aluisio" /></meta><meta name="dc.Creator" content="Jose Ignacio  Andres" /></meta><meta name="dc.Creator" content="Meri  De Angelis" /></meta><meta name="dc.Creator" content="Hong  Ao" /></meta><meta name="dc.Creator" content="Derek A.  Beauchamp" /></meta><meta name="dc.Creator" content="Pascal  Bonaventure" /></meta><meta name="dc.Creator" content="Stewart  Bryant" /></meta><meta name="dc.Creator" content="Nicholas I.  Carruthers" /></meta><meta name="dc.Creator" content="Marc  Ceusters" /></meta><meta name="dc.Creator" content="Kevin J.  Coe" /></meta><meta name="dc.Creator" content="Curt A.  Dvorak" /></meta><meta name="dc.Creator" content="Ian C.  Fraser" /></meta><meta name="dc.Creator" content="Christine F.  Gelin" /></meta><meta name="dc.Creator" content="Tatiana  Koudriakova" /></meta><meta name="dc.Creator" content="Jimmy  Liang" /></meta><meta name="dc.Creator" content="Brian  Lord" /></meta><meta name="dc.Creator" content="Timothy W.  Lovenberg" /></meta><meta name="dc.Creator" content="Monicah A.  Otieno" /></meta><meta name="dc.Creator" content="Freddy  Schoetens" /></meta><meta name="dc.Creator" content="Devin M.  Swanson" /></meta><meta name="dc.Creator" content="Qi  Wang" /></meta><meta name="dc.Creator" content="Alan D.  Wickenden" /></meta><meta name="dc.Creator" content="Anindya  Bhattacharya" /></meta><meta name="dc.Description" content="The synthesis and preclinical characterization of novel 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are potent and selective brain penetrant P2X7 antagonists are described. Optimizati..." /></meta><meta name="Description" content="The synthesis and preclinical characterization of novel 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are potent and selective brain penetrant P2X7 antagonists are described. Optimizati..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 25, 2017" /></meta><meta name="dc.Type" content="news" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00408" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2017 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00408" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00408" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00408" /></link>
        
    
    

<title>4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00408" /></meta><meta property="og:title" content="4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0016.jpeg" /></meta><meta property="og:description" content="The synthesis and preclinical characterization of novel 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are potent and selective brain penetrant P2X7 antagonists are described. Optimization efforts based on previously disclosed unsubstituted 6,7-dihydro-4H-triazolo[4,5-c]pyridines, methyl substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazines, and several other series lead to the identification of a series of 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are selective P2X7 antagonists with potency at the rodent and human P2X7 ion channels. These novel P2X7 antagonists have suitable physicochemical properties, and several analogs have an excellent pharmacokinetic profile, good partitioning into the CNS and show robust in vivo target engagement after oral dosing. Improvements in metabolic stability led to the identification of JNJ-54175446 (14) as a candidate for clinical development. The drug discovery efforts and strategies that resulted in the identification of the clinical candidate are described herein." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00408"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00408">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00408&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00408&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00408&amp;href=/doi/10.1021/acs.jmedchem.7b00408" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4559-4572</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01761" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Drug Annotation</span><a href="/doi/10.1021/acs.jmedchem.7b00554" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">4-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+A.++Letavic">Michael A. Letavic</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-7503-0189" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brad+M.++Savall">Brad M. Savall</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brett+D.++Allison">Brett D. Allison</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leah++Aluisio">Leah Aluisio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jose+Ignacio++Andres">Jose Ignacio Andres</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Meri++De+Angelis">Meri De Angelis</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hong++Ao">Hong Ao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Derek+A.++Beauchamp">Derek A. Beauchamp</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pascal++Bonaventure">Pascal Bonaventure</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stewart++Bryant">Stewart Bryant</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas+I.++Carruthers">Nicholas I. Carruthers</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc++Ceusters">Marc Ceusters</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+J.++Coe">Kevin J. Coe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Curt+A.++Dvorak">Curt A. Dvorak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian+C.++Fraser">Ian C. Fraser</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+F.++Gelin">Christine F. Gelin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tatiana++Koudriakova">Tatiana Koudriakova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jimmy++Liang">Jimmy Liang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Lord">Brian Lord</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Timothy+W.++Lovenberg">Timothy W. Lovenberg</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Monicah+A.++Otieno">Monicah A. Otieno</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Freddy++Schoetens">Freddy Schoetens</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Devin+M.++Swanson">Devin M. Swanson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Wang">Qi Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alan+D.++Wickenden">Alan D. Wickenden</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anindya++Bhattacharya">Anindya Bhattacharya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Janssen Research & Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Janssen Research & Development, a Division of Janssen-Cilag, Jarama 75, 45007 Toledo, Spain</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Janssen Research & Development, LLC, 1400 McKean Road, Spring House, Pennsylvania 19477, United States</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Janssen Research & Development, Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#ea87868f9e8b9c8389aa839e99c4808480c4898587"><span class="__cf_email__" data-cfemail="1c717079687d6a757f5c75686f32767276327f7371">[email protected]</span></a>. Phone: 1-858-450-2302.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00408&amp;href=/doi/10.1021%2Facs.jmedchem.7b00408" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4559–4572</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 11, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>14 March 2017</li><li><span class="item_label"><b>Published</b> online</span>25 May 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 June 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00408" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00408</a></div><div class="article_header-article-copyright"><strong>Copyright © 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4559%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichael%2BA.%2BLetavic%252C%2BBrad%2BM.%2BSavall%252C%2BBrett%2BD.%2BAllison%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D11%26contentID%3Dacs.jmedchem.7b00408%26title%3D4-Methyl-6%252C7-dihydro-4H-triazolo%255B4%252C5-c%255Dpyridine-Based%2BP2X7%2BReceptor%2BAntagonists%253A%2BOptimization%2Bof%2BPharmacokinetic%2BProperties%2BLeading%2Bto%2Bthe%2BIdentification%2Bof%2Ba%2BClinical%2BCandidate%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4572%26publicationDate%3DJune%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00408"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5146</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">29</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00408" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;A. Letavic&quot;},{&quot;first_name&quot;:&quot;Brad&quot;,&quot;last_name&quot;:&quot;M. Savall&quot;},{&quot;first_name&quot;:&quot;Brett&quot;,&quot;last_name&quot;:&quot;D. Allison&quot;},{&quot;first_name&quot;:&quot;Leah&quot;,&quot;last_name&quot;:&quot;Aluisio&quot;},{&quot;first_name&quot;:&quot;Jose&quot;,&quot;last_name&quot;:&quot;Ignacio Andres&quot;},{&quot;first_name&quot;:&quot;Meri&quot;,&quot;last_name&quot;:&quot;De Angelis&quot;},{&quot;first_name&quot;:&quot;Hong&quot;,&quot;last_name&quot;:&quot;Ao&quot;},{&quot;first_name&quot;:&quot;Derek&quot;,&quot;last_name&quot;:&quot;A. Beauchamp&quot;},{&quot;first_name&quot;:&quot;Pascal&quot;,&quot;last_name&quot;:&quot;Bonaventure&quot;},{&quot;first_name&quot;:&quot;Stewart&quot;,&quot;last_name&quot;:&quot;Bryant&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;I. Carruthers&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;Ceusters&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;J. Coe&quot;},{&quot;first_name&quot;:&quot;Curt&quot;,&quot;last_name&quot;:&quot;A. Dvorak&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;C. Fraser&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;F. Gelin&quot;},{&quot;first_name&quot;:&quot;Tatiana&quot;,&quot;last_name&quot;:&quot;Koudriakova&quot;},{&quot;first_name&quot;:&quot;Jimmy&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Lord&quot;},{&quot;first_name&quot;:&quot;Timothy&quot;,&quot;last_name&quot;:&quot;W. Lovenberg&quot;},{&quot;first_name&quot;:&quot;Monicah&quot;,&quot;last_name&quot;:&quot;A. Otieno&quot;},{&quot;first_name&quot;:&quot;Freddy&quot;,&quot;last_name&quot;:&quot;Schoetens&quot;},{&quot;first_name&quot;:&quot;Devin&quot;,&quot;last_name&quot;:&quot;M. Swanson&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Alan&quot;,&quot;last_name&quot;:&quot;D. Wickenden&quot;},{&quot;first_name&quot;:&quot;Anindya&quot;,&quot;last_name&quot;:&quot;Bhattacharya&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;4559-4572&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00408&quot;},&quot;abstract&quot;:&quot;The synthesis and preclinical characterization of novel 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are potent and selective brain penetrant P2X7 antagonists are described. Optimization efforts based on previously disclosed unsubstituted 6,7-dihydro-4H-triazolo[4,5-c]pyridines, methyl substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazines, and several other series lead to the identification of a series of 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are selective P2X7 antagonists with potency at the rodent and human P2X7 ion channels. These novel P2X7 antagonists have suitable physicochemical properties, and several analogs have an excellent pharmacokinetic profile, good partitioning into the CNS and show robust in vivo target engagement after oral dosing. Improvements in metabolic stability led to the identification of JNJ-54175446 (14) as a candidate for clinical development. The drug discovery efforts and strategies that resulted in the identification of the clinical candi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00408&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00408" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00408&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00408" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00408&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00408" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00408&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00408&amp;href=/doi/10.1021/acs.jmedchem.7b00408" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00408" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00408" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00408%26sid%3Dliteratum%253Aachs%26pmid%3D28493698%26genre%3Darticle%26aulast%3DLetavic%26date%3D2017%26atitle%3D4-Methyl-6%252C7-dihydro-4H-triazolo%255B4%252C5-c%255Dpyridine-Based%2BP2X7%2BReceptor%2BAntagonists%253A%2BOptimization%2Bof%2BPharmacokinetic%2BProperties%2BLeading%2Bto%2Bthe%2BIdentification%2Bof%2Ba%2BClinical%2BCandidate%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D11%26spage%3D4559%26epage%3D4572%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/jmcmar.2017.60.issue-11/20170608/jmcmar.2017.60.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The synthesis and preclinical characterization of novel 4-(<i>R</i>)-methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines that are potent and selective brain penetrant P2X7 antagonists are described. Optimization efforts based on previously disclosed unsubstituted 6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines, methyl substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazines, and several other series lead to the identification of a series of 4-(<i>R</i>)-methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines that are selective P2X7 antagonists with potency at the rodent and human P2X7 ion channels. These novel P2X7 antagonists have suitable physicochemical properties, and several analogs have an excellent pharmacokinetic profile, good partitioning into the CNS and show robust in vivo target engagement after oral dosing. Improvements in metabolic stability led to the identification of JNJ-54175446 (<b>14</b>) as a candidate for clinical development. The drug discovery efforts and strategies that resulted in the identification of the clinical candidate are described herein.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07676" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07676" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Depression is a debilitating disease that afflicts millions of adults at some time during their life, and chronic depression can shorten lifespan by over 10 years.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Many patients do not respond to current antidepressant treatments or become resistant to current medications, and as a result, there have been significant efforts to uncover novel mechanisms to treat depression. Unfortunately, identifying compounds targeting novel mechanisms with clinical utility for the treatment of mood disorders has been a daunting task. Recent studies suggest that there may be a link between neuroinflammation and mood disorders,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and there is an emerging body of work that implicates the production of proinflammatory cytokine IL-1β as a key mediator of neuroinflammation.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Interestingly, the P2X7 ion channel is expressed abundantly in microglia in the CNS where it is involved in IL-1β release,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> and microglial IL-1β appears to be a significant source of CNS IL-1β. Inhibition of P2X7 and P2X7 mediated IL-1β release might therefore represent a novel approach to the treatment of mood disorders. Indeed, there have been several reports suggesting a role for P2X7 in preclinical models of mood disorders,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and very recently two groups reported on the efficacy of P2X7 antagonists in chronic models of depression.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> However, to our knowledge, the effect of a P2X7 antagonist on depression or any related mood disorder has not yet been tested in the clinic.</div><div class="NLM_p">Several companies have progressed P2X7 antagonists into clinical development and tested the P2X7 mechanism for peripheral indications including rheumatoid arthritis (RA), Crohn’s disease, and osteoarthritic pain. Some examples of compounds that entered clinical trials are depicted in <a class="ref internalNav" href="#cht1" aria-label="Chart 1">Chart 1</a>. The AstraZeneca compound AZD9056 (<b>1</b>)<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> has been tested in both RA and Crohn’s disease.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The compound proved ineffective at treating RA but achieved the primary clinical efficacy end point in a small proof-of-concept study in Crohn’s disease. Pfizer reported phase IIb results for their lead compound (<b>2</b>, CE-224,535),<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and in a 3 month trial in RA patients <b>2</b> was shown to inhibit the release of IL-1β in blood but did not show efficacy in RA.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Both of these compounds are peripherally restricted and therefore would likely not be useful for treating CNS disorders. Notably, <b>1</b> demonstrated improvements in mental component score (SF-36) in the Crohn’s study. GlaxoSmithKline progressed the pyroglutamate-based compound (<b>3</b>, GSK1482160) into clinical development but never moved beyond phase I studies, possibly due to a lack of safety margins.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This compound is reported to be a negative allosteric modulator of P2X7 and has good CNS penetration (brain/blood ratio of ∼0.5).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Select P2X7 Antagonist Clinical Candidates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The first CNS penetrant compounds disclosed by Janssen are compounds <b>4</b> and <b>5</b> on <a class="ref internalNav" href="#cht2" aria-label="Chart 2">Chart 2</a>. These compounds are potent human and rat P2X7 antagonists that efficiently penetrate the CNS,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and they have proven to be good tool compounds for preclinical efficacy studies. In fact, <b>4</b> was shown to inhibit the stimulated release of IL-1β in rat brain and to attenuate amphetamine induced hyperactivity in rat.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Compound <b>4</b> has also shown effects in models of schizophrenia,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> temporal lobe epilepsy<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and in seizure models,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and compound <b>5</b> increased social interactions in a model of social stress.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Unfortunately, this class of compounds suffers from poor pharmacokinetic properties and we were unable to progress any of these analogs into clinical development. Due to the very interesting CNS effects that were observed with compounds <b>4</b> and <b>5</b>, we sought to identify novel, CNS penetrant compounds with pharmacokinetic profiles consistent with once daily oral dosing in human.</div><figure id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. CNS Penetrant Lead P2X7 Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Following the disclosure of a series of 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazines<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> by GSK that are potent P2X7 antagonists, we decided to investigate the effects of substitution on the tetrahydropyrazine core and this led to the identification of the 8-methyl-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazines as exemplified by <b>6</b> in <a class="ref internalNav" href="#cht3" aria-label="Chart 3">Chart 3</a>.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Optimized CNS Active Lead Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">These and related structures also demonstrated that substitution on the core ring could have dramatic effects on potency, speciation, and DMPK properties. At the same time a number of additional cores were also discovered including the 6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines (e.g., <b>7</b>),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> 4,5,6,7-tetrahydro-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridines (e.g., <b>8</b>),<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> and 6,7-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-8(5<i>H</i>)-ones (e.g., <b>9</b>),<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> among others.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p last">This publication details the results of efforts to optimize the in vivo properties of analogs prepared from the 4-methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridine core, some challenges that were encountered, and the solutions that were found that resulted in the identification of a clinical candidate with the potential to be useful for the treatment of mood disorders.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77627" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77627" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Previous publications highlighting compounds <b>6</b>–<b>9</b> established much of the in vitro SAR for the 6,5 fused heterocyclic-based structures. This work confirmed that the 2-chloro-3-trifluoromethyl benzamide or similar 2,3-disubstituted benzamides were the preferred substituents on the piperidine (or piperazine) nitrogen for P2X7 potency and also demonstrated the benefit of placing a substituent, such as methyl, on the tetrahydropyridine ring which resulted in both improvements in potency and reduced speciation. In many cases the methyl substituent also improved metabolic stability in microsomal preparations. These efforts also established that a heteroaromatic substituent was preferred at the <i>N</i>-1 position of the 1,2,3 triazole, imidazole, or <i>C</i>-3 position of the 1,2,4 triazole. In order to assess the effect of the <i>N</i>-1 substituent on in vivo properties of the 4-(<i>R</i>)-methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines, a limited set of new analogs were synthesized (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). The heteroaromatics that were installed on compounds <b>10</b>–<b>14</b> were chosen based on previous SAR with respect to potency, metabolic stability, and CYP inhibition profiles. The in vitro data for these compounds are shown on <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>. All five compounds have acceptable molecular weights and similar cLogP values and P2X7 potencies. As was noted in an earlier publication,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> installation of the methyl group on the core ring of related structures sometimes improved rat P2X7 potency rather dramatically,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and in this set, this was also true for compounds <b>11</b> and <b>13</b>. Next, these new compounds were comprehensively profiled in vitro and in vivo.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR for Select 4-(<i>R</i>)-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0014.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0015.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Human FLIPR pIC<sub>50</sub> measured in a Ca<sup>2+</sup> flux assay.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Rat FLIPR pIC<sub>50</sub> measured in a Ca<sup>2+</sup> flux assay. All data are the result of at least three assays run in triplicate with the mean value reported; pIC<sub>50</sub> ± sd is reported.</p></div></div><div></div></div><div class="NLM_p"><a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> contain data for microsomal stability, hERG binding, protein binding, and solubility for compounds <b>10</b>–<b>14</b>. To summarize, none of the compounds had significant hERG binding, all had acceptable protein binding, and solubility varied from acceptable to very good. Microsomal stability varies significantly for this set of compounds with human extraction ratios ranging from 0.66 to <0.30. The first compound that was prepared was compound <b>11</b>, and this compound was the first to be profiled in vivo. Prior to this, compound <b>11</b> was screened against a panel of 50 ion channels, receptors, and transporters (Eurofins-CEREP, <a href="http://www.eurofins.com/" class="extLink">http://www.eurofins.com/</a>) and a general kinase panel and did not have any significant activity (tested at 1 μM) in any of the assays.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Microsomal Stability Data and hERG IC<sub>50</sub> Values for Compounds <b>10</b>–<b>14</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">RLM stability<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t2fn7" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">HLM stability<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t2fn7" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">MLM stability<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a><sup>,</sup><a class="ref internalNav" href="#t2fn7" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">DLM stability<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a><sup>,</sup><a class="ref internalNav" href="#t2fn7" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">CMLM stability<a class="ref internalNav" href="#t2fn5" aria-label="e">e</a><sup>,</sup><a class="ref internalNav" href="#t2fn7" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">hERG IC<sub>50</sub><a class="ref internalNav" href="#t2fn6" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">0.54</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">0.68</td><td class="colsep0 rowsep0" align="left">0.66</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">0.57</td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">0.33</td><td class="colsep0 rowsep0" align="left">0.39</td><td class="colsep0 rowsep0" align="left">0.40</td><td class="colsep0 rowsep0" align="left"><0.26</td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">0.36</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">0.91</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left"><0.2</td><td class="colsep0 rowsep0" align="left"><0.3</td><td class="colsep0 rowsep0" align="left"><0.25</td><td class="colsep0 rowsep0" align="left"><0.26</td><td class="colsep0 rowsep0" align="left"><0.19</td><td class="colsep0 rowsep0" align="left">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Stability in rat liver microsomes.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Stability in human liver microsomes.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Stability in mouse liver microsomes.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Stability in dog liver microsomes.</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">Stability in cynomolgus monkey liver microsomes.</p></div><div class="footnote" id="t2fn7"><sup>f</sup><p class="last">All data are reported as hepatic extraction ratios where the predicted hepatic clearance is divided by the species specific hepatic blood flow.</p></div><div class="footnote" id="t2fn6"><sup>g</sup><p class="last">hERG IC<sub>50</sub> in μM as measured in an [<sup>3</sup>H]dofetilide competition binding assay in HEK-293 cells expressing the hERG channel.</p></div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Select in Vitro Data for Compounds <b>10</b>–<b>14</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">rat PPB<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (%)</th><th class="colsep0 rowsep0" align="center">human PPB<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (%)</th><th class="colsep0 rowsep0" align="center">mouse PPB<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (%)</th><th class="colsep0 rowsep0" align="center">rat brain binding<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a> (%)</th><th class="colsep0 rowsep0" align="center">solubility at pH 2 (μM)</th><th class="colsep0 rowsep0" align="center">solubility at pH 7 (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">94.8</td><td class="colsep0 rowsep0" align="left">97.6</td><td class="colsep0 rowsep0" align="left">95.8</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">93.7</td><td class="colsep0 rowsep0" align="left">91.6</td><td class="colsep0 rowsep0" align="left">94.7</td><td class="colsep0 rowsep0" align="left">95.0</td><td class="colsep0 rowsep0" align="left">48.2</td><td class="colsep0 rowsep0" align="left">94.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">92.4</td><td class="colsep0 rowsep0" align="left">91.6</td><td class="colsep0 rowsep0" align="left">92.6</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">>400</td><td class="colsep0 rowsep0" align="left">180</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">90.5</td><td class="colsep0 rowsep0" align="left">91.5</td><td class="colsep0 rowsep0" align="left">90.5</td><td class="colsep0 rowsep0" align="left">95.9</td><td class="colsep0 rowsep0" align="left">328</td><td class="colsep0 rowsep0" align="left">283</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">87.8</td><td class="colsep0 rowsep0" align="left">88.8</td><td class="colsep0 rowsep0" align="left">88.7</td><td class="colsep0 rowsep0" align="left">94.9</td><td class="colsep0 rowsep0" align="left">38.7</td><td class="colsep0 rowsep0" align="left">20.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Preliminary (tier 1) data.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Rat brain tissue binding.</p></div></div></div><div class="NLM_p">Compound <b>11</b> was dosed in rat and dog, and the pharmacokinetic profiles are summarized in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. Compound <b>11</b> has relatively high clearance in both species, consistent with the microsomal data shown in <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Rat and Dog Pharmacokinetic Parameters for Compound <b>11</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">3.3</td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">65</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Clearance.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">iv half-life.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Dosed at 1 mg/kg iv and 5 mg/kg po.</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">Dosed at 1 mg/kg iv and 3 mg/kg po.</p></div></div></div><div class="NLM_p">In order to further assess the in vivo properties of compound <b>11</b>, two studies were performed. First, P2X7 target engagement was assessed in rat using ex vivo autoradiography. Data are shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>. Compound <b>11</b> dose dependently occupied the P2X7 ion channel with an ED<sub>50</sub> of 0.3 mg/kg (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>A). Compound <b>11</b> also efficiently inhibited the release of IL-1β in rat hippocampus in a microdialysis experiment conducted as described previously.<a onclick="showRef(event, 'ref14 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref19">(14, 19)</a> In this experiment rats were either treated with vehicle or compound <b>11</b> before stimulation with 100 mM Bz-ATP perfused via a microdialysis probe. As seen in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, compound <b>11</b> reduced the levels of released IL-1β in a dose dependent fashion from 1 to 10 mg/kg. Although these in vivo pharmacology results were encouraging, when human PK predictions were conducted using two different approaches, single species allometry from rat and an in vitro/in vivo clearance extrapolation, both approaches predicted a relatively high human clearance of 13–15 mL min<sup>–1</sup> kg<sup>–1</sup> and a short half-life of approximately 3 h. In addition, compound <b>11</b> was found to be a moderately potent inhibitor of several cytochrome P450s, as detailed on <a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>. Allometric scaling predicted that a 300 mg b.i.d. dosing regimen would be needed in order to maintain >50% P2X7 occupancy in human and that this dosing schedule would result in a <i>C</i><sub>max</sub> of nearly 600 ng/mL. Given that robust and sustained target engagement in human is possibly required for efficacy, the short predicted human half-life and CYP profile made <b>11</b> a less attractive development candidate, and thus compounds with improved metabolic stability were profiled.</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Ex vivo P2X7 occupancy for compound <b>11</b> in rat brain: concentration–response after sc administration (data collected 60 min postdose (<i>n</i> = 3)). (B) Inhibition of IL-1β release in rat hippocampus. LLOQ = lower limit of quantitation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Select in Vitro Data for Compounds <b>10</b>–<b>14</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="6" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">CYP-1A2</th><th class="colsep0 rowsep0" align="center">CYP-2C19</th><th class="colsep0 rowsep0" align="center">CYP-2C8</th><th class="colsep0 rowsep0" align="center">CYP-2C9</th><th class="colsep0 rowsep0" align="center">CYP-2D6</th><th class="colsep0 rowsep0" align="center">CYP-3A4</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">4.3</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">9.6</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Preliminary (tier 1) data.</p></div></div></div><div class="NLM_p">The next compound characterized in vivo was compound <b>12</b>. Compound <b>12</b> incorporates a pyrimidine in place of the pyrazine in <b>11</b>, and this change resulted in an improved CYP inhibition profile, improved solubility (data shown in <a class="ref internalNav" href="#tbl3" aria-label="Tables 3">Tables 3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) with a similar selectivity profile when compared to <b>11</b> (using the same Eurofins-Cerep and kinase panels as was used for <b>10</b>). In the ex vivo target engagement assay compound <b>12</b> also dose dependently occupied the P2X7 ion channel with an ED<sub>50</sub> of 0.9 mg/kg (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Ex vivo P2X7 occupancy for compound <b>12</b> in rat brain: concentration–response after po administration. Data were collected 60 min postdose (<i>n</i> = 6).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The plasma concentration required for an EC<sub>50</sub> in this experiment was 27 ng/mL, and the brain/plasma drug ratio was found to be ∼0.8. Considering the favorable target engagement data, the pharmacokinetic properties of the compound were also assessed in rat, dog, mouse, and non-human primate. Key data are shown in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rat and Dog Pharmacokinetic Parameters for Compound <b>12</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">11.0</td><td class="colsep0 rowsep0" align="left">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse<a class="ref internalNav" href="#t6fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NHP<a class="ref internalNav" href="#t6fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>a</sup><p class="last">Clearance.</p></div><div class="footnote" id="t6fn2"><sup>b</sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t6fn3"><sup>c</sup><p class="last">iv half-life.</p></div><div class="footnote" id="t6fn4"><sup>d</sup><p class="last">Dosed at 1 mg/kg iv and 5 mg/kg po.</p></div><div class="footnote" id="t6fn5"><sup>e</sup><p class="last">Dosed at 0.5 mg/kg iv and 2.5 mg/kg po.</p></div></div></div><div class="NLM_p">The PK parameters contained in <a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a> were generally in agreement with the microsomal stability data generated earlier (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). However, the in vivo rat clearance was much higher than the clearance predicted by rat microsomes. Additional characterization of the metabolic fate of <b>12</b> in rat revealed that the compound was highly metabolized with only 0.4% <b>12</b> excreted unchanged. The major circulating metabolite, characterized by mass spectrometry, was consistent with the formation of (<i>R</i>)-(2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone resulting from loss of the pyrimidine ring. Given that this metabolic route of metabolism was more prevalent in rat than in other species, compound <b>12</b> was profiled further. By use of allometry and after correction for differences in P2X7 affinity in human vs rat (human p<i>K</i><sub>i</sub> = 7.89 and rat p<i>K</i><sub>i</sub> = 8.66) and small differences in protein binding, the estimated human dose required to maintain a trough concentration above the predicted human EC<sub>50</sub> of 80 ng/mL was 100 mg q.d.</div><div class="NLM_p">When incubated in recombinant human CYP enzymes assays, both 2C19 and 2C9 were found to be capable of metabolizing compound <b>12</b>, and follow-up chemical inhibition studies in human liver microsomes suggested that CYP2C19 was the major enzyme responsible for the metabolism of <b>12</b>, which would be anticipated to increase variability in human exposure given the known polymorphisms in CYP2C19 activity.</div><div class="NLM_p">The safety profile of compound <b>12</b> was then assessed in rats. In a rat single ascending dose toleration study <b>12</b> had only minor observations (slightly decreased activity) at 250 mg/kg, which corresponded to a plasma concentration of 175 μM. At higher doses (500 mg/kg and 1000 mg/kg) toxicological findings including decreased activity and ataxia were noted. In a rat 4-day repeated dose study (doses and exposures shown in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>) there was an increased incidence and severity of hepatic lipidosis at all doses, and this was associated with increased liver weights as well as signs of autoinduction at the 50 and 150 mg/kg doses. The hepatic lipidosis, which was observed at all doses, was the primary reason that compound <b>12</b> was not recommended for additional early development enabling studies.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plasma exposures in the rat multiple ascending dose study for compound <b>12</b> (administered po).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Given the metabolism challenges with compounds <b>11</b> and <b>12</b> and the possibly related hepatotoxicity, one approach that was taken to reduce the hepatic lipidosis was to modify the heteroaromatic substituent on the triazole in order to redirect or reduce metabolism via a presumed dearylation sequence. As such, among many others, compounds <b>13</b> and <b>14</b> were prepared and characterized. The hypothesis was the 4-methylpyrimidine present in <b>13</b> might change the metabolic fate of this compound toward oxidation of the methyl group and that the 5-fluoropyrimidine present in <b>14</b> would be less susceptible to oxidation as compared to the corresponding unsubstituted pyrimidine present in <b>12</b>.</div><div class="NLM_p">In keeping with our hypothesis, compounds <b>13</b> and <b>14</b> were generally more stable in liver microsomes than the previous compounds (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). The major metabolite observed with <b>13</b> was oxidation of the methyl group on the pyrimidine, and the 5-fluoropyimidine <b>14</b> was remarkably stable in both microsomes and hepatocytes. PK data for compound <b>13</b> in rat and dog are shown on <a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Rat and Dog Pharmacokinetic Parameters for Compound <b>13</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog<a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">86</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Clearance.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">iv half-life.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Dosed at 1 mg/kg iv and 5 mg/kg po.</p></div><div class="footnote" id="t7fn5"><sup>e</sup><p class="last">Dosed at 0.5 mg/kg iv and 2.5 mg/kg po.</p></div></div></div><div class="NLM_p">Compound <b>13</b> had high clearance in rat and a very poor bioavailability; however the dog PK was predicted by microsomal turnover and the human PK for this compound was expected to be suitable, and thus a target engagement experiment was completed for <b>13</b>. In an ex vivo P2X7 occupancy assay in rat <b>13</b> effectively occupied the channel with an ED<sub>50</sub> of 8.3 mg/kg, which is significantly higher than that measured with compounds <b>11</b> and <b>12</b>, likely due to the poor rat PK.</div><div class="NLM_p">The plasma EC<sub>50</sub> measured in this experiment for <b>13</b> was 51 ng/mL, which is consistent with the values measured for previous compounds. These data allowed for a human PK prediction, and preliminary estimates indicated that <b>13</b> would have a human half-life of around 3 h and 100 mg b.i.d. would be required for sustained P2X7 occupancy. Compound <b>13</b> was tested in a 4-day repeated dose toleration study at doses of 50, 125, and 500 mg kg<sup>–1</sup> day<sup>–1</sup> in rats. Autoinduction, associated with increased liver weight, was observed in that study. Given the relatively high predicted human dose needed for target engagement, the preliminary data indicating that <b>13</b> was also metabolized by the polymorphic 2C19 CYP, and the favorable data that were being generated for compound <b>14</b>, the progression of compound <b>13</b> was halted at this time.</div><div class="NLM_p">In vitro characterization of compound <b>14</b> is detailed in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. The compound is potent, stable in liver microsomes and has an acceptable protein binding profile. Compound <b>14</b> was also screened in a commercial panel of 50 ion channels, receptors, and transporters (Eurofins-CEREP, <a href="http://www.eurofins.com/" class="extLink">http://www.eurofins.com/</a>) (tested at 10 μM), a kinase panel (tested at 1 μM), and a panel of related P2X receptors (P2X1, P2X2, P2X3, P2X2/3, and P2X4 FLIPR assays, tested up to 10 μM), and no significant activity was detected. The compound is highly permeable and has no evidence of efflux as measured by a Caco-2 cell line (A to B <i>P</i><sub>app</sub> = 75.3 × 10<sup>–6</sup> cm<sup>–1</sup>/s, B to A <i>P</i><sub>app</sub> = 48.8 × 10<sup>–6</sup> cm<sup>–1</sup>/s). Compound <b>14</b> efficiently binds to recombinant rat and human P2X7 and to native tissues in both human and rat (human peripheral blood monocytes, human whole blood, and rat cortex) as shown on <a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>. The compound also inhibited P2X7 activity in human, rat, dog, mouse, and macaque Ca<sup>2+</sup> flux assays and inhibited IL1-β release in human peripheral blood monocytes (pIC<sub>50</sub> of 7.7 ± 0.1) and in human whole blood (pIC<sub>50</sub> of 8.1 ± 0.1).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Additional in Vitro Data for Compound <b>14</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">P2X7 FLIPR<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">P2X7 binding<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">blood<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">cortex</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">8.46 ± 0.36<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">8.3 ± 0.05</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">8.0 ± 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">8.81 ± 0.24<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">8.3 ± 0.1</td><td class="colsep0 rowsep0" align="left">8.1 ± 0.2</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">7.8 ± 0.1</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">7.5 ± 0.2</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="left">7.9 ± 0.1</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">6.8 ± 0.06</td><td class="colsep0 rowsep0" align="left">nt</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">macaque</td><td class="colsep0 rowsep0" align="left">8.1 ± 0.1</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td><td class="colsep0 rowsep0" align="left">nt</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">pIC<sub>50</sub>.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">p<i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Data from <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></div></div></div><div class="NLM_p">Target engagement in rat was also demonstrated for compound <b>14</b> utilizing ex vivo autoradiography as was done with previous compounds. Compound <b>14</b> showed dose-dependent occupancy in this experiment as shown on <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>. The measured ED<sub>50</sub> was 0.46 mg/kg, which corresponded to a plasma EC<sub>50</sub> of 105 ng/mL.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Ex vivo P2X7 occupancy for compound <b>14</b> in rat: concentration–response after po administration (<i>n</i> = 3) and time course for occupancy after a 10 mg/kg po dose in rat (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This compound has a brain/plasma ratio of approximately 1.1 in rat. As is also shown in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>, compound <b>14</b> has robust and sustained P2X7 occupancy in the rat following a 10 mg/kg po dose (>80% occupancy for 24 h). Given the excellent target engagement data for compound <b>14</b>, the low metabolic turnover in liver microsomes (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>), and the lack of CYP inhibition (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>), the compound was extensively characterized in vivo. Details of the PK in rat, dog, and NHP are shown in <a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Rat and Dog Pharmacokinetic Parameters for Compound <b>14</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">CL (mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)<a class="ref internalNav" href="#t9fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t9fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat<a class="ref internalNav" href="#t9fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2.9</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">8.6</td><td class="colsep0 rowsep0" align="left">96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog<a class="ref internalNav" href="#t9fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">164</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">NHP<a class="ref internalNav" href="#t9fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">6.9</td><td class="colsep0 rowsep0" align="left">157</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup>a</sup><p class="last">Clearance.</p></div><div class="footnote" id="t9fn2"><sup>b</sup><p class="last">Volume of distribution at steady state.</p></div><div class="footnote" id="t9fn3"><sup>c</sup><p class="last">iv half-life.</p></div><div class="footnote" id="t9fn4"><sup>d</sup><p class="last">Dosed at 1 mg/kg iv and 5 mg/kg po.</p></div><div class="footnote" id="t9fn5"><sup>e</sup><p class="last">Dosed at 0.5 mg/kg iv and 2.5 mg/kg po.</p></div></div></div><div class="NLM_p">As predicted by liver microsomes, compound <b>14</b> has very low clearance in all species and high bioavailability. By use of these data, three species allometry allowed for a prediction of the human pharmacokinetic parameters for <b>14</b>.</div><div class="NLM_p">This analysis predicted very low clearance in human (0.6 mL/kg) and a moderate <i>V</i><sub>ss</sub> of 1.4 L/kg. By use of these parameters, the human half-life was predicted to be 29 h and the dose required to maintain >50% occupancy over 24 h was estimated to be 8 mg q.d. with the assumption of 100% bioavailability. The robust rat target engagement data and human dose prediction for <b>14</b> prompted a decision to progress <b>14</b> into more extensive preclinical characterization.</div><div class="NLM_p">In rat and human brain sections, <b>14</b> concentration dependently blocked the binding of [<sup>3</sup>H]-(6<i>S</i>)-7-[[2-chloro-3-(trifluoromethyl)phenyl]methyl]-6-methyl-3-pyrimidin-2-yl-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin-8-one (<b>15</b>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> as shown in <a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>. Compound <b>14</b> also dose dependently inhibited the release of IL-1β in rat hippocampus after oral administration as shown in <a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Attempts to correlate P2X7 occupancy or inhibition of IL-1β release in rat brain with inhibition of IL-1β release in rat blood failed due to the fact that rat blood does not release measurable IL-β after stimulation with Bz-ATP.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Specific binding of <b>14</b> to P2X7 receptors in rat and human brain sections: FCx = frontal cortex; SFG = superior frontal gyrus; <i>n</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of IL-1β release in rat hippocampus after oral administration of compound <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As such, in order to establish a relationship between P2X7 occupancy in brain and IL-1β release in blood, dogs were dosed orally with <b>14</b> and blood and brain samples were taken at various time points. Drug levels in blood and brain were measured, the inhibition of ex vivo release was measured in blood, and the level of P2X7 occupancy was measured ex vivo in brain.</div><div class="NLM_p">The data are shown on <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>. In this experiment a rather high dose of <b>14</b> (3 mg/kg) was selected in order to achieve a high level of occupancy. Given the long dog half-life of <b>14</b>, the time points chosen for analysis were 4 h, 24 h, 96 h,and 168 h postdose. In this preliminary experiment robust inhibition of IL-1β release in blood was observed at the 4 h, 24 h, and 96 h time points, and this correlated well with drug levels measured in blood and the potency of <b>14</b> in dog blood in an in vitro assay (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>).</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0010.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Central and peripheral target engagement study for <b>14</b> in dog (3 mg/kg po). Blood was used to determine IL-1β release by ex vivo stimulation of LPS and Bz-ATP. Brains were collected, and level of P2X7 receptor occupancy was measured by ex vivo receptor occupancy. Plasma and brain samples were also used to determine exposure of <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By the 168 h time point drug levels were reduced to 500 nM or less which is consistent with the pharmacology of <b>14</b> in dog. In addition, P2X7 brain occupancy of compound <b>14</b> was assessed by ex vivo autoradiography. As shown in <a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>, full P2X7 brain occupancy was observed for 96 h postdose with brain exposures of >1 μM, again consistent with the pharmacology of the compound. Similar to the blood IL-1β data, drug levels started to fall at 168 h in the brain as well, with concomitant drop in occupancy. Although more experiments are needed (for example, a dose response) to definitively establish a stronger correlation between IL-1β release in blood and P2X7 target engagement in the CNS, this preliminary experiment indicates that a human whole blood IL-1β assay might be a useful proxy for predicting CNS P2X7 target engagement in the clinic.</div><div class="NLM_p">Toleration studies in rat and dog were also completed for <b>14</b>. In rat, the compound was evaluated in a 4-day study at doses of 62.5, 125, and 250 mg/kg. No significant clinical observations were noted in this study, and exposures were high at all doses. The exposure data are shown in <a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>. In a dog 5-day toleration study at doses of 30, 100, and 300 mg/kg, exposures were also high and no relevant changes in serum chemistry, necropsy, or histopathology were observed.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0011.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plasma concentrations of <b>14</b> in a rat toleration study on day 1 and day 4 (oral administration, <i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Given that <b>14</b> had excellent PK in multiple species, a very low predicted human efficacious dose, and an excellent preclinical safety profile, the compound was nominated for clinical development and has since been dosed in healthy volunteers at single doses from 0.5 mg to 600 mg. All doses were well tolerated. The details of clinical studies with <b>14</b> will be published in due course.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The medicinal chemistry synthesis used to prepared the 4-(<i>R</i>)-methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines is shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. A Pd catalyzed reaction of 4-chloro-3-nitropyridine with an aniline<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> formed the aminopyridines <b>16</b>, and subsequent Pd catalyzed hydrogenation provided the diamines <b>17</b> which were then treated with <i>tert</i>-butyl nitrite to give the triazolopyridines <b>18</b>. Reaction with 2-chloro-3-(trifluoromethyl)benzoyl chloride presumably formed the acylpyridinium species which when treated in situ with methylmagnesium bromide formed the (2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-aryl-1,4-dihydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanones <b>19</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0013.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-(<i>R</i>)-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines <b>10</b>–<b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, BINAP, K<sub>2</sub>CO<sub>3</sub>, toluene, reflux, 38–90%; (b) H<sub>2</sub>, Pd/C, EtOH, rt, 80–99%; (c) <i>t</i>-BuONO, HOAc, THF, rt, 70–90%; (d) 2-chloro-3-(trifluoromethyl)benzoyl chloride, THF, rt, then methylmagnesium bromide, THF, −45 to −10 °C; (e) catalyst, H<sub>2</sub> or ammonium formate, MeOH or HOAc; (f) SFC; (g) methyl magnesium bromide, THF, 0–23 °C, then THF/H<sub>2</sub>O/HOAc, DDQ, 0–23 °C, 81%; (h) Pd(OAc)<sub>2</sub>, DINAP, 2-amino-4-fluoropyridine, K<sub>2</sub>CO<sub>3</sub>, toluene, 110 °C, 38%; (i) 10% Pd/C, H<sub>2</sub>, EtOH, HOAc, 88%; (j) 10% Pt/C, HOAc, H-Cube, 60 bar, 60 °C, 51%; (k) 2-chloro-3-(trifluoromethyl)benzoic acid, HATU, Et<sub>3</sub>N, DMF, 23 °C, 90%.</p></p></figure><div class="NLM_p">Reduction to obtain the 4-methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines <b>20</b> was accomplished via transfer hydrogenation using ammonium formate and Pd catalysis or using Pd/C and H<sub>2</sub> gas. In this reaction varying amounts of the dechlorinated products <b>21</b> were also generated. The racemic mixtures <b>20</b> were then purified by chiral SFC to provide the desired 4-(<i>R</i>)-methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines <b>10</b>–<b>12</b>. The synthesis of compound <b>13</b> was completed via the addition of methylmagnesium bromide to compound <b>12</b> and oxidation with DDQ to form the methyl pyrimidine <b>13</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Compound <b>14</b> was prepared from 4-chloro-2-methyl-3-nitropyridine <b>23</b> in a very similar sequence.</div><div class="NLM_p">X-ray crystallography was used to determine the absolute configuration of compound <b>14</b> using anomalous dispersion as shown on <a class="ref internalNav" href="#fig9" aria-label="Figure 9">Figure 9</a> and confirms the (<i>R</i>)-configuration.</div><figure id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0012.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Ball and stick diagram depicting the X-ray crystal structure of <b>14</b>. The asymmetric unit contains one fully ordered molecule of <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82246" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82246" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Optimization of the pharmacokinetic properties of several lead series of P2X7 antagonists led to the identification of the 4-(<i>R</i>)-methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines, which are potent and selective, brain penetrant, and CNS active P2X7 antagonists. The first few compounds in this series had some challenges, including PK challenges that resulted in high dose predictions in human. These compounds also had issues in toleration studies that halted their progression. Several approaches were adopted in order to reduce metabolism and therefore lower the predicted dose in human, and this work ultimately resulted in the identification of compound <b>14</b> (JNJ-54175446) as a potential clinical candidate for the treatment of mood disorders. Compound <b>14</b> entered the early development portfolio and has been dosed in healthy volunteers and was well tolerated.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Methods</h4><div class="NLM_p">The following experimental and analytical protocols were followed unless otherwise indicated. Anhydrous solvents were obtained from a GlassContour solvent dispensing system. Unless otherwise stated, reaction mixtures were magnetically stirred at room temperature (rt) under a nitrogen atmosphere. Where solutions were “dried”, they were dried over a drying agent such as Na<sub>2</sub>SO<sub>4</sub> or MgSO<sub>4</sub>. Where mixtures, solutions, and extracts were “concentrated”, they were typically concentrated on a rotary evaporator under reduced pressure. Reactions under microwave irradiation conditions were carried out in a Biotage Initiator or CEM Discover instrument. Normal-phase silica gel column chromatography (sgc) was performed on silica gel (SiO<sub>2</sub>) using prepackaged cartridges, eluting with 2 M NH<sub>3</sub>/MeOH in CH<sub>2</sub>Cl<sub>2</sub> or EtOAc in hexanes unless otherwise indicated. Preparative reverse-phase high performance liquid chromatography (HPLC) was performed on a Agilent HPLC with an XBridge Prep C18 OBD (5 μm, 30 mm × 100 mm or 50 mm × 100 mm) column, with a gradient of 10–99% acetonitrile/water (20 mM NH<sub>4</sub>OH) over 12–18 min, and with a flow rate of 30 mL/min or 80 mL/min. Occasionally preparative reverse-phase high performance liquid chromatography (HPLC) is referred to as basic HPLC in the text. Preparative reverse-phase high performance liquid chromatography under acidic conditions (acidic HPLC) was performed using a Gilson HPLC with an Inertsil ODS-3 C18, 3 μm, 30 mm × 100 mm column at 45 °C, an acetonitrile/water with 0.05% TFA gradient over 7 min, and a flow rate of 80 mL/min. Mass spectra (MS) were obtained on an Agilent series 1100 MSD using electrospray ionization (ESI) in positive mode unless otherwise indicated. High resolution mass spectrometry data were obtained with a Bruker μTOf detector in positive mode, a Zorbax SB-C18 3.5 μm, 2.1 mm × 50 mm column at 40 °C, an acetonitrile/water with 0.05% formic acid gradient over 7 min, and a flow rate of 0.3 mL/min. All final compounds were determined to be >95% pure using this method. Calculated (calcd) mass corresponds to the exact mass. Nuclear magnetic resonance (NMR) spectra were obtained on Bruker model DRX spectrometers. The format of the <sup>1</sup>H NMR data below is chemical shift in ppm downfield of the tetramethylsilane reference (multiplicity, coupling constant <i>J</i> in Hz, integration). Chemical names were generated using ChemDraw Ultra 6.0.2 (CambridgeSoft Corp., Cambridge, MA) or ACD/Name version 9 (Advanced Chemistry Development, Toronto, Ontario, Canada). Reagents were purchased from commercial suppliers and were used without purification unless otherwise noted.</div><div class="NLM_p last">The following procedures were used to prepare compounds <b>10</b>–<b>14</b>. The compounds related to generic structure <b>17</b> were prepared as described previously.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div></div><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>R</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(4-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (<b>10</b>)</h4><div class="NLM_p">Step 1. A suspension of 1-(4-fluoropyridin-2-yl)-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine (200 mg, 0.93 mmol) in THF (5 mL) was treated with 2-chloro-3-(trifluoromethyl)benzoyl chloride (248 mg, 1.02 mmol), and the reaction was stirred for 10 min. The reaction was then cooled to 0 °C, and methylmagnesium bromide (0.34 mL, 1.0 M in THF) was added dropwise. The reaction mixture was then allowed to warm to 23 °C and stirred overnight. The reaction mixture was quenched with NaHCO<sub>3</sub> and extracted with EtOAc. The organic extracts were separated, dried (Na<sub>2</sub>SO<sub>4</sub>), the solvent concentrated in vacuo. The crude product was purified by chromatography (silica, EtOAc in heptane 50:50 to 70:30), the desired fractions were collected, and the solvent was evaporated to give a solid that was washed with diethyl ether/DIPE to give 2-chloro-3-(trifluoromethyl)phenyl-(1-(5-fluoropyridin-2-yl)-4-methyl-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone as a white solid (130 mg, 32%). 96.3% pure by LCMS.</div><div class="NLM_p">Step 2. 2-Chloro-3-(trifluoromethyl)phenyl-(1-(4-fluoropyridin-2-yl)-4-methyl-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (200 mg, 0.46 mmol) dissolved in acetic acid (10 mL) was subjected to a hydrogen atmosphere on a Thales Nano hydrogenation apparatus using Rh/C as the solid support at 80 psi at 80 °C and at a flow rate of 1 mL/min. The solvent was then evaporated, and the remaining materials were diluted with DCM and washed with saturated Na<sub>2</sub>CO<sub>3</sub>. The organic phase was separated, dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvent was evaporated in vacuo. The crude product was purified by chromatography (silica, EtOAc in heptane from 40:60 to 70:30), the desired fractions were collected, and the solvent was evaporated to give (2-chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (racemic <b>10</b>) as a white foam. 99.3% pure by LCMS.</div><div class="NLM_p last">Step 3. The racemic material obtained in step 2 was purified by chiral SFC using a Chiralcel OD-H 5 μm, 250 mm × 20 mm column and a mobile phase of 80% CO<sub>2</sub> and 20% EtOH containing 0.3% <i>i</i>-PrNH<sub>2</sub> to obtain compound <b>10</b>. Purity was confirmed by analytical SFC using a CHIRALCEL OD-H (250 mm × 4.6 mm) and a mobile phase of 80% CO<sub>2</sub>, 20% EtOH containing 0.3% <i>i</i>-PrNH<sub>2</sub> over 7 min (100% single enantiomer, 3.43 min retention time). MS (ESI): mass calculated for C<sub>19</sub>H<sub>14</sub>ClF<sub>4</sub>N<sub>5</sub>O, 439.1; <i>m</i>/<i>z</i> found, 439.9 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>), mixture of four rotamers 35:25:25:15, δ ppm 1.49 (d, <i>J</i> = 6.7 Hz, 0.75 H), 1.57 (d, <i>J</i> = 6.7 Hz, 0.45 H), 1.69 (d, <i>J</i> = 6.9 Hz, 0.75 H), 1.71 (d, <i>J</i> = 6.7 Hz, 1.05 H), 2.96–3.68 (m, 3.6 H), 4.76 (q, <i>J</i> = 6.9 Hz, 0.25 H), 4.87 (q, <i>J</i> = 6.7 Hz, 0.15 H), 5.09–5.17 (m, 0.4 H), 6.06 (q, <i>J</i> = 6.7 Hz, 0.35 H), 6.08 (q, <i>J</i> = 6.9 Hz, 0.25 H), 7.04–7.14 (m, 1 H), 7.28–7.32 (m, 0.15 H), 7.41 (t, <i>J</i> = 7.5 Hz, 0.15 H), 7.45–7.58 (m, 1.7 H), 7.75–7.81 (m, 1 H), 7.88–7.97 (m, 1 H), 8.40 (dd, <i>J</i> = 8.1, 5.5 Hz, 0.35 H), 8.43 (dd, <i>J</i> = 8.1, 5.5 Hz, 0.25 H), 8.47–8.52 (m, 0.4 H). HRMS calcd for C<sub>19</sub>H<sub>14</sub>ClF<sub>4</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 440.0896, observed 440.0886. [α]<sub>D</sub> −23.2 (<i>c</i> 0.56, DMF).</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (<i>R</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrazin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (<b>11</b>)</h4><div class="NLM_p">Step 1. A suspension of 1-pyrazin-2-yl-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine (100 mg, 0.5 mmol) in THF (2.5 mL) was treated with 2-chloro-3-(trifluoromethyl)benzoyl chloride (135 mg, 0.56 mmol), and the reaction was stirred for 10 min at 23 °C. The reaction was cooled to −50 °C and treated with methylmagnesium bromide (3.0 M solution in Et<sub>2</sub>O, 0.18 mL, 0.56 mmol) and then slowly warmed to 23 °C over 30 min. Saturated NaHCO<sub>3</sub> solution was added to the reaction mixture, which was then extracted with EtOAc and purified on 16 g SiO<sub>2</sub> with 0–50% ethyl acetate/hexanes to provide 174 mg (82%) of (2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrazin-2-yl)-1,4-dihydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone. MS (ESI): mass calcd for C<sub>18</sub>H<sub>12</sub>ClF<sub>3</sub>N<sub>6</sub>O, 420.1; <i>m</i>/<i>z</i> found, 421.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.64–9.45 (t, <i>J</i> = 1.8 Hz, 1H), 8.75–8.58 (d, <i>J</i> = 2.6 Hz, 1H), 8.51–8.38 (ddd, <i>J</i> = 6.8, 2.6, 1.5 Hz, 1H), 7.95–7.78 (dt, <i>J</i> = 4.5, 1.8 Hz, 1H), 7.70–7.38 (m, 2H), 6.69–6.54 (m, 1H), 6.44–6.22 (m, 2H), 1.70–1.50 (m, 4H).</div><div class="NLM_p">Step 2. A suspension of (2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrazin-2-yl)-1,4-dihydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (150 mg, 0.36 mmol) in MeOH (3.0 mL) and THF (1.0 mL) was treated with 10% Pd/C (30 mg), subjected to an atmosphere of H<sub>2</sub>, and stirred overnight. The reaction was filtered through Celite and purified on 12 g SiO<sub>2</sub> with 0–70% EtOAc/DCM to give (2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrazin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (racemic<b>11</b>). MS (ESI): mass calcd for C<sub>18</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>6</sub>O, 422.1; <i>m</i>/<i>z</i> found, 423.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 2 (Alternative Procedure). To a suspension of (2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrazin-2-yl)-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5(4<i>H</i>)-yl)methanone (3 g, 7.13 mmol) in MeOH (140 mL) was added ammonium formate (2 g, 31.718 mmol) and Johnson Mathey 5% Pd/Al<sub>2</sub>O<sub>3</sub> (0.5 g, 4.7 mmol). The reaction mixture was heated to reflux for 45 min. The reaction was cooled to room temperature and then filtered through a pad of Celite. The filtrate was concentrated to a solid that contained a mixture of <b>11</b> and (4-methyl-1-(pyrazin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)(3-(trifluoromethyl)phenyl)methanone which was then purified by silica gel chromatography (3 times) using 4/1 EtOAc/hexane to obtain (2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrazin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (racemic <b>11</b>) (2.1 g, 70%).</div><div class="NLM_p last">Step 3. The racemic material obtained in step 2 was purified by chiral SFC using a CHIRALPAK AD-H 5 μm, 250 mm × 20 mm column and a mobile phase of 75% CO<sub>2</sub>, 25% EtOH to obtain compound <b>11</b>. The enantiomeric purity was confirmed by analytical SFC using a CHIRALPAK AD-H (250 mm × 4.6 mm) and a mobile phase of 70% CO<sub>2</sub>, 30% EtOH containing 0.3% <i>i</i>-PrNH<sub>2</sub> over 7 min (100% single enantiomer, 2.57 min retention time). MS (ESI): mass calcd for C<sub>18</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>6</sub>O, 422.1; <i>m</i>/<i>z</i> found, 423.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.59–9.44 (m, 1H), 8.71–8.58 (m, 1H), 8.56–8.35 (m, 1H), 7.90–7.69 (m, 1H), 7.69–7.29 (m, 2H), 6.08 (dt, <i>J</i> = 13.2, 6.5 Hz, 0.6H), 5.14 (dd, <i>J</i> = 12.8, 5.7 Hz, 0.4H), 4.96–4.71 (m, 0.4H), 3.70–2.96 (m, 3.6H), 1.79–1.44 (m, 3H). HRMS calcd for C<sub>18</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 423.0942, observed 423.0957. [α]<sub>D</sub> −61.3 (<i>c</i> 0.31, MeOH).</div></div><div id="sec5_1_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (<i>R</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrimidin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (<b>12</b>)</h4><div class="NLM_p">Step 1. A suspension of 1-(pyrimidin-2-yl)-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine (120 g, 0.605 mol, 1 equiv), 2-chloro-3-(trifluoromethyl)benzoyl chloride (147.14 g, 0.605 mol, 1 equiv), and triisopropylsilyl trifluoromethanesulfonate (92.77 g, 0.303 mol, 0.5 equiv) in THF (1.8 L) was stirred for 5 h at room temperature to form a tan solid precipitate. The reaction mixture was chilled to −45 °C and then methylmagnesium bromide was slowly added dropwise over a period of 55 min maintaining internal temperature between −45 and −39 °C. The reaction was allowed to slowly warm up to −10 °C. After 1.5 h, the reaction was quenched with cold water (1 L) and DCM (500 mL) for 18 h. Any remaining insoluble solids were filtered off. The organic layer was extracted and the aqueous layer washed with DCM (2 × 500 mL). The combined organic layers were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to a crude oil. The product was precipitated out by stirring the crude in mixtures of TBME (900 mL) and hexane (50 mL) to recover solids after filtration. The procedure was repeated 2 more times to recover (2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrimidin-2-yl)-1,4-dihydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone as a white solid (103 g, 0.245 mol, 40% yield). A mixture of rotamers was observed by NMR. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.88–8.86 (m, 2H), 7.85–7.82 (m, 1H), 7.65–7.45 (m, 2H), 7.41–7.38 (t, 1H), 6.71–6.64 (dd, 1H), 6.39–6.26 (m, 2H), 1.64–1.60 (m, 3H). MS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>12</sub>ClF<sub>3</sub>N<sub>6</sub>O, 420.78; found, 421.0.</div><div class="NLM_p">Step 2. To a suspension of (2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrimidin-2-yl)-1,4-dihydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (126 g, 0.30 mol, 1.0 equiv) in DMF (1.7 L) were added ammonium formate (151.0 g, 2.4 mol, 8 equiv) and Johnson Mathey 5% Pd/Al<sub>2</sub>O<sub>3</sub> (13.6 g). The reaction was heated to 60 °C for 7 h and then filtered. The filtrate was concentrated to 1/3 volume and quenched with H<sub>2</sub>O (1 L). The mixture was stirred vigorously under ice bath for 18 h to form precipitation. The solids were filtered and dried to afford 113.2 g of <i>rac</i>-(2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrimidin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone as tan solid. An alternative route to <i>rac</i>-(2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrimidin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone and characterization of this compound have been published previously.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p last">Step 3. The racemic mixture obtained in step 2 was purified by chiral SFC (stationary phase, Chiraplpak AD 5 μm, 250 mm × 30 mm); mobile phase, 70% CO<sub>2</sub>, 30% mixture of MeOH/<i>i</i>-PrOH 50/50 v/v) to provide (<i>R</i>)-(2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrimidin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (49 g, 0.116 mol, 39%) as white solid. Chiral HPLC analysis: Chiral Pak AD-H column, 0.4 mL/min, 80% EtOH/20% hexane, <i>R</i> isomer 14.05 min, <i>S</i> isomer 10.60 min. MS-ESI (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>6</sub>O, 422.80; found, 423.10. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 8.80–8.43 (m, 2H), 7.82–7.44 (m, 1H), 7.27–7.15 (m, 2H), 6.66–6.60 (m, 1H), 5.95–4.92 (m, 1H), 3.77–2.54 (m, 3H), 1.74–1.53 (m, 3H). HRMS calcd for C<sub>18</sub>H<sub>14</sub>ClF<sub>3</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 423.0942, observed 423.0946. Elemental analysis: calculated C, 51.13; H, 3.34; N, 19.88; obtained C, 51.05; H, 3.47; N, 20.01. [α]<sub>D</sub> −148.8 (<i>c</i> 0.57, MeOH).</div></div><div id="sec5_1_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> (<i>R</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(4-methylpyrimidin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (<b>13</b>)</h4><div class="NLM_p last">Step 1. To a solution of (<i>R</i>)-(2-chloro-3-(trifluoromethyl)phenyl)(4-methyl-1-(pyrimidin-2-yl)-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (20.6 g, 48.7 mmol) in THF (244 mL) at 0 °C was added methylmagnesium bromide (3.0 M in Et<sub>2</sub>O, 33 mL, 97 mmol), and upon complete addition of methylmagnesium bromide the reaction mixture was warmed to room temperature and stirred for 30 min. Then, the reaction mixture was cooled to 0 °C, and a 20:1:1 solution of THF/H<sub>2</sub>O/AcOH (71 mL) was added and the resulting mixture stirred at 0 °C for 10 min. A solution of DDQ (11.6 g, 51.2 mmol) in THF (122 mL) was then added at 0 °C and the reaction mixture warmed to room temperature and stirred for 30 min. The mixture was diluted with EtOAc, washed with 1 M NaOH (3×) and brine (1×). The aqueous layer was extracted with EtOAc (2×). The combined organics were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give a brown foam, which was partially purified by silica gel chromatography (0–50% EtOAc/DCM) to give <b>13</b> (22 g), which was further purified by recrystallization from MTBE to give <b>13</b> as a white powder (17 g, 81%). MS (ESI) mass calcd C<sub>19</sub>H<sub>16</sub>ClF<sub>3</sub>N<sub>6</sub>O, 436.10; <i>m</i>/<i>z</i> found, 437.1 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, CDCl3) δ 8.71 (dd, J = 5.0, 2.5 Hz, 0.5H), 8.69–8.64 (m, 0.5H), 7.81–7.73 (m, 1H), 7.58–7.36 (m, 2H), 7.31–7.27 (m, 0.3H), 7.25–7.20 (m, 0.7H), 6.13–6.02 (m, 0.5H), 5.16–5.10 (m, 0.4H), 4.92–4.85 (m, 0.1H), 4.80–4.75 (m, 0.3H), 3.67–3.11 (m, 3.3H), 3.07–2.95 (m, 0.4H), 2.68–2.67 (m, 1.3H), 2.65 (s, 0.6H), 2.63 (s, 1H), 1.72 (d, <i>J</i> = 6.9 Hz, 0.9H), 1.70 (d, <i>J</i> = 7.0 Hz, 0.6H), 1.58 (d, <i>J</i> = 7.1 Hz, 0.5H), 1.50 (d, <i>J</i> = 6.7 Hz, 0.9H). HRMS calcd for C<sub>19</sub>H<sub>16</sub>ClF<sub>3</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 437.1099, observed 437.1089. Elemental analysis: calculated C, 52.24; H, 3.69; N, 19.24; obtained C, 51.94; H, 4.04; N, 19.20. [α]<sub>D</sub> −45.8 (<i>c</i> 0.545, MeOH).</div></div><div id="sec5_1_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>R</i>)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-4-methyl-1,4-dihydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (<b>14</b>)</h4><div class="NLM_p">Step 1. A solution of Pd(OAc)<sub>2</sub> (0.15 g, 0.68 mmol) and BINAP (0.42 g, 0.68 mmol) was stirred in toluene (2 mL) at rt for 10 min. This mixture was then added to a microwave vial which contained 4-chloro-2-methyl-3-nitropyridine (3.00 g, 16.8 mmol), 2-amino-4-fluoropyridine (2.20 g, 18.5 mmol), and K<sub>2</sub>CO<sub>3</sub> (2.6 g, 18.6 mmol) in toluene (10 mL). The reaction was irradiated in a microwave apparatus at 110 °C for 1 h. The reaction was then diluted with DCM, filtered through Celite, washed, and concentrated. Chromatography of the resulting residue (SiO<sub>2</sub>; EtOAc/Hex) gave 5-fluoro-<i>N</i>-(2-methyl-3-nitropyridin-4-yl)pyrimidin-2-amine (1.60 g, 38%). MS (ESI): mass calculated for C<sub>10</sub>H<sub>8</sub>ClFN<sub>5</sub>O<sub>2</sub>, 249.07; <i>m</i>/<i>z</i> found 250.0 [M + H]+.</div><div class="NLM_p">Step 2. To a solution of 5-fluoro-<i>N</i>-(2-methyl-3-nitropyridin-4-yl)pyrimidin-2-amine (4.0 g, 16.0 mmol) in degassed EtOH (100 mL) and AcOH (2 mL) was added 10% Pd/C (1.70 g, 1.61 mmol) in EtOH (10 mL). The reaction was placed under a balloon of hydrogen at atmospheric pressure and allowed to stir for 12 h. The reaction was filtered through Celite and washed with DCM. The organic solvent was concentrated to give <i>N</i>-(5-fluoropyrimidin-2-yl)-2-methylpyridine-3,4-diamine (3.10 g, 88%). MS (ESI): mass calculated for C<sub>10</sub>H<sub>10</sub>ClFN<sub>5</sub>, 219.09; <i>m</i>/<i>z</i> found 220.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 3. A solution of <i>N</i>-(5-fluoropyrimidin-2-yl)-2-methylpyridine-3,4-diamine (0.50 g, 2.28 mmol) in THF (15 mL) and HOAc (0.14 mL, 2.51 mmol) was treated with <i>tert</i>-butyl nitrite (0.45 mL, 3.42 mmol) and heated to 100 °C for 90 min. The reaction was concentrated, diluted with 1 N NaHCO<sub>3</sub>, and extracted with DCM (3 × 50 mL). The organic layers were combined, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Chromatography of the resulting residue (SiO<sub>2</sub>; EtOAc/Hex) provided 1-(5-fluoropyrimidin-2-yl)-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine (0.40 g, 77%). MS (ESI): mass calcd for C<sub>10</sub>H<sub>7</sub>FN<sub>6</sub>, 230.07; <i>m</i>/<i>z</i> found, 231.1 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 4. A solution of 1-(5-fluoropyrimidin-2-yl)-4-methyl-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridine (0.90 g, 3.91 mmol) in AcOH (50 mL) was passed through a 10% Pt/C catalyst cartridge on an H-Cube hydrogenation apparatus at a pressure of 60 bar, a temperature of 60 °C, and a flow rate of 1 mL/min. The reaction was subsequently concentrated, diluted with 1 N NaOH, and extracted with DCM (3 × 100 mL). The organic layers were combined, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Chromatography of the resulting residue (SiO<sub>2</sub>; MeOH (NH<sub>3</sub>)/DCM) gave 1-(5-fluoropyrimidin-2-yl)-4-methyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine (0.47 g, 51%). MS (ESI): mass calcd for C<sub>10</sub>H<sub>11</sub>FN<sub>6</sub>, 234.10; <i>m</i>/<i>z</i> found, 235.0 [M + H]<sup>+</sup>.</div><div class="NLM_p">Step 5. A solution of 1-(5-fluoropyrimidin-2-yl)-4-methyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridine (0.30 g, 1.28 mmol), 2-chloro-3-(trifluoromethyl)benzoic acid (0.34 g, 1.54 mmol), HATU (0.38 g, 1.28 mmol), and Et<sub>3</sub>N (0.18 mL, 1.28 mmol) in DMF (5 mL) was stirred for 30 min. The reaction was then diluted with EtOAc (30 mL) and washed with H<sub>2</sub>O (3 × 20 mL). The organic layers were combined, dried with Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Chromatography of the resulting residue (SiO<sub>2</sub>; MeOH (NH<sub>3</sub>)/DCM) gave (2-chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-4-methyl-1,4,6,7-tetrahydro-5<i>H</i>-[1,2,3]triazolo[4,5-<i>c</i>]pyridin-5-yl)methanone (racemic <b>14</b>). (0.51 g, 90%). MS (ESI): mass calculated for C<sub>18</sub>H<sub>13</sub>ClF<sub>4</sub>N<sub>6</sub>O, 440.08; <i>m</i>/<i>z</i> found, 441.0 [M + H]<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>), a mixture of rotamers was observed, δ 8.80–8.43 (m, 2H), 7.82–7.44 (m, 1H), 7.27–7.15 (m, 2H), 6.66–6.60 (m, 1H), 5.95–4.92 (m, 1H), 3.77–2.54 (m, 3H), 1.74–1.53 (m, 3H). HRMS calcd for C<sub>18</sub>H<sub>13</sub>ClF<sub>4</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 441.0848, observed 441.0862.</div><div class="NLM_p last">Step 6. Compound <b>14</b> was purified by chiral SFC on using a Chiracel OD-H 5 μm, 250 mm × 20 mm column and a mobile phase of 70% CO<sub>2</sub> and 30% EtOH. Compound <b>14</b> can also be prepared by the methods previously described.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Mp 197– 200 °C. Elemental analysis: calculated C, 49.04; H, 2.98; N, 19.05; obtained C, 48.93; H, 3.25; N, 19.02. [α]<sub>D</sub> −161.7 (<i>c</i> 0.42, MeOH).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> In Vitro Biology</h3><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Methods. P2X7 Antagonism in Human Peripheral Blood Mononuclear Cells (PBMCs) in Mouse and Human Whole Blood</h4><div class="NLM_p last">Human blood was collected using a blood donor program. PBMCs were isolated from blood using a Ficoll density gradient technique. Briefly, blood was laid on Ficoll solution and centrifuged at rt for 20 min at 2000 rpm. The buffy layer (between red blood cells and plasma) was carefully collected by aspiration, washed with PBS, and centrifuged again at 1500 rpm for 15 min. The resulting cell pellet was washed and plated on 96-well plates for experiments. For the whole blood experiments, 150 μL of either mouse or human blood was platted on 96-well plates. Lipopolysaccharide (LPS) (30 ng/mL) was added to each well and incubated for 1 h. Test compounds were then added and incubated for 30 min. The P2X7 agonist, 2′(3′)-0-(4-benzoylbenzoyl) adenosine 5′-triphosphate (Bz-ATP) was then added at a final concentration of 0.5 mM (PBMC) or 1 mM (blood). Cells were incubated for an additional 1.5 h. At that point, supernatant was collected and stored for IL-1β assay using the manufacturer’s protocol for enzyme linked immunosorbent assay (ELISA). Data were expressed as percent control, where control is defined as the difference in IL-1β release in LPS + Bz-ATP samples and LPS only samples. Data were plotted as response (% control) versus concentration to generate IC<sub>50</sub> values.</div></div><div id="sec5_2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> P2X7 Antagonism in Recombinant P2X7 Cells. Ca<sup>2+</sup> Flux</h4><div class="NLM_p last">1321Nl cells expressing the recombinant P2X7 channel were cultured in HyQ DME/(HyClone/Dulbecco’s modified Eagle medium) high glucose supplemented with 10% fetal bovine serum (FBS) and appropriate selection marker. Cells were seeded at a density of 25 000 cells/well (96-well clear bottom black walled plates) in 100 μL volume/well. On the day of the experiment, cell plates were washed with assay buffer, containing (in mM) 130 NaCl, 2 KCl, 1 CaCl<sub>2</sub>, 1 MgCl 2, 10 HEPES, 5 glucose; pH 7.40 and 300 mOs. After the wash, cells were loaded with the calcium-4 dye (Molecular Devices) and incubated in the dark for 60 min. Test compounds were prepared at 250× the test concentration in neat DMSO. Intermediate 96-well compound plates were prepared by transferring 1.2 μL of the compound into 300 μL of assay buffer. A further 3× dilution occurred when transferring 50 μL/well of the compound plate to 100 μL/well in the cell plate. Cells were incubated with test compounds and dye for 30 min. Calcium dye fluorescence was monitored in FLIPR as the cells were challenged by adding 50 μL/well of BzATP. The fluorescence change was measured 180 s after adding the agonist. Peak fluorescence was plotted as a function of test concentration to generate an IC<sub>50</sub> value.</div></div><div id="sec5_2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> P2X7 Radioligand Binding</h4><div class="NLM_p last">Recombinant P2X7 1321Nl cells were collected and frozen at −80 °C. On the day of the experiment, cell membrane preparations were made according to standard published methods. The total assay volume was 100 μL: 10 μL of compound (l0×) + (b) 40 μL of tracer (2.5×) + 50 μL of membrane (2×). The tracer used for the assay was [<sup>3</sup>H]-A-804598. The compound can be prepared as described in the literature (<contrib-group person-group-type="allauthors">Donnelly-Roberts, D.</contrib-group>;  <cite>Neuropharmacology</cite> <span class="NLM_year">2009</span>, <em>56</em> (1), 223−229, DOI: <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.06.012</pub-id>). Compounds, tracer, and membranes were incubated for 1 h at 4 °C. The assay was terminated by filtration (GFB filters presoaked with 0.3% PEI) and washed with washing buffer (Tris-HCl 50 mM). The IC<sub>50</sub> generated in the binding assay was corrected for tracer concentration and affinity of the tracer to derive at the affinity (<i>K</i>) of the test compounds.</div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> DMPK</h3><div id="sec5_3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Methods. Caco-2 Permeability</h4><div class="NLM_p last">Caco-2 bidirectional permeability assays were conducted at CEREP according to the company’s protocol. In brief, Caco-2 cells were seeded onto a 96-well Multiscreen plate (Millipore) at a cell density of 1 × 10<sup>5</sup> cells/cm<sup>2</sup> and cultured for at least 21 days before permeability studies were conducted. Test compounds were dissolved in DMSO and added to HBSS-HEPES, pH 7.4 culture media at a final concentration of 10 μM (1% DMSO v/v). The working solution was applied to cells on the donor side and incubated at 37 °C with gentle agitation for 60 and 40 min to determine the A → B and B → A permeability, respectively. Samples were extracted from the donor side at time zero and the end-point and from the receiver side at the end-point time only. Samples were then processed for LC/MS/MS analyses to determine the apparent permeability coefficient (<i>P</i><sub>app</sub>) of the test compound in the A → B and B → A direction ( <cite>Expert Opin. Drug Metab. Toxicol.</cite> <span class="NLM_year">2005</span>, <em>1</em> (2), 175–185) as well as the percent recovery.</div></div><div id="sec5_3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Plasma Protein Binding</h4><div class="NLM_p last">Plasma protein binding was determined by equilibrium dialysis using the RED device (Thermo Scientific, Rockford, IL) consisting of a Teflon base block and RED device inserts comprising two (sample and buffer) side-by-side chambers separated by a dialysis membrane. Compounds were prepared as 100 μM DMSO stocks and spiked into 1 mL of mouse, rat, and human plasma (Bioreclamations) to make a final concentration of 1 μM. Plasma (300 μL) was dispensed into wells separated by an 8 kDa permeable cellulose membrane from wells containing 100 mM potassium phosphate, pH 7.4 (500 μL). Each compound was tested in triplicate. The RED devise was sealed, and equilibrium was permitted for 6 h in a 37 °C incubator with gentle agitation at 100 rpm. After incubation, plasma samples were prepared by transferring 10 μL from plasma wells to 90 μL of fresh 100 mM potassium phosphate, pH 7.4, and buffer samples were prepared by transferring 90 μL from buffer wells to 10 μL of naive plasma. In addition, a reference sample without equilibration was prepared in triplicate by mixing 10 μL of plasma containing 1 μM compound with 90 μL of buffer in order to determine compound recovery from the assay. Two volumes of 1:1 acetonitrile/methanol spiked with the internal standard phenytoin (0.2 μg/mL) were added to reference and samples. Precipitation of plasma protein binding was allowed for 15 min before reference and samples were centrifuge clarified. Supernatant (10 μL) was used for LC/MS/MS analyses.</div></div><div id="sec5_3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Brain Tissue Binding</h4><div class="NLM_p last">Brain tissue binding was assessed by equilibrium dialysis using the RED device similar to the procedure described for plasma protein binding. Rat brain tissue homogenate, prepared in PBS buffer, pH 7.4 (1:10, w/v), was spiked with compound DMSO stock solution to yield a final concentration of 5 μM. The dialysis was carried out in a shaking incubator at 37 °C for 5 h in triplicate. After incubation, 25 μL of homogenate or 50 μL of buffer was extracted with 50 μL of DMSO and 300 μL of acetonitrile and analyzed by LC/MS/MS using the calibration curves across an appropriate concentration range and quality control samples. The apparent unbound fraction (<i>f</i><sub>u,app</sub>) was derived from the formula:<span class="NLM_disp-formula" id="ueq1"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/jm-2017-00408q_m001.gif" alt="" /></img></span>where [A]<sub>homogenate</sub> and [A]<sub>buffer</sub> are the concentrations measured in the homogenate and buffer, respectively. The unbound fraction in undiluted brain (<i>f</i><sub>u,brain</sub>) was calculated from the formula<span class="NLM_disp-formula" id="ueq2"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/jm-2017-00408q_m002.gif" alt="" /></img></span>where <i>D</i> is the dilution factor of 10. Subsequently, the percentage compound bound to brain tissue (% BTB) was calculated from the formula<span class="NLM_disp-formula" id="ueq3"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/jm-2017-00408q_m003.gif" alt="" /></img></span></div></div><div id="sec5_3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Liver Microsomal Stability</h4><div class="NLM_p last">Microsomal stability studies were conducted on a Biomek FX robotic liquid handling workstation (Beckman Coulter, Brea, CA), which consists of a 96-channel pipet head, a 12-postion workstation deck, and a plate incubator. Test compounds (1 μM) were spiked in a reaction mix consisting of 100 mM potassium phosphate buffer (pH 7.4), 3 mM MgCl<sub>2</sub>, and 0.5 mg/mL liver microsomes from mouse, rat, dog, monkey, and human (BD Gentest). The reaction was brought to 37 °C and initiated by adding NADPH to a final concentration of 1 mM. After mixing on the plate deck, 50 μL aliquots were excised from the reaction plate at 0, 5, 10, 20, 40, and 60 min and quenched with four volumes of acetonitrile spiked with 500 μg/nL of the internal standard phenytoin. Quenched plates were centrifuged at 5700 rpm for 10 min at 4 °C, and supernatant was diluted 1:3 in water before LC/MS/MS analysis. The compound half-lives were derived from plots of the ln of percent remaining compound over time to determine the intrinsic clearance. The predicted hepatic clearance was derived from the intrinsic clearance value using equations from the well-stirred model ( <cite>Curr. Drug Metab.</cite> <span class="NLM_year">2008</span>, <em>9</em>, 940−951), where protein binding in plasma and microsomal proteins is assumed to be similar and the blood to plasma concentration ratio is assumed to be 1. The hepatic extraction ratio (ER) was calculated by dividing the predicted hepatic clearance by species blood flow (<i>Q</i>), where <i>Q</i> is 90, 55, 31, 44, and 21.7 mL min<sup>–1</sup> kg<sup>–1</sup> for mouse, rat dog, monkey, and human, respectively.</div></div><div id="sec5_3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Solubility in Aqueous Systems</h4><div class="NLM_p last">Solubility in 30 mM phosphate buffers (pH 2 and pH 7), simulated gastric (SGF, 0.2% NaCl in 0.1 N HCl, pH 1.2) and intestinal fluids (FasSIF, 0.029 M phosphate buffer, 5 mM sodium taurocholate, and 1.5 mM lecithin, pH 6.8) was investigated. Compound was dissolved in DMSO solutions at a concentration of 10 mM and was used for the solubility experiment. DMSO solutions (20 μL) are dispensed in 96-well plates, and the solvent is removed by evaporation using a Caliper TurboVap 96 set at 30 °C and a flow rate of 40 Fh. Buffers (400 μL) of interest are added to the residual solids, and the resulting mixtures are stirred at room temperature for 3 days using magnetic stir bars. The samples are then filtered using an AcroPrep 1 mL 96 filter plate, and the supernatant is analyzed for compound concentration, against external standards.</div></div><div id="sec5_3_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Cocktail CYP Inhibition Assay</h4><div class="NLM_p last">DMSO stocks were prepared for test compounds (10 mM) and for the assay positive controls: furafylline (CYP1A2, 8 mM), quercetin (CYP2C8, 12 mM), sulfaphenazole (CYP2C9, 2 mM), <i>N</i>-3-benzylphenobarbital (CYP2C19, 1.2 mM), quinidine (CYP2D6, 0.16 mM), and ketoconazole (CYP3A, 0.16 mM). In a solution of 1:1 acetonitrile/water, stocks were diluted 10-fold and serial diluted in 2-fold increments. For test compounds, the final incubation concentrations were 10, 5, 2.5, 1.25, 0.63, and 0.3 μM. To simultaneously measure the activity of multiple CYPs in the same incubation, a cocktail probe solution was prepared that contained six substrates at the following final concentrations: phenacetin (CYP1A2, 50 μM), paclitaxel (CYP2C8, 10 μM), diclofenac (CYP2C9, 4 μM), <i>S</i>-mephenytoin (CYP2C19, 30 μM), dextromethorphan (CYP2D6, 3 μM), and midazolam (CYP3A, 2 μM). Human liver microsomes (BD Gentest) from a mixed donor pool were prepared in 0.1 mM potassium phosphate buffer (pH 7.4) supplemented with 3 mM MgCl<sub>2</sub> and preincubated for 5 min at 37 °C. Human liver microsomes (0.1 mg of protein/mL) were then mixed with the cocktail probe solution, test compounds, or assay positive controls, and the reaction was initiated by the addition of NADPH (1 mM final concentration). The catalysis of probe substrates was permitted for 15 min at 37 °C and quenched in one volume of 1:1 acetonitrile/methanol mixture containing the internal standard phenytoin (0.2 μg/mL). Samples were vortexed for 2 min and centrifuged for 10 min. Supernatant (300 μL) was diluted in water (125 μL), mixed, and used for LC–MS/MS analysis. A 20 μL aliquot was analyzed for probe metabolite formation using a Shimadzu LC-20A HPLC system and a Sciex API 5000 (Applied Biosystems, Foster City, CA) mass spectrometer in the multiple reaction monitoring (MRM) scan mode with electrospray ionization (ESI). The mobile phase consisted of water (A) and acetonitrile (B) both containing 0.1% formic acid. The chromatography was performed on Phenomenex Kinetex XB-C18 (2.0 mm × 50 mm, 5.0 μm) column using a gradient elution method (2% B from 0.0 to 0.3 min, followed by a linear increase to 50% B over 2.7 min and subsequently 95% B for 0.1 min, and held at 95% B for an additional 0.0.9 min before returning back to 2% B) at a flow rate of 0.6 mL/min. The following transitions were monitored: <i>m</i>/<i>z</i> 152.1 → 110.0 (acetaminophen, CYP1A2), <i>m</i>/<i>z</i> 870.3 → 105.1 (6α-hydroxy-paclitaxel, CYP2C8), <i>m</i>/<i>z</i> 312.1 → 230.0 (4-hydroxy-diclofenac, CYP2C9), <i>m</i>/<i>z</i> 235.3 → 150.2 (4-hydroxy-<i>S</i>-mephenytoin, CYP2C19), <i>m</i>/<i>z</i> 258.2 → 157.1 (dextrorphan, CYP2D6), <i>m</i>/<i>z</i> 342.2 → 297.1 (1-hydroxy-midazolam, CYP3A), and <i>m</i>/<i>z</i> 253.1 → 182.2 for phenytoin (internal standard). Data were processed using Analyst software and included probe metabolite to internal standard peak area ratios electronically exported into Excel 2000 (Microsoft Corp., Seattle, WA) format.</div></div><div id="sec5_3_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> Pharmacokinetic Studies</h4><div class="NLM_p last">Single dose pharmacokinetic studies in preclinical species (male Balb/c mice, Sprague Dawley rats, beagle dogs, or cynomolgus monkeys) were conducted following iv (1 mg/kg) and po (5 mg/kg) administration as a solution in 20% hydroxypropyl-β- cyclodextrin (HP-β-CD). Blood was sampled at predose and at 0.033 (iv), 0.083 (iv), 0.25, 0.5, 1, 2, 4, 6, 8, and 24 h postdose. In dogs, instead of 6 and 8 h time points, blood was drawn at 7 h. Plasma concentrations were quantitated by LC–MS/MS using a Sciex API 4000 (Applied Biosystems, Foster City, CA) mass spectrometer interfaced with a Shimadzu LC-20 AD system. Pharmacokinetic parameters were derived from noncompartmental analysis of the plasma concentration vs time data using WinNonlin software (Pharsight, Palo Alto, CA).</div></div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Toleration Studies</h3><div id="sec5_4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> General Methods. 1- and 4-Day Repeat Dose Oral Toxicology Studies</h4><div class="NLM_p last">For the single dose study animals were administered test compound via oral gavage with necropsy performed on the next day. For the repeat dose toxicology group animals were administered oral doses (gavage) of test compound for 4 days, with necropsy performed on day 5. Clinical observations were recorded daily, and at necropsy, a list of tissues from control and treated groups were embedded in paraffin, processed into slides by sectioning at 4 μm, stained with hematoxylin and eosin, and examined microscopically. Organ weights of a number of organs were also determined. Clinical pathology parameters were also measured at the end of the dosing period.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00408">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86687" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86687" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00408" class="ext-link">10.1021/acs.jmedchem.7b00408</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Coordinates for the crystal structure of compound <b>14</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00408/suppl_file/jm7b00408_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00408/suppl_file/jm7b00408_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00408/suppl_file/jm7b00408_si_001.pdf">jm7b00408_si_001.pdf (107.91 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00408/suppl_file/jm7b00408_si_002.csv">jm7b00408_si_002.csv (0.88 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.7b00408" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael A. Letavic</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7503-0189" title="Orcid link">http://orcid.org/0000-0002-7503-0189</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#fe93929b8a9f88979dbe978a8dd0949094d09d9193"><span class="__cf_email__" data-cfemail="bad7d6dfcedbccd3d9fad3cec994d0d4d094d9d5d7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brad M. Savall</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brett D. Allison</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leah Aluisio</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jose Ignacio Andres</span> - <span class="hlFld-Affiliation affiliation">Janssen Research & Development, a
Division of Janssen-Cilag, Jarama 75, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Meri De Angelis</span> - <span class="hlFld-Affiliation affiliation">Janssen Research & Development, a
Division of Janssen-Cilag, Jarama 75, 45007 Toledo, Spain</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hong Ao</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Derek A. Beauchamp</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 1400 McKean Road, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pascal Bonaventure</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stewart Bryant</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 1400 McKean Road, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas I. Carruthers</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc Ceusters</span> - <span class="hlFld-Affiliation affiliation">Janssen Research & Development, Janssen
Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin J. Coe</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Curt A. Dvorak</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian C. Fraser</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine F. Gelin</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tatiana Koudriakova</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jimmy Liang</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Lord</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Timothy W. Lovenberg</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Monicah A. Otieno</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 1400 McKean Road, Spring House, Pennsylvania 19477, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Freddy Schoetens</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Devin M. Swanson</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Wang</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alan D. Wickenden</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anindya Bhattacharya</span> - <span class="hlFld-Affiliation affiliation">Janssen Research
& Development, LLC, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Anindya Bhattacharya, Michael A. Letavic, and Brad M. Savall contributed equally to this work. The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">The authors will release the atomic coordinates and experimental data for <b>14</b> upon article publication.</p></div></li></ul></div><div class="ack" id="ACK-d84e4063-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46038" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46038" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors gratefully acknowledge the following colleagues for their contributions to the discovery and characterization of the compounds disclosed in this manuscript: Heather Mcallister, Jiejun Wu, Sandrine Jolly, Laurence Queguiner, Sabastien Thomas, David Speybrouck, Judith Skaptason, Michael Hack, Kia Sepassi, Brian Scott, Joy Fuerst, and Hector Novoa De Armas.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i44" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i44"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i45" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i45"> Abbreviations Used</h2><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">IL-1β</td><td class="NLM_def"><p class="first last">interleukin-1β</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetics</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorescence imaging plate reader</p></td></tr><tr><td class="NLM_term">po</td><td class="NLM_def"><p class="first last">per os</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">mass spectra</p></td></tr><tr><td class="NLM_term">NHP</td><td class="NLM_def"><p class="first last">non-human primate</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">half-life</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">percent bioavailability</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsome</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">MLM</td><td class="NLM_def"><p class="first last">mouse liver microsome</p></td></tr><tr><td class="NLM_term">CMLM</td><td class="NLM_def"><p class="first last">cynomolgus liver microsome</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">RO</td><td class="NLM_def"><p class="first last">receptor occupancy</p></td></tr><tr><td class="NLM_term">Bz-ATP</td><td class="NLM_def"><p class="first last">benzoyl adenosine triphosphate</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77741" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77741" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 30 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Walker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druss, B. G.</span><span> </span><span class="NLM_article-title">Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis</span> <span class="citation_source-journal">JAMA Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.1001/jamapsychiatry.2014.2502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1001%2Fjamapsychiatry.2014.2502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2015&pages=334-341&issue=4&author=E.+Walkerauthor=R.+E.+McGeeauthor=B.+G.+Druss&title=Mortality+in+mental+disorders+and+global+disease+burden+implications%3A+A+systematic+review+and+meta-analysis&doi=10.1001%2Fjamapsychiatry.2014.2502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Fjamapsychiatry.2014.2502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamapsychiatry.2014.2502%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DE.%26aulast%3DMcGee%26aufirst%3DR.%2BE.%26aulast%3DDruss%26aufirst%3DB.%2BG.%26atitle%3DMortality%2520in%2520mental%2520disorders%2520and%2520global%2520disease%2520burden%2520implications%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DJAMA%2520Psychiatry%26date%3D2015%26volume%3D72%26issue%3D4%26spage%3D334%26epage%3D341%26doi%3D10.1001%2Fjamapsychiatry.2014.2502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dowlati, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swardfager, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reim, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanctot, K. L.</span><span> </span><span class="NLM_article-title">A Meta-analysis of cytokines in major depression</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2009.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.biopsych.2009.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=20015486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2rsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=446-457&issue=5&author=Y.+Dowlatiauthor=N.+Herrmannauthor=W.+Swardfagerauthor=H.+Liuauthor=L.+Shamauthor=E.+K.+Reimauthor=K.+L.+Lanctot&title=A+Meta-analysis+of+cytokines+in+major+depression&doi=10.1016%2Fj.biopsych.2009.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">A Meta-Analysis of Cytokines in Major Depression</span></div><div class="casAuthors">Dowlati, Yekta; Herrmann, Nathan; Swardfager, Walter; Liu, Helena; Sham, Lauren; Reim, Elyse K.; Lanctot, Krista L.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">446-457</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Major depression occurs in 4.4% to 20% of the general population.  Studies suggest that major depression is accompanied by immune dysregulation and activation of the inflammatory response system (IRS).  Our objective was to quant. summarize the data on concns. of specific cytokines in patients diagnosed with a major depressive episode and controls.  We performed a meta-anal. of studies measuring cytokine concn. in patients with major depression, with a database search of the English literature (to August 2009) and a manual search of refs.  Twenty-four studies involving unstimulated measurements of cytokines in patients meeting DSM criteria for major depression were included in the meta-anal.; 13 for tumor necrosis factor (TNF)-α, 9 for interleukin (IL)-1β, 16 for IL-6, 5 for IL-4, 5 for IL-2, 4 for IL-8, 6 for IL-10, and 4 for interferon (IFN)-γ.  There were significantly higher concns. of TNF-α (p < .00001), weighted mean difference (WMD) (95% confidence interval) 3.97 pg/mL (2.24 to 5.71), in depressed subjects compared with control subjects (438 depressed/350 nondepressed).  Also, IL-6 concns. were significantly higher (p < .00001) in depressed subjects compared with control subjects (492 depressed/400 nondepressed) with an overall WMD of 1.78 pg/mL (1.23 to 2.33).  There were no significant differences among depressed and nondepressed subjects for the other cytokines studied.  This meta-anal. reports significantly higher concns. of the proinflammatory cytokines TNF-α and IL-6 in depressed subjects compared with control subjects.  While both pos. and neg. results have been reported in individual studies, this meta-analytic result strengthens evidence that depression is accompanied by activation of the IRS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOAN0dKQ7dBLVg90H21EOLACvtfcHk0lhqI2b5Jx-MYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2rsrw%253D&md5=d09e51e1298203434771c3f9c6a2b63a</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2009.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2009.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DDowlati%26aufirst%3DY.%26aulast%3DHerrmann%26aufirst%3DN.%26aulast%3DSwardfager%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSham%26aufirst%3DL.%26aulast%3DReim%26aufirst%3DE.%2BK.%26aulast%3DLanctot%26aufirst%3DK.%2BL.%26atitle%3DA%2520Meta-analysis%2520of%2520cytokines%2520in%2520major%2520depression%26jtitle%3DBiol.%2520Psychiatry%26date%3D2010%26volume%3D67%26issue%3D5%26spage%3D446%26epage%3D457%26doi%3D10.1016%2Fj.biopsych.2009.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Raison, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. H.</span><span> </span><span class="NLM_article-title">Cytokines sing the blues: inflammation and the pathogenesis of depression</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1016/j.it.2005.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.it.2005.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=16316783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=24-31&issue=1&author=C.+L.+Raisonauthor=L.+Capuronauthor=A.+H.+Miller&title=Cytokines+sing+the+blues%3A+inflammation+and+the+pathogenesis+of+depression&doi=10.1016%2Fj.it.2005.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokines sing the blues: inflammation and the pathogenesis of depression</span></div><div class="casAuthors">Raison, Charles L.; Capuron, Lucile; Miller, Andrew H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-31</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Increasing amts. of data suggest that inflammatory responses have an important role in the pathophysiol. of depression.  Depressed patients have been found to have higher levels of proinflammatory cytokines, acute phase proteins, chemokines and cellular adhesion mols.  In addn., therapeutic administration of the cytokine interferon-α leads to depression in up to 50% of patients.  Moreover, proinflammatory cytokines have been found to interact with many of the pathophysiol. domains that characterize depression, including neurotransmitter metab., neuroendocrine function, synaptic plasticity and behavior.  Stress, which can ppt. depression, can also promote inflammatory responses through effects on sympathetic and parasympathetic nervous system pathways.  Finally, depression might be a behavioral byproduct of early adaptive advantages conferred by genes that promote inflammation.  These findings suggest that targeting proinflammatory cytokines and their signaling pathways might represent a novel strategy to treat depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUQeAudNpT3rVg90H21EOLACvtfcHk0lj4C2hXsUS94g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVylsg%253D%253D&md5=0d3c1631fe0d202ac8fd5ae4b251d1a8</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2005.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2005.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DRaison%26aufirst%3DC.%2BL.%26aulast%3DCapuron%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DA.%2BH.%26atitle%3DCytokines%2520sing%2520the%2520blues%253A%2520inflammation%2520and%2520the%2520pathogenesis%2520of%2520depression%26jtitle%3DTrends%2520Immunol.%26date%3D2006%26volume%3D27%26issue%3D1%26spage%3D24%26epage%3D31%26doi%3D10.1016%2Fj.it.2005.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derecki, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drevets, W. C.</span><span> </span><span class="NLM_article-title">Role of neuro-immunological factors in the pathophysiology of mood disorders</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1623</span><span class="NLM_x">–</span> <span class="NLM_lpage">1636</span><span class="refDoi"> DOI: 10.1007/s00213-016-4214-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1007%2Fs00213-016-4214-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=26803500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2016&pages=1623-1636&issue=9&author=A.+Bhattacharyaauthor=N.+C.+Dereckiauthor=T.+W.+Lovenbergauthor=W.+C.+Drevets&title=Role+of+neuro-immunological+factors+in+the+pathophysiology+of+mood+disorders&doi=10.1007%2Fs00213-016-4214-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Role of neuro-immunological factors in the pathophysiology of mood disorders</span></div><div class="casAuthors">Bhattacharya, Anindya; Derecki, Noel C.; Lovenberg, Timothy W.; Drevets, Wayne C.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1623-1636</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mood disorders, despite the widespread availability of monoamine-based antidepressant treatments, are assocd. with persistently high rates of disability, together with elevated rates of mortality due to suicide, cardiovascular disease, and other causes.  The development of more effective treatments has been hindered by the lack of knowledge about the etiol. and pathogenesis of mood disorders.  An emerging area of science that promises novel pathways to antidepressant and mood stabilizing therapies surrounds evidence that immune cells and their signaling play a major role in the pathophysiol. of major depressive disorder (MDD) and bipolar disorder (BD).  Here, we review evidence that the release of neuroactive cytokines, particularly interleukins such as IL-1β, IL-6, and TNF-α, is altered in these disorders and discuss mechanisms such as the ATP-gated ion channel P2X7, through which cytokine signaling can influence neuro-glial interactions.  Brain P2X7, an emerging target and antagonism of P2X7 holds promise as a novel mechanism for targeting treatment-resistant depression.  We further discuss the role of microglia and astroglia in central neuroinflammation and their interaction with the peripheral immune system.  We present extant clin. evidence that bolsters the role of neuroinflammation and neuroactive cytokines in mood disorders.  To that end, the role of clin. imaging by probing neuroinflammatory markers is also discussed briefly.  Finally, we present data using preclin. neuroinflammation models that produce depression-like behaviors in exptl. animals to identify neuroinflammatory mechanisms which may aid in novel neuroimmune target identification for the development of exciting pharmacol. interventions in mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3LHj0rffjabVg90H21EOLACvtfcHk0lj4C2hXsUS94g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKgs7c%253D&md5=94cfc55223e0c7c21dad372c00e502cb</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4214-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4214-0%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DDerecki%26aufirst%3DN.%2BC.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DDrevets%26aufirst%3DW.%2BC.%26atitle%3DRole%2520of%2520neuro-immunological%2520factors%2520in%2520the%2520pathophysiology%2520of%2520mood%2520disorders%26jtitle%3DPsychopharmacology%26date%3D2016%26volume%3D233%26issue%3D9%26spage%3D1623%26epage%3D1636%26doi%3D10.1007%2Fs00213-016-4214-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goshen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreisel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Menachem-Zidon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidenfeld, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Hur, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yirmiya, R.</span><span> </span><span class="NLM_article-title">Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span><span class="refDoi"> DOI: 10.1038/sj.mp.4002055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1038%2Fsj.mp.4002055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=17700577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1alt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=717-728&issue=7&author=I.+Goshenauthor=T.+Kreiselauthor=O.+Ben-Menachem-Zidonauthor=T.+Lichtauthor=J.+Weidenfeldauthor=T.+Ben-Hurauthor=R.+Yirmiya&title=Brain+interleukin-1+mediates+chronic+stress-induced+depression+in+mice+via+adrenocortical+activation+and+hippocampal+neurogenesis+suppression&doi=10.1038%2Fsj.mp.4002055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression</span></div><div class="casAuthors">Goshen, I.; Kreisel, T.; Ben-Menachem-Zidon, O.; Licht, T.; Weidenfeld, J.; Ben-Hur, T.; Yirmiya, R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">717-728</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Several lines of evidence implicate the pro-inflammatory cytokine interleukin-1 (IL-1) in the etiol. and pathophysiol. of major depression.  To explore the role of IL-1 in chronic stress-induced depression and some of its underlying biol. mechanisms, we used the chronic mild stress (CMS) model of depression.  Mice subjected to CMS for 5 wk exhibited depressive-like symptoms, including decreased sucrose preference, reduced social exploration and adrenocortical activation, concomitantly with increased IL-1β levels in the hippocampus.  In contrast, mice with deletion of the IL-1 receptor type I (IL-1rKO) or mice with transgenic, brain-restricted overexpression of IL-1 receptor antagonist did not display CMS-induced behavioral or neuroendocrine changes.  Similarly, whereas in wild-type (WT) mice CMS significantly reduced hippocampal neurogenesis, measured by incorporation of bromodeoxyuridine (BrdU) and by doublecortin immunohistochem., no such decrease was obsd. IL-1rKO mice.  The blunting of the adrenocortical activation in IL-1rKO mice may play a causal role in their resistance to depression, because removal of endogenous glucocorticoids by adrenalectomy also abolished the depressive-like effects of CMS, whereas chronic administration of corticosterone for 4 wk produced depressive symptoms and reduced neurogenesis in both WT and IL-1rKO mice.  The effects of CMS on both behavioral depression and neurogenesis could be mimicked by exogenous s.c. administration of IL-1β via osmotic minipumps for 4 wk.  These findings indicate that elevation in brain IL-1 levels, which characterizes many medical conditions, is both necessary and sufficient for producing the high incidence of depression found in these conditions.  Thus, procedures aimed at reducing brain IL-1 levels may have potent antidepressive actions.  Mol. Psychiatry (2008) 13, 717-728; doi:10.1038/sj.mp.4002055; published online 14 August 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPMCepUnKjv7Vg90H21EOLACvtfcHk0lj4C2hXsUS94g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1alt7w%253D&md5=b7681e8cbc5837318e5f6163c606ee99</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4002055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4002055%26sid%3Dliteratum%253Aachs%26aulast%3DGoshen%26aufirst%3DI.%26aulast%3DKreisel%26aufirst%3DT.%26aulast%3DBen-Menachem-Zidon%26aufirst%3DO.%26aulast%3DLicht%26aufirst%3DT.%26aulast%3DWeidenfeld%26aufirst%3DJ.%26aulast%3DBen-Hur%26aufirst%3DT.%26aulast%3DYirmiya%26aufirst%3DR.%26atitle%3DBrain%2520interleukin-1%2520mediates%2520chronic%2520stress-induced%2520depression%2520in%2520mice%2520via%2520adrenocortical%2520activation%2520and%2520hippocampal%2520neurogenesis%2520suppression%26jtitle%3DMol.%2520Psychiatry%26date%3D2008%26volume%3D13%26issue%3D7%26spage%3D717%26epage%3D728%26doi%3D10.1038%2Fsj.mp.4002055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koo, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">456</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1016/j.neulet.2009.03.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.neulet.2009.03.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=456&publication_year=2009&pages=39-43&issue=1&author=J.+W.+Kooauthor=R.+S.+Duman&title=Interleukin-1+receptor+null+mutant+mice+show+decreased+anxiety-like+behavior+and+enhanced+fear+memory&doi=10.1016%2Fj.neulet.2009.03.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2009.03.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2009.03.068%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DJ.%2BW.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DInterleukin-1%2520receptor%2520null%2520mutant%2520mice%2520show%2520decreased%2520anxiety-like%2520behavior%2520and%2520enhanced%2520fear%2520memory%26jtitle%3DNeurosci.%2520Lett.%26date%3D2009%26volume%3D456%26issue%3D1%26spage%3D39%26epage%3D43%26doi%3D10.1016%2Fj.neulet.2009.03.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Koo, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nestler, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2669</span><span class="NLM_x">–</span> <span class="NLM_lpage">2674</span><span class="refDoi"> DOI: 10.1073/pnas.0910658107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1073%2Fpnas.0910658107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2669-2674&issue=6&author=J.+W.+Kooauthor=S.+J.+Russoauthor=D.+Fergusonauthor=E.+J.+Nestlerauthor=R.+S.+Duman&title=Nuclear+factor-kappaB+is+a+critical+mediator+of+stress-impaired+neurogenesis+and+depressive+behavior&doi=10.1073%2Fpnas.0910658107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0910658107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0910658107%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DJ.%2BW.%26aulast%3DRusso%26aufirst%3DS.%2BJ.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DNestler%26aufirst%3DE.%2BJ.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DNuclear%2520factor-kappaB%2520is%2520a%2520critical%2520mediator%2520of%2520stress-impaired%2520neurogenesis%2520and%2520depressive%2520behavior%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D6%26spage%3D2669%26epage%3D2674%26doi%3D10.1073%2Fpnas.0910658107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Stokes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluyter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skarratt, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. S.</span><span> </span><span class="NLM_article-title">Two haplotypes of the P2X7 receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1{beta} secretion</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2916</span><span class="NLM_x">–</span> <span class="NLM_lpage">2927</span><span class="refDoi"> DOI: 10.1096/fj.09-150862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1096%2Ffj.09-150862" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=2916-2927&issue=8&author=L.+Stokesauthor=S.+J.+Fullerauthor=R.+Sluyterauthor=K.+K.+Skarrattauthor=B.+J.+Guauthor=J.+S.+Wiley&title=Two+haplotypes+of+the+P2X7+receptor+containing+the+Ala-348+to+Thr+polymorphism+exhibit+a+gain-of-function+effect+and+enhanced+interleukin-1%7Bbeta%7D+secretion&doi=10.1096%2Ffj.09-150862"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1096%2Ffj.09-150862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.09-150862%26sid%3Dliteratum%253Aachs%26aulast%3DStokes%26aufirst%3DL.%26aulast%3DFuller%26aufirst%3DS.%2BJ.%26aulast%3DSluyter%26aufirst%3DR.%26aulast%3DSkarratt%26aufirst%3DK.%2BK.%26aulast%3DGu%26aufirst%3DB.%2BJ.%26aulast%3DWiley%26aufirst%3DJ.%2BS.%26atitle%3DTwo%2520haplotypes%2520of%2520the%2520P2X7%2520receptor%2520containing%2520the%2520Ala-348%2520to%2520Thr%2520polymorphism%2520exhibit%2520a%2520gain-of-function%2520effect%2520and%2520enhanced%2520interleukin-1%257Bbeta%257D%2520secretion%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26issue%3D8%26spage%3D2916%26epage%3D2927%26doi%3D10.1096%2Ffj.09-150862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Solle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrushova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Altered cytokine production in mice lacking P2X(7) receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1074/jbc.M006781200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1074%2Fjbc.M006781200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=125-132&issue=1&author=M.+Solleauthor=J.+Labasiauthor=D.+G.+Perregauxauthor=E.+Stamauthor=N.+Petrushovaauthor=B.+H.+Kollerauthor=R.+J.+Griffithsauthor=C.+A.+Gabel&title=Altered+cytokine+production+in+mice+lacking+P2X%287%29+receptors&doi=10.1074%2Fjbc.M006781200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M006781200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M006781200%26sid%3Dliteratum%253Aachs%26aulast%3DSolle%26aufirst%3DM.%26aulast%3DLabasi%26aufirst%3DJ.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DStam%26aufirst%3DE.%26aulast%3DPetrushova%26aufirst%3DN.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26aulast%3DGriffiths%26aufirst%3DR.%2BJ.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DAltered%2520cytokine%2520production%2520in%2520mice%2520lacking%2520P2X%25287%2529%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D1%26spage%3D125%26epage%3D132%26doi%3D10.1074%2Fjbc.M006781200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biber, K.</span><span> </span><span class="NLM_article-title">The microglial ATP-gated ion channel P2X7 as a CNS drug target</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1772</span><span class="NLM_x">–</span> <span class="NLM_lpage">1787</span><span class="refDoi"> DOI: 10.1002/glia.23001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1002%2Fglia.23001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2016&pages=1772-1787&issue=10&author=A.+Bhattacharyaauthor=K.+Biber&title=The+microglial+ATP-gated+ion+channel+P2X7+as+a+CNS+drug+target&doi=10.1002%2Fglia.23001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fglia.23001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.23001%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DBiber%26aufirst%3DK.%26atitle%3DThe%2520microglial%2520ATP-gated%2520ion%2520channel%2520P2X7%2520as%2520a%2520CNS%2520drug%2520target%26jtitle%3DGlia%26date%3D2016%26volume%3D64%26issue%3D10%26spage%3D1772%26epage%3D1787%26doi%3D10.1002%2Fglia.23001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Csolle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goloncser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baranyi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soproni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelena, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperlagh, B.</span><span> </span><span class="NLM_article-title">The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1017/S1461145711001933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1017%2FS1461145711001933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=22243662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A280%3ADC%252BC38vgtlGgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=213-233&issue=1&author=C.+Csolleauthor=R.+D.+Andoauthor=A.+Kittelauthor=F.+Goloncserauthor=M.+Baranyiauthor=K.+Soproniauthor=D.+Zelenaauthor=J.+Hallerauthor=T.+Nemethauthor=A.+Mocsaiauthor=B.+Sperlagh&title=The+absence+of+P2X7+receptors+%28P2rx7%29+on+non-haematopoietic+cells+leads+to+selective+alteration+in+mood-related+behaviour+with+dysregulated+gene+expression+and+stress+reactivity+in+mice&doi=10.1017%2FS1461145711001933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice</span></div><div class="casAuthors">Csolle Cecilia; Ando Romeo D; Kittel Agnes; Goloncser Flora; Baranyi Maria; Soproni Krisztina; Zelena Dora; Haller Jozsef; Nemeth Tamas; Mocsai Attila; Sperlagh Beata</div><div class="citationInfo"><span class="NLM_cas:title">The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The purpose of this study was to explore how genetic deletion and pharmacological antagonism of the P2X7 receptor (P2rx7) alter mood-related behaviour, gene expression and stress reactivity in the brain.  The forced swim test (FST), tail suspension test (TST) and amphetamine-induced hyperlocomotion (AH) tests were used in wild-type (P2rx7(+/+)) and P2rx7-deficient (P2rx7(-/-)) mice.  Biogenic amine levels were analysed in the amygdala and striatum, adrenocorticotropic hormone (ACTH) and corticosterone levels were measured in the plasma and pituitary after restraint stress.  Chimeric mice were generated by bone marrow transplantation.  A whole genome microarray analysis with real-time polymerase chain reaction validation was performed on the amygdala.  In the absence of P2rx7s decreased behavioural despair in the FST, reduced immobility in the TST and attenuated amphetamine-induced hyperactivity were detected.  Basal norepinephrine levels were elevated in the amygdala, whereas stress-induced ACTH and corticosterone responses were alleviated in P2rx7(-/-) mice.  Sub-acute treatment with the selective P2rx7 antagonist, Brilliant Blue G, reproduced the effect of genetic deletion in the TST and AH test in P2rx7(+/+) but not P2rx7(-/-) mice.  No change in behavioural phenotype was observed in chimeras lacking the P2rx7 in their haematopoietic compartment.  Whole genome microarray analysis indicated a widespread up- and down-regulation of genes crucial for synaptic function and neuroplasticity by genetic deletion.  Here, we present evidence that the absence of P2rx7s on non-haematopoietic cells leads to a mood-stabilizing phenotype in several behavioural models and suggest a therapeutic potential of P2rx7 antagonists for the treatment of mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRhnfe6sBFWl9FxYDaSSP8XfW6udTcc2eZ-8fC58rqjO7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vgtlGgsA%253D%253D&md5=7acf270a1c234428ff37628d2b6a32dd</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1017%2FS1461145711001933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145711001933%26sid%3Dliteratum%253Aachs%26aulast%3DCsolle%26aufirst%3DC.%26aulast%3DAndo%26aufirst%3DR.%2BD.%26aulast%3DKittel%26aufirst%3DA.%26aulast%3DGoloncser%26aufirst%3DF.%26aulast%3DBaranyi%26aufirst%3DM.%26aulast%3DSoproni%26aufirst%3DK.%26aulast%3DZelena%26aufirst%3DD.%26aulast%3DHaller%26aufirst%3DJ.%26aulast%3DNemeth%26aufirst%3DT.%26aulast%3DMocsai%26aufirst%3DA.%26aulast%3DSperlagh%26aufirst%3DB.%26atitle%3DThe%2520absence%2520of%2520P2X7%2520receptors%2520%2528P2rx7%2529%2520on%2520non-haematopoietic%2520cells%2520leads%2520to%2520selective%2520alteration%2520in%2520mood-related%2520behaviour%2520with%2520dysregulated%2520gene%2520expression%2520and%2520stress%2520reactivity%2520in%2520mice%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D16%26issue%3D1%26spage%3D213%26epage%3D233%26doi%3D10.1017%2FS1461145711001933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses</span> <span class="citation_source-journal">Brain, Behav., Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span><span class="refDoi"> DOI: 10.1016/j.bbi.2012.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.bbi.2012.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=23261775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=105-114&author=M.+Iwataauthor=K.+T.+Otaauthor=R.+S.+Duman&title=The+inflammasome%3A+Pathways+linking+psychological+stress%2C+depression%2C+and+systemic+illnesses&doi=10.1016%2Fj.bbi.2012.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses</span></div><div class="casAuthors">Iwata, Masaaki; Ota, Kristie T.; Duman, Ronald S.</div><div class="citationInfo"><span class="NLM_cas:title">Brain, Behavior, and Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-114</span>CODEN:
                <span class="NLM_cas:coden">BBIMEW</span>;
        ISSN:<span class="NLM_cas:issn">0889-1591</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Stress is a common occurrence in everyday life and repeated or traumatic stress can be a pptg. factor for illnesses of the central nervous system, as well as peripheral organ systems.  For example, severe or long-term psychol. stress can not only induce depression, a leading illness worldwide, but can also cause psychosomatic diseases such as asthma and rheumatoid arthritis.  Related key questions include how psychol. stress influences both brain and peripheral systems, and what detection mechanisms underlie these effects A clue is provided by the discovery of the pathways underlying the responses to host danger substances that cause systemic diseases, but can also contribute to depression.  The inflammasome is a protein complex that can detect diverse danger signals and produce the accompanying immune-inflammatory reactions.  Interestingly, the inflammasome can detect not only pathogen-assocd. mols., but also cell damage-assocd. mols. such as ATP.  Here, we propose a new inflammasome hypothesis of depression and related comorbid systemic illnesses.  According to this hypothesis, the inflammasome is a central mediator by which psychol. and phys. stressors can contribute to the development of depression, and as well as a bridge to systemic diseases.  This hypothesis includes an explanation for how psychol. stress can influence systemic diseases, and conversely how systemic diseases can lead to psychiatric illnesses.  The evidence suggests that the inflammasome may be a new target for the development of treatments for depression, as well as psychosomatic and somato-psycho diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFE-2qYPjgtLVg90H21EOLACvtfcHk0lhmOPBOToHcpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFWktg%253D%253D&md5=64387d9412f24dd44e46b5d5b5bcd844</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2012.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2012.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DIwata%26aufirst%3DM.%26aulast%3DOta%26aufirst%3DK.%2BT.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DThe%2520inflammasome%253A%2520Pathways%2520linking%2520psychological%2520stress%252C%2520depression%252C%2520and%2520systemic%2520illnesses%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2013%26volume%3D31%26spage%3D105%26epage%3D114%26doi%3D10.1016%2Fj.bbi.2012.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutheil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banasr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glasebrook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koester, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smagin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2015.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.biopsych.2015.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=26831917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2murw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=12-22&author=M.+Iwataauthor=K.+T.+Otaauthor=X.+Y.+Liauthor=F.+Sakaueauthor=N.+Liauthor=S.+Dutheilauthor=M.+Banasrauthor=V.+Duricauthor=T.+Yamanashiauthor=K.+Kanekoauthor=K.+Rasmussenauthor=A.+Glasebrookauthor=A.+Koesterauthor=D.+Songauthor=K.+A.+Jonesauthor=S.+Zornauthor=G.+Smaginauthor=R.+S.+Duman&title=Psychological+stress+activates+the+inflammasome+via+release+of+adenosine+triphosphate+and+stimulation+of+the+purinergic+type+2X7+receptor&doi=10.1016%2Fj.biopsych.2015.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor</span></div><div class="casAuthors">Iwata, Masaaki; Ota, Kristie T.; Li, Xiao-Yuan; Sakaue, Fumika; Li, Nanxin; Dutheil, Sophie; Banasr, Mounira; Duric, Vanja; Yamanashi, Takehiko; Kaneko, Koichi; Rasmussen, Kurt; Glasebrook, Andrew; Koester, Anja; Song, Dekun; Jones, Kenneth A.; Zorn, Stevin; Smagin, Gennady; Duman, Ronald S.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-22</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mechanisms underlying stress-induced inflammation that contribute to major depressive disorder are unknown.  We examine the role of the ATP (ATP)/purinergic type 2X7 receptor (P2X7R) pathway and the NLRP3 (nucleotide-binding, leucine-rich repeat, pyrin domain contg. 3) inflammasome in interleukin (IL)-1β and depressive behavioral responses to stress.  The influence of acute restraint stress on extracellular ATP, glutamate, IL-1β, and tumor necrosis factor alpha in hippocampus was detd. by microdialysis, and the influence of acute restraint stress on the NLRP3 inflammasome was detd. by Western blot anal.  The influence of P2X7R antagonist administration on IL-1β and tumor necrosis factor alpha and on anxiety and depressive behaviors was detd. in the chronic unpredictable stress rodent model.  The role of the NLRP3 inflammasome was detd. by anal. of Nlrp3 null mice.  Acute restraint stress rapidly increased extracellular ATP, an endogenous agonist of P2X7R; the inflammatory cytokine IL-1β; and the active form of the NLRP3 inflammasome in the hippocampus.  Administration of a P2X7R antagonist completely blocked the release of IL-1β and tumor necrosis factor alpha, another stress-induced cytokine, and activated NLRP3.  Moreover, P2X7R antagonist administration reversed the anhedonic and anxiety behaviors caused by chronic unpredictable stress exposure, and deletion of the Nlrp3 gene rendered mice resistant to development of depressive behaviors caused by chronic unpredictable stress.  These findings demonstrate that psychol. "stress" is sensed by the innate immune system in the brain via the ATP/P2X7R-NLRP3 inflammasome cascade, and they identify novel therapeutic targets for the treatment of stress-related mood disorders and comorbid illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPT4PeBplcG7Vg90H21EOLACvtfcHk0lhmOPBOToHcpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2murw%253D&md5=f17ad7ff32906696e07f3b9e52a7591e</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DIwata%26aufirst%3DM.%26aulast%3DOta%26aufirst%3DK.%2BT.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DSakaue%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DDutheil%26aufirst%3DS.%26aulast%3DBanasr%26aufirst%3DM.%26aulast%3DDuric%26aufirst%3DV.%26aulast%3DYamanashi%26aufirst%3DT.%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DGlasebrook%26aufirst%3DA.%26aulast%3DKoester%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DK.%2BA.%26aulast%3DZorn%26aufirst%3DS.%26aulast%3DSmagin%26aufirst%3DG.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DPsychological%2520stress%2520activates%2520the%2520inflammasome%2520via%2520release%2520of%2520adenosine%2520triphosphate%2520and%2520stimulation%2520of%2520the%2520purinergic%2520type%25202X7%2520receptor%26jtitle%3DBiol.%2520Psychiatry%26date%3D2016%26volume%3D80%26spage%3D12%26epage%3D22%26doi%3D10.1016%2Fj.biopsych.2015.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Keystone, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span> </span><span class="NLM_article-title">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1635</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2011-143578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1136%2Fannrheumdis-2011-143578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=22966146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=1630-1635&issue=10&author=E.+C.+Keystoneauthor=M.+M.+Wangauthor=M.+Laytonauthor=S.+Hollisauthor=I.+B.+McInnes&title=Clinical+evaluation+of+the+efficacy+of+the+P2X7+purinergic+receptor+antagonist+AZD9056+on+the+signs+and+symptoms+of+rheumatoid+arthritis+in+patients+with+active+disease+despite+treatment+with+methotrexate+or+sulphasalazine&doi=10.1136%2Fannrheumdis-2011-143578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span></div><div class="casAuthors">Keystone, Edward C.; Wang, Millie M.; Layton, Mark; Hollis, Sally; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1630-1635</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objectives: The P2X7 purinergic receptor antagonist AZD9056 was evaluated in a phase IIa study and subsequently in a phase IIb study to assess the effects of orally administered AZD9056 on the signs/symptoms of rheumatoid arthritis (RA), with American College of Rheumatol. 20% response criteria (ACR20) as the primary outcome.  Methods: Both studies were randomized, double-blind, placebo-controlled, parallel-group studies in patients with RA receiving methotrexate or sulphasalazine.  Phase IIa was an ascending-dose trial in two cohorts (n=75) using AZD9056 administered daily over 4 wk.  Phase IIb included an open-label etanercept treatment group.  Patients were randomized to receive treatment for 6 mo with 50, 100, 200 or 400 mg AZD9056 (oral, once a day) or matching placebo (oral, once a day), or s.c. etanercept (50 mg once a week).  Results: In phase IIa, 65% of AZD9056 recipients at 400 mg/day responded at the ACR20 level compared with 27% of placebo-treated patients.  A significant redn. in swollen and tender joint count was obsd. in the actively treated group compared with placebo, whereas no effect on acute-phase response was obsd.  Of 385 randomized patients in the phase IIb study, 383 received treatment.  AZD9056 (all doses) had no clin. or statistically significant effect on RA relative to placebo as measured by the proportion of patients meeting the ACR20 criteria at 6 mo and further supported by secondary end points.  In both studies AZD9056 was well tolerated up to 400 mg/day.  Conclusions: AZD9056 does not have significant efficacy in the treatment of RA, and the P2X7 receptor does not appear to be a therapeutically useful target in RA.  Trial registration no. ClinicalTrials.gov NCT00520572.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzCebkc5d0gLVg90H21EOLACvtfcHk0lgNZmb6zk9R1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL&md5=97ca48663327aa8578f11001fa96d8c0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2011-143578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2011-143578%26sid%3Dliteratum%253Aachs%26aulast%3DKeystone%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DM.%2BM.%26aulast%3DLayton%26aufirst%3DM.%26aulast%3DHollis%26aufirst%3DS.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DClinical%2520evaluation%2520of%2520the%2520efficacy%2520of%2520the%2520P2X7%2520purinergic%2520receptor%2520antagonist%2520AZD9056%2520on%2520the%2520signs%2520and%2520symptoms%2520of%2520rheumatoid%2520arthritis%2520in%2520patients%2520with%2520active%2520disease%2520despite%2520treatment%2520with%2520methotrexate%2520or%2520sulphasalazine%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2012%26volume%3D71%26issue%3D10%26spage%3D1630%26epage%3D1635%26doi%3D10.1136%2Fannrheumdis-2011-143578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Eser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelsang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braddock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinisch, W.</span><span> </span><span class="NLM_article-title">Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn’s disease: A randomized placebo-controlled, double-blind, Phase IIa study</span> <span class="citation_source-journal">Inflammatory Bowel Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2453</span><span class="refDoi"> DOI: 10.1097/MIB.0000000000000514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1097%2FMIB.0000000000000514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=26197451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FltVSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=2247-2453&issue=10&author=A.+Eserauthor=J.+F.+Colombelauthor=P.+Rutgeertsauthor=S.+Vermeireauthor=H.+Vogelsangauthor=M.+Braddockauthor=T.+Perssonauthor=W.+Reinisch&title=Safety+and+efficacy+of+an+oral+inhibitor+of+the+purinergic+receptor+P2X7+in+adult+patients+with+moderately+to+severely+active+Crohn%E2%80%99s+disease%3A+A+randomized+placebo-controlled%2C+double-blind%2C+Phase+IIa+study&doi=10.1097%2FMIB.0000000000000514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study</span></div><div class="casAuthors">Eser Alexander; Colombel Jean-Frederic; Rutgeerts Paul; Vermeire Severine; Vogelsang Harald; Braddock Martin; Persson Tore; Reinisch Walter</div><div class="citationInfo"><span class="NLM_cas:title">Inflammatory bowel diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2247-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  AZD9056 is a selective orally active inhibitor of the purinergic receptor P2X7, which is a key player in the generation and secretion of several proinflammatory cytokines involved in the pathogenesis of Crohn's disease (CD).  The aim of this phase IIa study was to assess the efficacy and safety of AZD9056 for the treatment of moderately to severely active CD.  METHODS:  We conducted a placebo-controlled, multicenter, double-blind phase IIa study in patients with moderately to severely active CD as defined by a CD Activity Index (CDAI) of at least 220.  Patients were randomized in a 2:1 mode either to 200 mg of AZD9056 administered orally as a tablet once daily for 28 days or matching placebo.  Primary endpoint was the change in CDAI from baseline at day 28, and secondary endpoints included clinical remission (CDAI < 150) and CDAI 70 response and improvement in the quality of life measures Short Form 36 and Inflammatory Bowel Disease Questionnaire.  Changes in serum C-reactive protein and fecal calprotectin were assessed.  RESULTS:  In total, 34 patients were enrolled, 24 to AZD9056 and 10 to placebo.  The CDAI dropped in AZD9056-treated subjects from a baseline mean of 311 to 242 and from 262 to 239 in placebo-treated subjects (P = 0.049).  Remission and response rates were numerically higher with AZD9056 versus placebo, (n = 5, 24% versus n = 1, 11%, P = 0.43 and n = 11, 52% versus n = 2, 22%, P = 0.13, respectively).  Marked decrease in disease activity was observed for the CDAI subcomponents, pain and general well-being.  Apart from a statistically significant improvement in the Mental Component Score of Short Form 36 for AZD9056 versus placebo (P = 0.017), no other differences in measurements of quality of life could be observed.  There was no decrease in concentrations of serum C-reactive protein and fecal calprotectin during treatment.  AZD9056 was well-tolerated, and no serious adverse events were reported.  CONCLUSIONS:  Our data suggest that the purinergic receptor P2X7 antagonist AZD9056 has the potential to improve symptoms in patients with moderate-to-severe CD combined with a beneficial risk profile.  Although the lack in change of inflammatory biomarkers questions its anti-inflammatory potential, the results obtained in this study rather suggest P2X7 antagonism for the treatment of chronic abdominal pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHjK0qgS5fO0g6wdEZmT2rfW6udTcc2eYxlciCDHC00Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FltVSqtA%253D%253D&md5=8ade69d316c57adae49fb595e35ab2f7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2FMIB.0000000000000514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMIB.0000000000000514%26sid%3Dliteratum%253Aachs%26aulast%3DEser%26aufirst%3DA.%26aulast%3DColombel%26aufirst%3DJ.%2BF.%26aulast%3DRutgeerts%26aufirst%3DP.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DVogelsang%26aufirst%3DH.%26aulast%3DBraddock%26aufirst%3DM.%26aulast%3DPersson%26aufirst%3DT.%26aulast%3DReinisch%26aufirst%3DW.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520an%2520oral%2520inhibitor%2520of%2520the%2520purinergic%2520receptor%2520P2X7%2520in%2520adult%2520patients%2520with%2520moderately%2520to%2520severely%2520active%2520Crohn%25E2%2580%2599s%2520disease%253A%2520A%2520randomized%2520placebo-controlled%252C%2520double-blind%252C%2520Phase%2520IIa%2520study%26jtitle%3DInflammatory%2520Bowel%2520Dis.%26date%3D2015%26volume%3D21%26issue%3D10%26spage%3D2247%26epage%3D2453%26doi%3D10.1097%2FMIB.0000000000000514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mussari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevena, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney-Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, K.</span><span> </span><span class="NLM_article-title">Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3708</span><span class="NLM_x">–</span> <span class="NLM_lpage">3711</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.bmcl.2011.04.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3708-3711&issue=12&author=A.+J.+Duplantierauthor=M.+A.+Dombroskiauthor=C.+Subramanyamauthor=A.+M.+Beaulieuauthor=S.+P.+Changauthor=C.+A.+Gabelauthor=C.+Jordanauthor=A.+S.+Kalgutkarauthor=K.+G.+Krausauthor=J.+M.+Labasiauthor=C.+Mussariauthor=D.+G.+Perregauxauthor=R.+Shepardauthor=T.+J.+Taylorauthor=K.+A.+Trevenaauthor=C.+Whitney-Pickettauthor=K.+Yoon&title=Optimization+of+the+physicochemical+and+pharmacokinetic+attributes+in+a+6-azauracil+series+of+P2X7+receptor+antagonists+leading+to+the+discovery+of+the+clinical+candidate+CE-224%2C535&doi=10.1016%2Fj.bmcl.2011.04.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.077%26sid%3Dliteratum%253Aachs%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBeaulieu%26aufirst%3DA.%2BM.%26aulast%3DChang%26aufirst%3DS.%2BP.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26aulast%3DJordan%26aufirst%3DC.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKraus%26aufirst%3DK.%2BG.%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DMussari%26aufirst%3DC.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DShepard%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DT.%2BJ.%26aulast%3DTrevena%26aufirst%3DK.%2BA.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DYoon%26aufirst%3DK.%26atitle%3DOptimization%2520of%2520the%2520physicochemical%2520and%2520pharmacokinetic%2520attributes%2520in%2520a%25206-azauracil%2520series%2520of%2520P2X7%2520receptor%2520antagonists%2520leading%2520to%2520the%2520discovery%2520of%2520the%2520clinical%2520candidate%2520CE-224%252C535%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D12%26spage%3D3708%26epage%3D3711%26doi%3D10.1016%2Fj.bmcl.2011.04.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Stock, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishaq, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebus, C. A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.3899/jrheum.110874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.3899%2Fjrheum.110874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=22382341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=720-727&issue=4&author=T.+C.+Stockauthor=B.+J.+Bloomauthor=N.+Weiauthor=S.+Ishaqauthor=W.+Parkauthor=X.+Wangauthor=P.+Guptaauthor=C.+A.+Mebus&title=Efficacy+and+safety+of+CE-224%2C535%2C+an+antagonist+of+P2X7+receptor%2C+in+treatment+of+patients+with+rheumatoid+arthritis+inadequately+controlled+by+methotrexate&doi=10.3899%2Fjrheum.110874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span></div><div class="casAuthors">Stock, Thomas C.; Bloom, Bradley J.; Wei, Nathan; Ishaq, Saliha; Park, Won; Wang, Xin; Gupta, Pankaj; Mebus, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">720-727</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">To evaluate efficacy and safety of CE-224,535, a selective P2X7 receptor antagonist, vs. placebo, in patients with active rheumatoid arthritis (RA) and inadequate response to methotrexate (MTX).  In our phase IIA study (ClinicalTrials.gov no. NCT00628095; A6341009), patients aged ≥ 18 years with active RA were randomized to receive either CE-224,535 (500 mg bid) or placebo for 12 wk; all patients continued a stable background dose of ≥ 7.5 mg MTX.  The American College of Rheumatol. 20% (ACR20) response rate (primary efficacy endpoint) was not significantly different from placebo for CE-224,535 (34.0% vs 36.2%; p = 0.591) at Week 12, or at any timepoint over the 12-wk treatment period.  There was no significant difference at Week 12 for the ACR20 response rate following subgroup analyses by age, sex, baseline disease activity, baseline duration of disease, geog. region, or concomitant use of steroids.  ACR50/ACR70 response rates and change from baseline in Disease Activity Score 28-joint C-reactive protein (DAS28-3-CRP) and Health Assessment Questionnaire-Disability Index for CE-224,535 were not significant at Week 12 vs. placebo.  Treatment-emergent adverse events (AE) were reported by 62.3% (CE-224,535) and 55.3% (placebo) of patients; the most common AE were nausea (11.3%, CE-224,535; 4.3%, placebo) and diarrhea (7.5%, CE-224,535; 4.3%, placebo).  The proportion of patients discontinuing due to an AE was 9.4% (CE-224,535) and 6.4% (placebo); no deaths were reported.  Serious AE occurred in 3.8% (CE-224,535) and 2.1% (placebo) of patients; none was considered treatment-related.  CE-224,535 was not efficacious, compared with placebo, for the treatment of RA in patients with an inadequate response to MTX.  CE-224,535 demonstrated an acceptable safety and tolerability profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorblWg-aNBNLVg90H21EOLACvtfcHk0lgNZmb6zk9R1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D&md5=dc919436c3c6e7f3f624c57b77c5dbb2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.110874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.110874%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DT.%2BC.%26aulast%3DBloom%26aufirst%3DB.%2BJ.%26aulast%3DWei%26aufirst%3DN.%26aulast%3DIshaq%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DMebus%26aufirst%3DC.%2BA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520CE-224%252C535%252C%2520an%2520antagonist%2520of%2520P2X7%2520receptor%252C%2520in%2520treatment%2520of%2520patients%2520with%2520rheumatoid%2520arthritis%2520inadequately%2520controlled%2520by%2520methotrexate%26jtitle%3DJ.%2520Rheumatol.%26date%3D2012%26volume%3D39%26issue%3D4%26spage%3D720%26epage%3D727%26doi%3D10.3899%2Fjrheum.110874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Ali, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurijssens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostenfeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stylianou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott-Stevens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosking, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewit, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04320.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1111%2Fj.1365-2125.2012.04320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=22568863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=197-207&issue=1&author=Z.+Aliauthor=B.+Laurijssensauthor=T.+Ostenfeldauthor=S.+McHughauthor=A.+Stylianouauthor=P.+Scott-Stevensauthor=L.+Hoskingauthor=O.+Dewitauthor=J.+C.+Richardsonauthor=C.+Chen&title=Pharmacokinetic+and+pharmacodynamic+profiling+of+a+P2X7+receptor+allosteric+modulator+GSK1482160+in+healthy+human+subjects&doi=10.1111%2Fj.1365-2125.2012.04320.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span></div><div class="casAuthors">Ali, Zahid; Laurijssens, Bart; Ostenfeld, Thor; McHugh, Simon; Stylianou, Anastasia; Scott-Stevens, Paul; Hosking, Louise; Dewit, Odile; Richardson, Jill C.; Chen, Chao</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • P2X7 receptors are involved in the prodn. of pro-inflammatory cytokines, such as Il-1β, by central and peripheral immune cells.  Il-1β has been implicated as an important mediator of inflammation.  Therefore, the P2X7 receptor is an attractive therapeutic target for inflammatory diseases.  WHAT THIS STUDY ADDS • Findings in pharmacokinetics, pharmacodynamics, safety and tolerability of a P2X7 receptor modulator, GSK1482160, from the first human study for the mol. are described.  A pharmacokinetic/pharmacodynamic model for LPS-stimulated ATP-induced Il-1β prodn. in blood allowed the integration of all relevant data and provided in vivo evidence of the nature of the drug-receptor interaction.  The model has the potential to be used to simulate future trials.  AIMS This paper describes findings from the first-in-human study for GSK1482160, an orally available allosteric P2X7 receptor modulator.  The study aimed to assess the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of the compd. in healthy subjects.  METHODS Escalating single doses of up to 1 g were administered to healthy subjects in a single-blind and placebo-controlled fashion.  Safety, tolerability, blood drug concns. and ex vivo Il-1β prodn. in blood were evaluated.  RESULTS. Drug concn. peaked within 3.5 h of dosing under fasting conditions and declined thereafter with a relatively short half-life of less than 4.5 h.  Exposure was proportional to dose with between subject variability of less than 60%.  A PK/PD model quantified Il-1β as a function of drug exposure.  The model allowed simulation of in vivo pharmacol. for various untested dose levels and regimens.  Furthermore, the mechanistic model supported the hypothesis that the compd. reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity.  No major safety or tolerability concerns were identified in this small study (n= 29), except for one case of asymptomatic accelerated idioventricular rhythm at the top dose.  CONCLUSION. The model-based approach maximized anal. power by integrating all biomarker data and revealed mechanistic insight into the pharmacol. of P2X7 modulation by GSK1482160.  Simulations by this model ultimately led to the discontinuation of the development of this compd.  The therapeutic relevance of the P2X7 receptor remains to be tested in patients.  The mechanistic-model-based approach can be applied widely to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr41Bz54gV-qLVg90H21EOLACvtfcHk0lh6zqXNxs2dHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF&md5=835023636e0c5b039245344c2a9a207a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04320.x%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DLaurijssens%26aufirst%3DB.%26aulast%3DOstenfeld%26aufirst%3DT.%26aulast%3DMcHugh%26aufirst%3DS.%26aulast%3DStylianou%26aufirst%3DA.%26aulast%3DScott-Stevens%26aufirst%3DP.%26aulast%3DHosking%26aufirst%3DL.%26aulast%3DDewit%26aufirst%3DO.%26aulast%3DRichardson%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DPharmacokinetic%2520and%2520pharmacodynamic%2520profiling%2520of%2520a%2520P2X7%2520receptor%2520allosteric%2520modulator%2520GSK1482160%2520in%2520healthy%2520human%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D75%26issue%3D1%26spage%3D197%26epage%3D207%26doi%3D10.1111%2Fj.1365-2125.2012.04320.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Abdi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billinton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonfria, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleave, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lejeune, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingsby, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steadman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D. S.</span><span> </span><span class="NLM_article-title">Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5080</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.bmcl.2010.07.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5080-5084&issue=17&author=M.+H.+Abdiauthor=P.+J.+Beswickauthor=A.+Billintonauthor=L.+J.+Chambersauthor=A.+Charltonauthor=S.+D.+Collinsauthor=K.+L.+Collisauthor=D.+K.+Deanauthor=E.+Fonfriaauthor=R.+J.+Gleaveauthor=C.+L.+Lejeuneauthor=D.+G.+Livermoreauthor=S.+J.+Medhurstauthor=A.+D.+Michelauthor=A.+P.+Mosesauthor=L.+Pageauthor=S.+Patelauthor=S.+A.+Romanauthor=S.+Sengerauthor=B.+Slingsbyauthor=J.+G.+Steadmanauthor=A.+J.+Stevensauthor=D.+S.+Walter&title=Discovery+and+structure-activity+relationships+of+a+series+of+pyroglutamic+acid+amide+antagonists+of+the+P2X7+receptor&doi=10.1016%2Fj.bmcl.2010.07.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DAbdi%26aufirst%3DM.%2BH.%26aulast%3DBeswick%26aufirst%3DP.%2BJ.%26aulast%3DBillinton%26aufirst%3DA.%26aulast%3DChambers%26aufirst%3DL.%2BJ.%26aulast%3DCharlton%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DS.%2BD.%26aulast%3DCollis%26aufirst%3DK.%2BL.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DFonfria%26aufirst%3DE.%26aulast%3DGleave%26aufirst%3DR.%2BJ.%26aulast%3DLejeune%26aufirst%3DC.%2BL.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DMedhurst%26aufirst%3DS.%2BJ.%26aulast%3DMichel%26aufirst%3DA.%2BD.%26aulast%3DMoses%26aufirst%3DA.%2BP.%26aulast%3DPage%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRoman%26aufirst%3DS.%2BA.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DSlingsby%26aufirst%3DB.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DWalter%26aufirst%3DD.%2BS.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationships%2520of%2520a%2520series%2520of%2520pyroglutamic%2520acid%2520amide%2520antagonists%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D17%26spage%3D5080%26epage%3D5084%26doi%3D10.1016%2Fj.bmcl.2010.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawryluk, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sales, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickenden, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological characterization of two novel, brain penetrating P2X7 antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span><span class="refDoi"> DOI: 10.1021/ml400040v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400040v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=419-422&issue=4&author=M.+A.+Letavicauthor=B.+Lordauthor=F.+Bischoffauthor=N.+A.+Hawrylukauthor=S.+Pietersauthor=J.+C.+Rechauthor=Z.+Salesauthor=A.+I.+Velterauthor=H.+Aoauthor=P.+Bonaventureauthor=V.+Contrerasauthor=X.+Jiangauthor=K.+L.+Mortonauthor=B.+Scottauthor=Q.+Wangauthor=A.+D.+Wickendenauthor=N.+I.+Carruthersauthor=A.+Bhattacharya&title=Synthesis+and+pharmacological+characterization+of+two+novel%2C+brain+penetrating+P2X7+antagonists&doi=10.1021%2Fml400040v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fml400040v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400040v%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DHawryluk%26aufirst%3DN.%2BA.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DSales%26aufirst%3DZ.%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DContreras%26aufirst%3DV.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMorton%26aufirst%3DK.%2BL.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520pharmacological%2520characterization%2520of%2520two%2520novel%252C%2520brain%2520penetrating%2520P2X7%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D4%26spage%3D419%26epage%3D422%26doi%3D10.1021%2Fml400040v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoblock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepomuceno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neff, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickenden, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span><span class="refDoi"> DOI: 10.1111/bph.12314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1111%2Fbph.12314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=23889535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=624-640&issue=3&author=A.+Bhattacharyaauthor=Q.+Wangauthor=H.+Aoauthor=J.+R.+Shoblockauthor=B.+Lordauthor=L.+Aluisioauthor=I.+Fraserauthor=D.+Nepomucenoauthor=R.+A.+Neffauthor=N.+Weltyauthor=T.+W.+Lovenbergauthor=P.+Bonaventureauthor=A.+D.+Wickendenauthor=M.+A.+Letavic&title=Pharmacological+characterization+of+a+novel+centrally+permeable+P2X7+receptor+antagonist%3A+JNJ-47965567&doi=10.1111%2Fbph.12314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span></div><div class="casAuthors">Bhattacharya, Anindya; Wang, Qi; Ao, Hong; Shoblock, James R.; Lord, Brian; Aluisio, Leah; Fraser, Ian; Nepomuceno, Diane; Neff, Robert A.; Welty, Natalie; Lovenberg, Timothy W.; Bonaventure, Pascal; Wickenden, Alan D.; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">624-640</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : An increasing body of evidence suggests that the purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7) in the CNS may play a key role in neuropsychiatry, neurodegeneration and chronic pain.  In this study, we characterized JNJ-47965567, a centrally permeable, high-affinity, selective P2X7 antagonist.  Exptl. Approach : We have used a combination of in vitro assays (calcium flux, radioligand binding, electrophysiol., IL-1β release) in both recombinant and native systems.  Target engagement of JNJ-47965567 was demonstrated by ex vivo receptor binding autoradiog. and in vivo blockade of Bz-ATP induced IL-1β release in the rat brain.  Finally, the efficacy of JNJ-47965567 was tested in std. models of depression, mania and neuropathic pain.  Key Results : JNJ-47965567 is potent high affinity (pKi 7.9 ± 0.07), selective human P2X7 antagonist, with no significant obsd. speciation.  In native systems, the potency of the compd. to attenuate IL-1β release was 6.7 ± 0.07 (human blood), 7.5 ± 0.07 (human monocytes) and 7.1 ± 0.1 (rat microglia).  JNJ-47965567 exhibited target engagement in rat brain, with a brain EC50 of 78 ± 19 ng·mL-1 (P2X7 receptor autoradiog.) and functional block of Bz-ATP induced IL-1β release.  JNJ-47965567 (30 mg·kg-1) attenuated amphetamine-induced hyperactivity and exhibited modest, yet significant efficacy in the rat model of neuropathic pain.  No efficacy was obsd. in forced swim test.  Conclusion and Implications : JNJ-47965567 is centrally permeable, high affinity P2X7 antagonist that can be used to probe the role of central P2X7 in rodent models of CNS pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS_bU7fI8KzLVg90H21EOLACvtfcHk0li6Mlg61tFlOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI&md5=29d3bc1d3ecedda01f3d33b53d96c289</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fbph.12314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12314%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DNepomuceno%26aufirst%3DD.%26aulast%3DNeff%26aufirst%3DR.%2BA.%26aulast%3DWelty%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPharmacological%2520characterization%2520of%2520a%2520novel%2520centrally%2520permeable%2520P2X7%2520receptor%2520antagonist%253A%2520JNJ-47965567%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D170%26issue%3D3%26spage%3D624%26epage%3D640%26doi%3D10.1111%2Fbph.12314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kovanyi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csolle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calovi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanuska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koles, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperlagh, B.</span><span> </span><span class="NLM_article-title">The role of P2X7 receptors in a rodent PCP-induced schizophrenia model</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">36680</span><span class="refDoi"> DOI: 10.1038/srep36680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1038%2Fsrep36680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=27824163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVeht7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=36680&author=B.+Kovanyiauthor=C.+Csolleauthor=S.+Caloviauthor=A.+Hanuskaauthor=E.+Katoauthor=L.+Kolesauthor=A.+Bhattacharyaauthor=J.+Hallerauthor=B.+Sperlagh&title=The+role+of+P2X7+receptors+in+a+rodent+PCP-induced+schizophrenia+model&doi=10.1038%2Fsrep36680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The role of P2X7 receptors in a rodent PCP-induced schizophrenia model</span></div><div class="casAuthors">Kovanyi, Bence; Csolle, Cecilia; Calovi, Stefano; Hanuska, Adrienn; Kato, Erzsebet; Koles, Laszlo; Bhattacharya, Anindya; Haller, Jozsef; Sperlagh, Beata</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36680</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P2X7 receptors (P2X7Rs) are ligand-gated ion channels sensitive to extracellular ATP.  Here we examd. for the first time the role of P2X7R in an animal model of schizophrenia.  Using the PCP induced schizophrenia model we show that both genetic deletion and pharmacol. inhibition of P2X7Rs alleviate schizophrenia-like behavioral alterations.  In P2rx7+/+ mice, PCP induced hyperlocomotion, stereotype behavior, ataxia and social withdrawal.  In P2X7 receptor deficient mice (P2rx7-/-), the social interactions were increased, whereas the PCP induced hyperlocomotion and stereotype behavior were alleviated.  The selective P2X7 receptor antagonist JNJ-47965567 partly replicated the effect of gene deficiency on PCP-induced behavioral changes and counteracted PCP-induced social withdrawal.  We also show that PCP treatment upregulates and increases the functional responsiveness of P2X7Rs in the prefrontal cortex of young adult animals.  The amplitude of NMDA evoked currents recorded from layer V pyramidal neurons of cortical slices were slightly decreased by both genetic deletion of P2rx7 and by JNJ-47965567.  PCP induced alterations in mRNA expression encoding schizophrenia-related genes, such as NR2A, NR2B, neuregulin 1, NR1 and GABA α1 subunit were absent in the PFC of young adult P2rx7-/- animals.  Our findings point to P2X7R as a potential therapeutic target in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE7IvuTAwyvbVg90H21EOLACvtfcHk0li6Mlg61tFlOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVeht7fI&md5=336145e37b57f1d3a569afdc10dcdf70</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsrep36680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep36680%26sid%3Dliteratum%253Aachs%26aulast%3DKovanyi%26aufirst%3DB.%26aulast%3DCsolle%26aufirst%3DC.%26aulast%3DCalovi%26aufirst%3DS.%26aulast%3DHanuska%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DE.%26aulast%3DKoles%26aufirst%3DL.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DHaller%26aufirst%3DJ.%26aulast%3DSperlagh%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520P2X7%2520receptors%2520in%2520a%2520rodent%2520PCP-induced%2520schizophrenia%2520model%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D36680%26doi%3D10.1038%2Fsrep36680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Jimenez-Pacheco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Hernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas-Blazquez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz-Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivos-Ore, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artalejo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miras-Portugal, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conroy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delanty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henshall, D. C.</span><span> </span><span class="NLM_article-title">Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">5920</span><span class="NLM_x">–</span> <span class="NLM_lpage">5932</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4009-15.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1523%2FJNEUROSCI.4009-15.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=27251615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2lsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=5920-5932&issue=22&author=A.+Jimenez-Pachecoauthor=M.+Diaz-Hernandezauthor=M.+Arribas-Blazquezauthor=A.+Sanz-Rodriguezauthor=L.+A.+Olivos-Oreauthor=A.+R.+Artalejoauthor=M.+Alvesauthor=M.+Letavicauthor=M.+T.+Miras-Portugalauthor=R.+M.+Conroyauthor=N.+Delantyauthor=M.+A.+Farrellauthor=D.+F.+O%E2%80%99Brienauthor=A.+Bhattacharyaauthor=T.+Engelauthor=D.+C.+Henshall&title=Transient+P2X7+receptor+antagonism+produces+lasting+reductions+in+spontaneous+seizures+and+gliosis+in+experimental+temporal+lobe+epilepsy&doi=10.1523%2FJNEUROSCI.4009-15.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy</span></div><div class="casAuthors">Jimenez-Pacheco, Alba; Diaz-Hernandez, Miguel; Arribas-Blazquez, Marina; Sanz-Rodriguez, Amaya; Olivos-Ore, Luis A.; Artalejo, Antonio R.; Alves, Mariana; Letavic, Michael; Miras-Portugal, M. Teresa; Conroy, Ronan M.; Delanty, Norman; Farrell, Michael A.; O'Brien, Donncha F.; Bhattacharya, Anindya; Engel, Tobias; Henshall, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5920-5932</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neuroinflammation is thought to contribute to the pathogenesis and maintenance of temporal lobe epilepsy, but the underlying cell and mol. mechanisms are not fully understood.  The P2X7 receptor is an ionotropic receptor predominantly expressed on the surface of microglia, although neuronal expression has also been reported.  The receptor is activated by the release of ATP from intracellular sources that occurs during neurodegeneration, leading to microglial activation and inflammasome-mediated interleukin 1β release that contributes to neuroinflammation.  Using a reporter mouse in which green fluorescent protein is induced in response to the transcription of P2rx7, we show that expression of the receptor is selectively increased in CA1 pyramidal and dentate granule neurons, as well as in microglia in mice that developed epilepsy after intra-amygdala kainic acid-induced status epilepticus.  P2X7 receptor levels were increased in hippocampal subfields in the mice and in resected hippocampus from patients with pharmacoresistant temporal lobe epilepsy.  Cells transcribing P2rx7 in hippocampal slices from epileptic mice displayed enhanced agonist-evoked P2X7 receptor currents, and synaptosomes from these animals showed increased P2X7 receptor levels and altered calcium responses.  A 5 d treatment of epileptic mice with systemic injections of the centrally available, potent, and specific P2X7 receptor antagonist JNJ-47965567 (30 mg/kg) significantly reduced spontaneous seizures during continuous video-EEG monitoring that persisted beyond the time of drug presence in the brain.  Hippocampal sections from JNJ-47965567-treated animals obtained >5 d after treatment ceased displayed strongly reduced microgliosis and astrogliosis.  The present study suggests that targeting the P2X7 receptor has anticonvulsant and possibly disease-modifying effects in exptl. epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKv2tFIlA_-7Vg90H21EOLACvtfcHk0liYTMfDZy6Apg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2lsbbN&md5=2b57d7145b13968cea54920a6583de9a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4009-15.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4009-15.2016%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez-Pacheco%26aufirst%3DA.%26aulast%3DDiaz-Hernandez%26aufirst%3DM.%26aulast%3DArribas-Blazquez%26aufirst%3DM.%26aulast%3DSanz-Rodriguez%26aufirst%3DA.%26aulast%3DOlivos-Ore%26aufirst%3DL.%2BA.%26aulast%3DArtalejo%26aufirst%3DA.%2BR.%26aulast%3DAlves%26aufirst%3DM.%26aulast%3DLetavic%26aufirst%3DM.%26aulast%3DMiras-Portugal%26aufirst%3DM.%2BT.%26aulast%3DConroy%26aufirst%3DR.%2BM.%26aulast%3DDelanty%26aufirst%3DN.%26aulast%3DFarrell%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DD.%2BF.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DEngel%26aufirst%3DT.%26aulast%3DHenshall%26aufirst%3DD.%2BC.%26atitle%3DTransient%2520P2X7%2520receptor%2520antagonism%2520produces%2520lasting%2520reductions%2520in%2520spontaneous%2520seizures%2520and%2520gliosis%2520in%2520experimental%2520temporal%2520lobe%2520epilepsy%26jtitle%3DJ.%2520Neurosci.%26date%3D2016%26volume%3D36%26issue%3D22%26spage%3D5920%26epage%3D5932%26doi%3D10.1523%2FJNEUROSCI.4009-15.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Fischer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krugel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinkel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henshall, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, T.</span><span> </span><span class="NLM_article-title">Critical evaluation of P2X7 receptor antagonists in selected seizure models</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">e0156468</span><span class="refDoi"> DOI: 10.1371/journal.pone.0156468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1371%2Fjournal.pone.0156468" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0156468&issue=6&author=W.+Fischerauthor=H.+Frankeauthor=U.+Krugelauthor=H.+Mullerauthor=K.+Dinkelauthor=B.+Lordauthor=M.+A.+Letavicauthor=D.+C.+Henshallauthor=T.+Engel&title=Critical+evaluation+of+P2X7+receptor+antagonists+in+selected+seizure+models&doi=10.1371%2Fjournal.pone.0156468"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0156468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0156468%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DW.%26aulast%3DFranke%26aufirst%3DH.%26aulast%3DKrugel%26aufirst%3DU.%26aulast%3DMuller%26aufirst%3DH.%26aulast%3DDinkel%26aufirst%3DK.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DHenshall%26aufirst%3DD.%2BC.%26aulast%3DEngel%26aufirst%3DT.%26atitle%3DCritical%2520evaluation%2520of%2520P2X7%2520receptor%2520antagonists%2520in%2520selected%2520seizure%2520models%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3De0156468%26doi%3D10.1371%2Fjournal.pone.0156468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoblock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neff, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varlinskaya, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceusters, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span> </span><span class="NLM_article-title">Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">628</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span><span class="refDoi"> DOI: 10.1124/jpet.114.218487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1124%2Fjpet.114.218487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=25271258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWhu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=628-641&issue=3&author=B.+Lordauthor=L.+Aluisioauthor=J.+R.+Shoblockauthor=R.+A.+Neffauthor=E.+I.+Varlinskayaauthor=M.+Ceustersauthor=T.+W.+Lovenbergauthor=N.+Carruthersauthor=P.+Bonaventureauthor=M.+A.+Letavicauthor=T.+Deakauthor=W.+Drinkenburgauthor=A.+Bhattacharya&title=Pharmacology+of+a+novel+central+nervous+system-penetrant+P2X7+antagonist+JNJ-42253432&doi=10.1124%2Fjpet.114.218487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432</span></div><div class="casAuthors">Lord, Brian; Aluisio, Leah; Shoblock, James R.; Neff, Robert A.; Varlinskaya, Elena I.; Ceusters, Marc; Lovenberg, Timothy W.; Carruthers, Nicholas; Bonaventure, Pascal; Letavic, Michael A.; Deak, Terrence; Drinkenburg, Wilhelmus; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">628-641, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In the central nervous system, the ATP-gated Purinergic receptor P2X ligand-gated ion channel 7 (P2X7) is expressed in glial cells and modulates neurophysiol. via release of gliotransmitters, including the proinflammatory cytokine interleukin (IL)-1β.  In this study, we characterized JNJ-42253432 [2-methyl-N-([1-(4-phenylpiperazin-1-yl)cyclohexyl]methyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide] as a centrally permeable (brain-to-plasma ratio of 1), high-affinity P2X7 antagonist with desirable pharmacokinetic and pharmacodynamic properties for in vivo testing in rodents.  JNJ-42253432 is a high-affinity antagonist for the rat (pKi 9.1 ± 0.07) and human (pKi 7.9 ± 0.08) P2X7 channel.  The compd. blocked the ATP-induced current and Bz-ATP [2'(3')-O-(4-benzoylbenzoyl)adenosine-5'-triphosphate tri(triethylammonium)]-induced release of IL-1β in a concn.-dependent manner.  When dosed in rats, JNJ-42253432 occupied the brain P2X7 channel with an ED50 of 0.3 mg/kg, corresponding to a mean plasma concn. of 42 ng/mL.  The compd. blocked the release of IL-1β induced by Bz-ATP in freely moving rat brain.  At higher doses/exposure, JNJ-42253432 also increased serotonin levels in the rat brain, which is due to antagonism of the serotonin transporter (SERT) resulting in an ED50 of 10 mg/kg for SERT occupancy.  JNJ-42253432 reduced electroencephalog. spectral power in the α-1 band in a dose-dependent manner; the compd. also attenuated amphetamine-induced hyperactivity.  JNJ-42253432 significantly increased both overall social interaction and social preference, an effect that was independent of stress induced by foot-shock.  Surprisingly, there was no effect of the compd. on either neuropathic pain or inflammatory pain behaviors.  In summary, in this study, we characterize JNJ-42253432 as a novel brain-penetrant P2X7 antagonist with high affinity and selectivity for the P2X7 channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU5MO_PDXIeLVg90H21EOLACvtfcHk0liYTMfDZy6Apg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWhu7fN&md5=1ab23844891e251b37713c5cd80162a7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.218487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.218487%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DNeff%26aufirst%3DR.%2BA.%26aulast%3DVarlinskaya%26aufirst%3DE.%2BI.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DDeak%26aufirst%3DT.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DPharmacology%2520of%2520a%2520novel%2520central%2520nervous%2520system-penetrant%2520P2X7%2520antagonist%2520JNJ-42253432%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D351%26issue%3D3%26spage%3D628%26epage%3D641%26doi%3D10.1124%2Fjpet.114.218487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Dean, D. K.; Munoz-Muriedas, J.; Sime, M.; Steadman, J. G. A.; Thewlis, R. E. A.; Trani, G.; Walter, D. S.</span><span> </span><span class="NLM_article-title">Preparation of Tetrahydro[1,2,4]triazolo[4,3-a]pyrazine Derivatives for Use as P2X7 Modulators</span>. WO 2010125102 A1, November 4,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+K.+Dean&author=J.+Munoz-Muriedas&author=M.+Sime&author=J.+G.+A.+Steadman&author=R.+E.+A.+Thewlis&author=G.+Trani&author=D.+S.+Walter&title=Preparation+of+Tetrahydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazine+Derivatives+for+Use+as+P2X7+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DD.%2BK.%26atitle%3DPreparation%2520of%2520Tetrahydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazine%2520Derivatives%2520for%2520Use%2520as%2520P2X7%2520Modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrovian, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">3157</span><span class="NLM_x">–</span> <span class="NLM_lpage">3163</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.bmcl.2015.06.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3157-3163&issue=16&author=D.+A.+Rudolphauthor=J.+Alcazarauthor=M.+K.+Ameriksauthor=A.+B.+Antonauthor=H.+Aoauthor=P.+Bonaventureauthor=N.+I.+Carruthersauthor=C.+C.+Chrovianauthor=M.+De+Angelisauthor=B.+Lordauthor=J.+C.+Rechauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=J.+I.+Andresauthor=M.+A.+Letavic&title=Novel+methyl+substituted+1-%285%2C6-dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%29methanones+are+P2X7+antagonists&doi=10.1016%2Fj.bmcl.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DAnton%26aufirst%3DA.%2BB.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520methyl%2520substituted%25201-%25285%252C6-dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%2529methanones%2520are%2520P2X7%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D16%26spage%3D3157%26epage%3D3163%26doi%3D10.1016%2Fj.bmcl.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Synthesis, SAR, and pharmacological characterization of brain penetrant P2X7 receptor antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00089</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00089" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=671-676&issue=6&author=B.+M.+Savallauthor=D.+Wuauthor=M.+De+Angelisauthor=N.+I.+Carruthersauthor=H.+Aoauthor=Q.+Wangauthor=B.+Lordauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Synthesis%2C+SAR%2C+and+pharmacological+characterization+of+brain+penetrant+P2X7+receptor+antagonists&doi=10.1021%2Facsmedchemlett.5b00089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00089%26sid%3Dliteratum%253Aachs%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%252C%2520SAR%252C%2520and%2520pharmacological%2520characterization%2520of%2520brain%2520penetrant%2520P2X7%2520receptor%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D6%26spage%3D671%26epage%3D676%26doi%3D10.1021%2Facsmedchemlett.5b00089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Swanson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoetens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaptason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepassi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-di hydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a small molecule antagonist of the P2X7 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">8535</span><span class="NLM_x">–</span> <span class="NLM_lpage">8548</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8535-8548&issue=18&author=D.+M.+Swansonauthor=B.+M.+Savallauthor=K.+J.+Coeauthor=F.+Schoetensauthor=T.+Koudriakovaauthor=J.+Skaptasonauthor=J.+Wallauthor=J.+Rechauthor=X.+Dengauthor=M.+De+Angelisauthor=A.+Eversonauthor=B.+Lordauthor=Q.+Wangauthor=H.+Aoauthor=B.+Scottauthor=K.+Sepassiauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Identification+of+%28R%29-%282-Chloro-3-%28trifluoromethyl%29phenyl%29%281-%285-fluoropyridin-2-yl%29-4-methyl-6%2C7-di+hydro-1H-imidazo%5B4%2C5-c%5Dpyridin-5%284H%29-yl%29methanone+%28JNJ+54166060%29%2C+a+small+molecule+antagonist+of+the+P2X7+receptor&doi=10.1021%2Facs.jmedchem.6b00989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00989%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DD.%2BM.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DSkaptason%26aufirst%3DJ.%26aulast%3DWall%26aufirst%3DJ.%26aulast%3DRech%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DEverson%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%2520%2528R%2529-%25282-Chloro-3-%2528trifluoromethyl%2529phenyl%2529%25281-%25285-fluoropyridin-2-yl%2529-4-methyl-6%252C7-di%2520hydro-1H-imidazo%255B4%252C5-c%255Dpyridin-5%25284H%2529-yl%2529methanone%2520%2528JNJ%252054166060%2529%252C%2520a%2520small%2520molecule%2520antagonist%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D18%26spage%3D8535%26epage%3D8548%26doi%3D10.1021%2Facs.jmedchem.6b00989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.bmcl.2015.12.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=257-261&issue=2&author=M.+K.+Ameriksauthor=H.+Aoauthor=N.+I.+Carruthersauthor=B.+Lordauthor=S.+Ravulaauthor=J.+C.+Rechauthor=B.+M.+Savallauthor=J.+L.+Wallauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Preclinical+characterization+of+substituted+6%2C7-dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-8%285H%29-one+P2X7+receptor+antagonists&doi=10.1016%2Fj.bmcl.2015.12.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DRavula%26aufirst%3DS.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWall%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPreclinical%2520characterization%2520of%2520substituted%25206%252C7-dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-8%25285H%2529-one%2520P2X7%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D257%26epage%3D261%26doi%3D10.1016%2Fj.bmcl.2015.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ziff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shireman, B. T.</span><span> </span><span class="NLM_article-title">Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 antagonists</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvVemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=498-504&issue=4&author=J.+Ziffauthor=D.+A.+Rudolphauthor=B.+Stenneauthor=T.+Koudriakovaauthor=B.+Lordauthor=P.+Bonaventureauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=A.+Bhattacharyaauthor=M.+A.+Letavicauthor=B.+T.+Shireman&title=Substituted+5%2C6-%28Dihydropyrido%5B3%2C4-d%5Dpyrimidin-7%288H%29-yl%29-methanones+as+P2X7+antagonists&doi=10.1021%2Facschemneuro.5b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 Antagonists</span></div><div class="casAuthors">Ziff, Jeannie; Rudolph, Dale A.; Stenne, Brice; Koudriakova, Tatiana; Lord, Brian; Bonaventure, Pascal; Lovenberg, Timothy W.; Carruthers, Nicholas I.; Bhattacharya, Anindya; Letavic, Michael A.; Shireman, Brock T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">498-504</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the synthesis of a novel class of brain penetrating P2X7 antagonists with high potency at both the rat and human P2X7 receptors.  Disclosed herein are druglike mols. with demonstrated target engagement of the rat P2X7 receptors after an oral dose.  Specifically, compd. 20 occupied the P2X7 receptors >80% over the 6 h time course as measured by an ex vivo radioligand binding expt.  In a dose-response assay, this mol. has a plasma EC50 of 8 ng/mL.  Overall, 20 has suitable druglike properties and pharmacokinetics in rat and dog.  This mol. and others disclosed herein will serve as addnl. tools to elucidate the role of the P2X7 receptor in neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4iuRhC8lPbVg90H21EOLACvtfcHk0lguGVK5qC2EMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvVemsA%253D%253D&md5=7f3f1afa4dad4db259189b98d97c8ae9</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00304%26sid%3Dliteratum%253Aachs%26aulast%3DZiff%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DStenne%26aufirst%3DB.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26atitle%3DSubstituted%25205%252C6-%2528Dihydropyrido%255B3%252C4-d%255Dpyrimidin-7%25288H%2529-yl%2529-methanones%2520as%2520P2X7%2520antagonists%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D498%26epage%3D504%26doi%3D10.1021%2Facschemneuro.5b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chrovian, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soyode-Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacani, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Novel phenyl-substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 antagonists with robust target engagement in rat brain</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00303</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00303" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=490-497&issue=4&author=C.+C.+Chrovianauthor=A.+Soyode-Johnsonauthor=H.+Aoauthor=G.+M.+Bacaniauthor=N.+I.+Carruthersauthor=B.+Lordauthor=L.+Nguyenauthor=J.+C.+Rechauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Novel+phenyl-substituted+5%2C6-Dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazine+P2X7+antagonists+with+robust+target+engagement+in+rat+brain&doi=10.1021%2Facschemneuro.5b00303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Phenyl-Substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 Antagonists with Robust Target Engagement in Rat Brain</span></div><div class="casAuthors">Chrovian, Christa C.; Soyode-Johnson, Akinola; Ao, Hong; Bacani, Genesis M.; Carruthers, Nicholas I.; Lord, Brian; Nguyen, Leslie; Rech, Jason C.; Wang, Qi; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">490-497</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 antagonists were optimized to allow for good blood-brain barrier permeability and high P2X7 target engagement in the brain of rats.  Compd. I (huP2X7 IC50 = 9 nM; rat P2X7 IC50 = 42 nM) achieved 80% receptor occupancy for 6 h when dosed orally at 10 mg/kg in rats as measured by ex vivo radioligand binding autoradiog.  Structure-activity relationships within this series are described, as well as in vitro ADME results.  In vivo pharmacokinetic data for key compds. is also included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFc11o0pApUbVg90H21EOLACvtfcHk0lguGVK5qC2EMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlGmsA%253D%253D&md5=a51ac05ebd3115489ddbabecf0cd1170</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00303%26sid%3Dliteratum%253Aachs%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DSoyode-Johnson%26aufirst%3DA.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBacani%26aufirst%3DG.%2BM.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520phenyl-substituted%25205%252C6-Dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazine%2520P2X7%2520antagonists%2520with%2520robust%2520target%2520engagement%2520in%2520rat%2520brain%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D490%26epage%3D497%26doi%3D10.1021%2Facschemneuro.5b00303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourgeaud, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vliegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verluyten, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haspeslagh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span> </span><span class="NLM_article-title">A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">765</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.ejphar.2015.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=26386289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFOrs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=765&publication_year=2015&pages=551-559&author=B.+Lordauthor=M.+K.+Ameriksauthor=Q.+Wangauthor=L.+Fourgeaudauthor=M.+Vliegenauthor=W.+Verluytenauthor=P.+Haspeslaghauthor=N.+I.+Carruthersauthor=T.+W.+Lovenbergauthor=P.+Bonaventureauthor=M.+A.+Letavicauthor=A.+Bhattacharya&title=A+novel+radioligand+for+the+ATP-gated+ion+channel+P2X7%3A+%5B3H%5D+JNJ-54232334&doi=10.1016%2Fj.ejphar.2015.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334</span></div><div class="casAuthors">Lord, Brian; Ameriks, Michael K.; Wang, Qi; Fourgeaud, Lawrence; Vliegen, Maarten; Verluyten, Willy; Haspeslagh, Pieter; Carruthers, Nicholas I.; Lovenberg, Timothy W.; Bonaventure, Pascal; Letavic, Michael A.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">765</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">551-559</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ATP-gated ion channel P2X7 has emerged as a potential central nervous system (CNS) drug target based on the hypotheses that pro-inflammatory cytokines such as IL-1β that are released by microglia, may contribute to the etiol. of various disorders of the CNS including depression.  In this study, we identified two closely related P2X7 antagonists, JNJ-54232334 and JNJ-54140515, and then tritium labeled the former to produce a new radioligand for P2X7.  JNJ-54232334 is a high affinity ligand for the rat P2X7 with a pKi of 9.3±0.1.  In rat cortical membranes, [3H] JNJ-54232334 reached saturable binding with equil. dissocn. (Kd) const. of 4.9±1.3 nM.  The compd. displayed monophasic assocn. and dissocn. kinetics with fast on and off rates.  In rat brain sections, specific binding of [3H] JNJ-54232334 was markedly improved compared to the previously described P2X7 radioligand, [3H] A-804598.  In P2X7 knockout mouse brain sections, [3H] A-804598 bound to non-P2X7 binding sites in contrast to [3H] JNJ-54232334.  In rat or wild type mouse brain sections [3H] JNJ-54232334 bound in a more homogenous and region independent manner.  The ubiquitous expression of P2X7 receptors was confirmed with immunohistochem. in rat brain sections.  The partial displacement of [3H] A-804598 binding resulted in the underestimation of the level of ex vivo P2X7 occupancy for JNJ-54140515.  Higher levels of P2X7 ex vivo occupancy were measured using [3H] JNJ-54232334 due to less non-specific binding.  In summary, we describe [3H] JNJ-54232334 as a novel P2X7 radioligand, with improved properties over [3H] A-804598.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqr6Nqq14QSLVg90H21EOLACvtfcHk0lguGVK5qC2EMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFOrs7zP&md5=b7d9da772882fa3d9e405fa54444d0f3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DFourgeaud%26aufirst%3DL.%26aulast%3DVliegen%26aufirst%3DM.%26aulast%3DVerluyten%26aufirst%3DW.%26aulast%3DHaspeslagh%26aufirst%3DP.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DA%2520novel%2520radioligand%2520for%2520the%2520ATP-gated%2520ion%2520channel%2520P2X7%253A%2520%255B3H%255D%2520JNJ-54232334%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D765%26spage%3D551%26epage%3D559%26doi%3D10.1016%2Fj.ejphar.2015.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Altman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koval, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Copper-catalyzed N-arylation of imidazoles and benzimidazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">6190</span><span class="NLM_x">–</span> <span class="NLM_lpage">6199</span><span class="refDoi"> DOI: 10.1021/jo070807a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo070807a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=6190-6199&issue=16&author=R.+A.+Altmanauthor=E.+D.+Kovalauthor=S.+L.+Buchwald&title=Copper-catalyzed+N-arylation+of+imidazoles+and+benzimidazoles&doi=10.1021%2Fjo070807a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1021%2Fjo070807a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo070807a%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DR.%2BA.%26aulast%3DKoval%26aufirst%3DE.%2BD.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DCopper-catalyzed%2520N-arylation%2520of%2520imidazoles%2520and%2520benzimidazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D16%26spage%3D6190%26epage%3D6199%26doi%3D10.1021%2Fjo070807a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Antilla, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baskin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barder, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Copper–diamine-catalyzed N-arylation of pyrroles, pyrazoles, indazoles, imidazoles, and triazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5578</span><span class="NLM_x">–</span> <span class="NLM_lpage">5587</span><span class="refDoi"> DOI: 10.1021/jo049658b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo049658b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=5578-5587&issue=17&author=J.+C.+Antillaauthor=J.+M.+Baskinauthor=T.+E.+Barderauthor=S.+L.+Buchwald&title=Copper%E2%80%93diamine-catalyzed+N-arylation+of+pyrroles%2C+pyrazoles%2C+indazoles%2C+imidazoles%2C+and+triazoles&doi=10.1021%2Fjo049658b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1021%2Fjo049658b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049658b%26sid%3Dliteratum%253Aachs%26aulast%3DAntilla%26aufirst%3DJ.%2BC.%26aulast%3DBaskin%26aufirst%3DJ.%2BM.%26aulast%3DBarder%26aufirst%3DT.%2BE.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DCopper%25E2%2580%2593diamine-catalyzed%2520N-arylation%2520of%2520pyrroles%252C%2520pyrazoles%252C%2520indazoles%252C%2520imidazoles%252C%2520and%2520triazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26issue%3D17%26spage%3D5578%26epage%3D5587%26doi%3D10.1021%2Fjo049658b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Khanna, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weier, R. M.</span><span> </span><span class="NLM_article-title">Regiospecific addition of Grignard reagents to the 4-position of activated imidazo[4,5-c]pyridine. A convenient method fot the synthesisof 4-alkylarylimidazopyrazines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1885</span><span class="NLM_x">–</span> <span class="NLM_lpage">1888</span><span class="refDoi"> DOI: 10.1016/S0040-4039(00)91954-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2FS0040-4039%2800%2991954-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=1885-1888&issue=12&author=I.+K.+Khannaauthor=R.+M.+Weier&title=Regiospecific+addition+of+Grignard+reagents+to+the+4-position+of+activated+imidazo%5B4%2C5-c%5Dpyridine.+A+convenient+method+fot+the+synthesisof+4-alkylarylimidazopyrazines&doi=10.1016%2FS0040-4039%2800%2991954-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2991954-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252991954-3%26sid%3Dliteratum%253Aachs%26aulast%3DKhanna%26aufirst%3DI.%2BK.%26aulast%3DWeier%26aufirst%3DR.%2BM.%26atitle%3DRegiospecific%2520addition%2520of%2520Grignard%2520reagents%2520to%2520the%25204-position%2520of%2520activated%2520imidazo%255B4%252C5-c%255Dpyridine.%2520A%2520convenient%2520method%2520fot%2520the%2520synthesisof%25204-alkylarylimidazopyrazines%26jtitle%3DTetrahedron%2520Lett.%26date%3D1993%26volume%3D34%26issue%3D12%26spage%3D1885%26epage%3D1888%26doi%3D10.1016%2FS0040-4039%2800%2991954-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Deng, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N. S.</span><span> </span><span class="NLM_article-title">Allyl-assisted, Cu(I)-catalyzed azide-alkyne cycloaddition/allylation reaction: Assembly of the [1,2,3]triazolo-4,5,6,7-tetrahydropyridine core structure</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">11003</span><span class="NLM_x">–</span> <span class="NLM_lpage">11012</span><span class="refDoi"> DOI: 10.1021/acs.joc.5b02174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b02174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=11003-11012&issue=21&author=X.+H.+Dengauthor=J.+Liangauthor=B.+B.+Allisonauthor=C.+Dvorakauthor=H.+McAllisterauthor=B.+M.+Savallauthor=N.+S.+Mani&title=Allyl-assisted%2C+Cu%28I%29-catalyzed+azide-alkyne+cycloaddition%2Fallylation+reaction%3A+Assembly+of+the+%5B1%2C2%2C3%5Dtriazolo-4%2C5%2C6%2C7-tetrahydropyridine+core+structure&doi=10.1021%2Facs.joc.5b02174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b02174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b02174%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%2BH.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DAllison%26aufirst%3DB.%2BB.%26aulast%3DDvorak%26aufirst%3DC.%26aulast%3DMcAllister%26aufirst%3DH.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DMani%26aufirst%3DN.%2BS.%26atitle%3DAllyl-assisted%252C%2520Cu%2528I%2529-catalyzed%2520azide-alkyne%2520cycloaddition%252Fallylation%2520reaction%253A%2520Assembly%2520of%2520the%2520%255B1%252C2%252C3%255Dtriazolo-4%252C5%252C6%252C7-tetrahydropyridine%2520core%2520structure%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26issue%3D21%26spage%3D11003%26epage%3D11012%26doi%3D10.1021%2Facs.joc.5b02174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Alcazar Vaca, M. J.; Andres Gil, J. I.; Chrovian, C. C.; Coate, H. R.; De Angelis, M.; Gelin, C. F.; Letavic, M. A.; Savall, B. M.; Soyode-Johnson, A.; Stenne, B. M.; Swanson, D. M.</span><span> </span><span class="NLM_article-title">Preparation of Imidazo[4,5-c]pyridines and 1,2,3-Triazolopyridines as P2X7 Modulators for Therapy</span>. US 2014 0275015 A1 September 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+J.+Alcazar+Vaca&author=J.+I.+Andres+Gil&author=C.+C.+Chrovian&author=H.+R.+Coate&author=M.+De+Angelis&author=C.+F.+Gelin&author=M.+A.+Letavic&author=B.+M.+Savall&author=A.+Soyode-Johnson&author=B.+M.+Stenne&author=D.+M.+Swanson&title=Preparation+of+Imidazo%5B4%2C5-c%5Dpyridines+and+1%2C2%2C3-Triazolopyridines+as+P2X7+Modulators+for+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlcazar%2BVaca%26aufirst%3DM.%2BJ.%26atitle%3DPreparation%2520of%2520Imidazo%255B4%252C5-c%255Dpyridines%2520and%25201%252C2%252C3-Triazolopyridines%2520as%2520P2X7%2520Modulators%2520for%2520Therapy%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2a','cit2b','cit2c'],'ref3':['cit3a','cit3b','cit3c','cit3d'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7a'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25a','cit25b'],'ref26':['cit26'],'ref27':['cit27a','cit27b'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 29 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Allen T. Hopper, Martin Juhl, Jorrit Hornberg, Lassina Badolo, John Paul Kilburn, Annemette Thougaard, Gennady Smagin, Dekun Song, Londye Calice, Veena Menon, Elena Dale, Hong Zhang, Manuel Cajina, Megan E. Nattini, Adarsh Gandhi, Michel Grenon, Ken Jones, Tanzilya Khayrullina, Gamini Chandrasena, Christian Thomsen, Stevin H. Zorn, Robb Brodbeck, Suresh Babu Poda, Roland Staal, <span class="NLM_string-name hlFld-ContribAuthor">Thomas Möller</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Characterization of the Novel Rodent-Active and CNS-Penetrant P2X7 Receptor Antagonist Lu AF27139. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4891-4902. <a href="https://doi.org/10.1021/acs.jmedchem.0c02249" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02249</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02249%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BCharacterization%252Bof%252Bthe%252BNovel%252BRodent-Active%252Band%252BCNS-Penetrant%252BP2X7%252BReceptor%252BAntagonist%252BLu%252BAF27139%26aulast%3DHopper%26aufirst%3DAllen%2BT.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28122020%26date%3D06042021%26volume%3D64%26issue%3D8%26spage%3D4891%26epage%3D4902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Francesco Calzaferri, Paloma Narros-Fernández, Ricardo de Pascual, Antonio M.G. de Diego, Annette Nicke, Javier Egea, Antonio G. García, <span class="NLM_string-name hlFld-ContribAuthor">Cristóbal de los Ríos</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Pharmacological Evaluation of Novel Non-nucleotide Purine Derivatives as P2X7 Antagonists for the Treatment of Neuroinflammation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (4)
                                     , 2272-2290. <a href="https://doi.org/10.1021/acs.jmedchem.0c02145" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02145</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02145&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02145%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BPharmacological%252BEvaluation%252Bof%252BNovel%252BNon-nucleotide%252BPurine%252BDerivatives%252Bas%252BP2X7%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BNeuroinflammation%26aulast%3DCalzaferri%26aufirst%3DFrancesco%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D11122020%26date%3D09022021%26volume%3D64%26issue%3D4%26spage%3D2272%26epage%3D2290" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christa C. Chrovian, Akinola Soyode-Johnson, Brice Stenne, Daniel J. Pippel, Jeffrey Schoellerman, Brian Lord, Alexandra S. Needham, Chungfang Xia, Kevin J. Coe, Kia Sepassi, Freddy Schoetens, Brian Scott, Leslie Nguyen, Xiaohui Jiang, Tatiana Koudriakova, Bartosz Balana, <span class="NLM_string-name hlFld-ContribAuthor">Michael A. Letavic</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Preclinical Evaluation of 3-Methyl-6-(5-thiophenyl)-1,3-dihydro-imidazo[4,5-b]pyridin-2-ones as Selective GluN2B Negative Allosteric Modulators for the Treatment of Mood Disorders. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (17)
                                     , 9181-9196. <a href="https://doi.org/10.1021/acs.jmedchem.9b02113" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02113%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BPreclinical%252BEvaluation%252Bof%252B3-Methyl-6-%2525285-thiophenyl%252529-1%25252C3-dihydro-imidazo%25255B4%25252C5-b%25255Dpyridin-2-ones%252Bas%252BSelective%252BGluN2B%252BNegative%252BAllosteric%252BModulators%252Bfor%252Bthe%252BTreatment%252Bof%252BMood%252BDisorders%26aulast%3DChrovian%26aufirst%3DChrista%2BC.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06022020%26date%3D28082020%26date%3D31072020%26volume%3D63%26issue%3D17%26spage%3D9181%26epage%3D9196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Where Do Recent Small Molecule Clinical Development Candidates Come From?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (21)
                                     , 9442-9468. <a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhere%252BDo%252BRecent%252BSmall%252BMolecule%252BClinical%252BDevelopment%252BCandidates%252BCome%252BFrom%25253F%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27042018%26date%3D09072018%26date%3D19062018%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christa C.  Chrovian</span>, <span class="hlFld-ContribAuthor ">Akinola  Soyode-Johnson</span>, <span class="hlFld-ContribAuthor ">Alexander A.  Peterson</span>, <span class="hlFld-ContribAuthor ">Christine F.  Gelin</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Deng</span>, <span class="hlFld-ContribAuthor ">Curt A.  Dvorak</span>, <span class="hlFld-ContribAuthor ">Nicholas I.  Carruthers</span>, <span class="hlFld-ContribAuthor ">Brian  Lord</span>, <span class="hlFld-ContribAuthor ">Ian  Fraser</span>, <span class="hlFld-ContribAuthor ">Leah  Aluisio</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Coe</span>, <span class="hlFld-ContribAuthor ">Brian  Scott</span>, <span class="hlFld-ContribAuthor ">Tatiana  Koudriakova</span>, <span class="hlFld-ContribAuthor ">Freddy  Schoetens</span>, <span class="hlFld-ContribAuthor ">Kia  Sepassi</span>, <span class="hlFld-ContribAuthor ">David J.  Gallacher</span>, <span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, and <span class="hlFld-ContribAuthor ">Michael A.  Letavic</span>  . </span><span class="cited-content_cbyCitation_article-title">A Dipolar Cycloaddition Reaction To Access 6-Methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridines Enables the Discovery Synthesis and Preclinical Profiling of a P2X7 Antagonist Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (1)
                                     , 207-223. <a href="https://doi.org/10.1021/acs.jmedchem.7b01279" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01279%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BDipolar%252BCycloaddition%252BReaction%252BTo%252BAccess%252B6-Methyl-4%25252C5%25252C6%25252C7-tetrahydro-1H-%25255B1%25252C2%25252C3%25255Dtriazolo%25255B4%25252C5-c%25255Dpyridines%252BEnables%252Bthe%252BDiscovery%252BSynthesis%252Band%252BPreclinical%252BProfiling%252Bof%252Ba%252BP2X7%252BAntagonist%252BClinical%252BCandidate%26aulast%3DChrovian%26aufirst%3DChrista%2BC.%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D28082017%26date%3D20122017%26date%3D11012018%26date%3D06122017%26volume%3D61%26issue%3D1%26spage%3D207%26epage%3D223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Drill</span>, <span class="hlFld-ContribAuthor ">Nigel C.  Jones</span>, <span class="hlFld-ContribAuthor ">Martin  Hunn</span>, <span class="hlFld-ContribAuthor ">Terence J.  O’Brien</span>, <span class="hlFld-ContribAuthor ">Mastura  Monif</span>. </span><span class="cited-content_cbyCitation_article-title">Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer. </span><span class="cited-content_cbyCitation_journal-name">Purinergic Signalling</span><span> <strong>2021,</strong> <em>17 </em>
                                    (2)
                                     , 215-227. <a href="https://doi.org/10.1007/s11302-021-09776-9" title="DOI URL">https://doi.org/10.1007/s11302-021-09776-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11302-021-09776-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11302-021-09776-9%26sid%3Dliteratum%253Aachs%26jtitle%3DPurinergic%2520Signalling%26atitle%3DAntagonism%252Bof%252Bthe%252BATP-gated%252BP2X7%252Breceptor%25253A%252Ba%252Bpotential%252Btherapeutic%252Bstrategy%252Bfor%252Bcancer%26aulast%3DDrill%26aufirst%3DMatthew%26date%3D2021%26date%3D2021%26volume%3D17%26issue%3D2%26spage%3D215%26epage%3D227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefania  Merighi</span>, <span class="hlFld-ContribAuthor ">Tino Emanuele  Poloni</span>, <span class="hlFld-ContribAuthor ">Anna  Terrazzan</span>, <span class="hlFld-ContribAuthor ">Eva  Moretti</span>, <span class="hlFld-ContribAuthor ">Stefania  Gessi</span>, <span class="hlFld-ContribAuthor ">Davide  Ferrari</span>. </span><span class="cited-content_cbyCitation_article-title">Alzheimer and Purinergic Signaling: Just a Matter of Inflammation?. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2021,</strong> <em>10 </em>
                                    (5)
                                     , 1267. <a href="https://doi.org/10.3390/cells10051267" title="DOI URL">https://doi.org/10.3390/cells10051267</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells10051267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells10051267%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DAlzheimer%252Band%252BPurinergic%252BSignaling%25253A%252BJust%252Ba%252BMatter%252Bof%252BInflammation%25253F%26aulast%3DMerighi%26aufirst%3DStefania%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D5%26spage%3D1267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul R.  Territo</span>, <span class="hlFld-ContribAuthor ">Hamideh  Zarrinmayeh</span>. </span><span class="cited-content_cbyCitation_article-title">P2X7 Receptors in Neurodegeneration: Potential Therapeutic Applications From Basic to Clinical Approaches. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Cellular Neuroscience</span><span> <strong>2021,</strong> <em>15 </em><a href="https://doi.org/10.3389/fncel.2021.617036" title="DOI URL">https://doi.org/10.3389/fncel.2021.617036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fncel.2021.617036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffncel.2021.617036%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Cellular%2520Neuroscience%26atitle%3DP2X7%252BReceptors%252Bin%252BNeurodegeneration%25253A%252BPotential%252BTherapeutic%252BApplications%252BFrom%252BBasic%252Bto%252BClinical%252BApproaches%26aulast%3DTerrito%26aufirst%3DPaul%2BR.%26date%3D2021%26date%3D2021%26volume%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavithra  Suresh</span>, <span class="hlFld-ContribAuthor ">Sarayut  Phasuk</span>, <span class="hlFld-ContribAuthor ">IngridY  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Modulation of microglia activation and Alzheimer's disease: CX3 chemokine ligand 1/CX3CR and P2X7R signaling. </span><span class="cited-content_cbyCitation_journal-name">Tzu Chi Medical Journal</span><span> <strong>2021,</strong> <em>33 </em>
                                    (1)
                                     , 1. <a href="https://doi.org/10.4103/tcmj.tcmj_144_20" title="DOI URL">https://doi.org/10.4103/tcmj.tcmj_144_20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4103/tcmj.tcmj_144_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4103%2Ftcmj.tcmj_144_20%26sid%3Dliteratum%253Aachs%26jtitle%3DTzu%2520Chi%2520Medical%2520Journal%26atitle%3DModulation%252Bof%252Bmicroglia%252Bactivation%252Band%252BAlzheimer%252527s%252Bdisease%25253A%252BCX3%252Bchemokine%252Bligand%252B1%25252FCX3CR%252Band%252BP2X7R%252Bsignaling%26aulast%3DSuresh%26aufirst%3DPavithra%26date%3D2021%26volume%3D33%26issue%3D1%26spage%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Calzaferri</span>, <span class="hlFld-ContribAuthor ">Cristina  Ruiz‐Ruiz</span>, <span class="hlFld-ContribAuthor ">Antonio M. G.  Diego</span>, <span class="hlFld-ContribAuthor ">Ricardo  Pascual</span>, <span class="hlFld-ContribAuthor ">Iago  Méndez‐López</span>, <span class="hlFld-ContribAuthor ">María F.  Cano‐Abad</span>, <span class="hlFld-ContribAuthor ">Victoria  Maneu</span>, <span class="hlFld-ContribAuthor ">Cristóbal  Ríos</span>, <span class="hlFld-ContribAuthor ">Luis  Gandía</span>, <span class="hlFld-ContribAuthor ">Antonio G.  García</span>. </span><span class="cited-content_cbyCitation_article-title">The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (6)
                                     , 2427-2465. <a href="https://doi.org/10.1002/med.21710" title="DOI URL">https://doi.org/10.1002/med.21710</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21710&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21710%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DThe%252Bpurinergic%252BP2X7%252Breceptor%252Bas%252Ba%252Bpotential%252Bdrug%252Btarget%252Bto%252Bcombat%252Bneuroinflammation%252Bin%252Bneurodegenerative%252Bdiseases%26aulast%3DCalzaferri%26aufirst%3DFrancesco%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D6%26spage%3D2427%26epage%3D2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kasper  Recourt</span>, <span class="hlFld-ContribAuthor ">Jasper  van der Aart</span>, <span class="hlFld-ContribAuthor ">Gabriel  Jacobs</span>, <span class="hlFld-ContribAuthor ">Marieke  de Kam</span>, <span class="hlFld-ContribAuthor ">Wayne  Drevets</span>, <span class="hlFld-ContribAuthor ">Luc  van Nueten</span>, <span class="hlFld-ContribAuthor ">Kawita  Kanhai</span>, <span class="hlFld-ContribAuthor ">Pieter  Siebenga</span>, <span class="hlFld-ContribAuthor ">Rob  Zuiker</span>, <span class="hlFld-ContribAuthor ">Paulien  Ravenstijn</span>, <span class="hlFld-ContribAuthor ">Maarten  Timmers</span>, <span class="hlFld-ContribAuthor ">Joop  van Gerven</span>, <span class="hlFld-ContribAuthor ">Peter  de Boer</span>. </span><span class="cited-content_cbyCitation_article-title">Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2020,</strong> <em>34 </em>
                                    (9)
                                     , 1030-1042. <a href="https://doi.org/10.1177/0269881120914206" title="DOI URL">https://doi.org/10.1177/0269881120914206</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0269881120914206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0269881120914206%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DCharacterisation%252Bof%252Bthe%252Bpharmacodynamic%252Beffects%252Bof%252Bthe%252BP2X7%252Breceptor%252Bantagonist%252BJNJ-54175446%252Busing%252Ban%252Boral%252Bdexamphetamine%252Bchallenge%252Bmodel%252Bin%252Bhealthy%252Bmales%252Bin%252Ba%252Brandomised%25252C%252Bdouble-blind%25252C%252Bplacebo-controlled%25252C%252Bmultiple%252Bascending%252Bdose%252Btrial%26aulast%3DRecourt%26aufirst%3DKasper%26date%3D2020%26date%3D2020%26volume%3D34%26issue%3D9%26spage%3D1030%26epage%3D1042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberta  Andrejew</span>, <span class="hlFld-ContribAuthor ">Ágatha  Oliveira-Giacomelli</span>, <span class="hlFld-ContribAuthor ">Deidiane Elisa  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Talita  Glaser</span>, <span class="hlFld-ContribAuthor ">Vanessa Fernandes  Arnaud-Sampaio</span>, <span class="hlFld-ContribAuthor ">Claudiana  Lameu</span>, <span class="hlFld-ContribAuthor ">Henning  Ulrich</span>. </span><span class="cited-content_cbyCitation_article-title">The P2X7 Receptor: Central Hub of Brain Diseases. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2020,</strong> <em>13 </em><a href="https://doi.org/10.3389/fnmol.2020.00124" title="DOI URL">https://doi.org/10.3389/fnmol.2020.00124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2020.00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2020.00124%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DThe%252BP2X7%252BReceptor%25253A%252BCentral%252BHub%252Bof%252BBrain%252BDiseases%26aulast%3DAndrejew%26aufirst%3DRoberta%26date%3D2020%26date%3D2020%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristina  Ruiz-Ruiz</span>, <span class="hlFld-ContribAuthor ">Francesco  Calzaferri</span>, <span class="hlFld-ContribAuthor ">Antonio G.  García</span>. </span><span class="cited-content_cbyCitation_article-title">P2X7 Receptor Antagonism as a Potential Therapy in Amyotrophic Lateral Sclerosis. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Molecular Neuroscience</span><span> <strong>2020,</strong> <em>13 </em><a href="https://doi.org/10.3389/fnmol.2020.00093" title="DOI URL">https://doi.org/10.3389/fnmol.2020.00093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnmol.2020.00093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnmol.2020.00093%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Molecular%2520Neuroscience%26atitle%3DP2X7%252BReceptor%252BAntagonism%252Bas%252Ba%252BPotential%252BTherapy%252Bin%252BAmyotrophic%252BLateral%252BSclerosis%26aulast%3DRuiz-Ruiz%26aufirst%3DCristina%26date%3D2020%26date%3D2020%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Xu</span>, <span class="hlFld-ContribAuthor ">Xin  Miao</span>, <span class="hlFld-ContribAuthor ">Paulien  Ravenstijn</span>, <span class="hlFld-ContribAuthor ">Anja  Hijzen</span>, <span class="hlFld-ContribAuthor ">Mark E.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Partha  Nandy</span>, <span class="hlFld-ContribAuthor ">Honghui  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Translational Model‐Informed Dose Selection for a Human Positron Emission Tomography Imaging Study of JNJ‐54175446, a P2X7 Receptor Antagonist. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Science</span><span> <strong>2020,</strong> <em>13 </em>
                                    (2)
                                     , 309-317. <a href="https://doi.org/10.1111/cts.12711" title="DOI URL">https://doi.org/10.1111/cts.12711</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cts.12711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcts.12711%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Science%26atitle%3DTranslational%252BModel%2525E2%252580%252590Informed%252BDose%252BSelection%252Bfor%252Ba%252BHuman%2525C2%2525A0Positron%252BEmission%252BTomography%252BImaging%252BStudy%252Bof%252BJNJ%2525E2%252580%25259054175446%25252C%252Ba%252BP2X7%252BReceptor%252BAntagonist%26aulast%3DXu%26aufirst%3DYan%26date%3D2020%26date%3D2019%26volume%3D13%26issue%3D2%26spage%3D309%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christine F.  Gelin</span>, <span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Michael A.  Letavic</span>. </span><span class="cited-content_cbyCitation_article-title">P2X7 receptor antagonists for the treatment of systemic inflammatory disorders. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 63-99. <a href="https://doi.org/10.1016/bs.pmch.2019.11.002" title="DOI URL">https://doi.org/10.1016/bs.pmch.2019.11.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2019.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2019.11.002%26sid%3Dliteratum%253Aachs%26atitle%3DP2X7%252Breceptor%252Bantagonists%252Bfor%252Bthe%252Btreatment%252Bof%252Bsystemic%252Binflammatory%252Bdisorders%26aulast%3DGelin%26aufirst%3DChristine%2BF.%26date%3D2020%26spage%3D63%26epage%3D99%26pub%3DElsevier%26date%3D2020%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Marc  Ceusters</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2020,</strong> <em>45 </em>
                                    (1)
                                     , 234-235. <a href="https://doi.org/10.1038/s41386-019-0502-9" title="DOI URL">https://doi.org/10.1038/s41386-019-0502-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-019-0502-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-019-0502-9%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DTargeting%252Bneuroinflammation%252Bwith%252Bbrain%252Bpenetrant%252BP2X7%252Bantagonists%252Bas%252Bnovel%252Btherapeutics%252Bfor%252Bneuropsychiatric%252Bdisorders%26aulast%3DBhattacharya%26aufirst%3DAnindya%26date%3D2020%26date%3D2019%26volume%3D45%26issue%3D1%26spage%3D234%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tamara  Berdyyeva</span>, <span class="hlFld-ContribAuthor ">Chunfang  Xia</span>, <span class="hlFld-ContribAuthor ">Natalie  Taylor</span>, <span class="hlFld-ContribAuthor ">Yingbo  He</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Chaofeng  Huang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Hartmuth  Kolb</span>, <span class="hlFld-ContribAuthor ">Michael  Letavic</span>, <span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Anna Katrin  Szardenings</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of the P2X7 Ion Channel with a Novel Tracer [18F]JNJ-64413739 in a Rat Model of Neuroinflammation. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging and Biology</span><span> <strong>2019,</strong> <em>21 </em>
                                    (5)
                                     , 871-878. <a href="https://doi.org/10.1007/s11307-018-01313-2" title="DOI URL">https://doi.org/10.1007/s11307-018-01313-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11307-018-01313-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11307-018-01313-2%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%2520and%2520Biology%26atitle%3DPET%252BImaging%252Bof%252Bthe%252BP2X7%252BIon%252BChannel%252Bwith%252Ba%252BNovel%252BTracer%252B%25255B18F%25255DJNJ-64413739%252Bin%252Ba%252BRat%252BModel%252Bof%252BNeuroinflammation%26aulast%3DBerdyyeva%26aufirst%3DTamara%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D5%26spage%3D871%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lumei  Huang</span>, <span class="hlFld-ContribAuthor ">Lilla  Otrokocsi</span>, <span class="hlFld-ContribAuthor ">Beáta  Sperlágh</span>. </span><span class="cited-content_cbyCitation_article-title">Role of P2 receptors in normal brain development and in neurodevelopmental psychiatric disorders. </span><span class="cited-content_cbyCitation_journal-name">Brain Research Bulletin</span><span> <strong>2019,</strong> <em>151 </em>, 55-64. <a href="https://doi.org/10.1016/j.brainresbull.2019.01.030" title="DOI URL">https://doi.org/10.1016/j.brainresbull.2019.01.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.brainresbull.2019.01.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.brainresbull.2019.01.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Research%2520Bulletin%26atitle%3DRole%252Bof%252BP2%252Breceptors%252Bin%252Bnormal%252Bbrain%252Bdevelopment%252Band%252Bin%252Bneurodevelopmental%252Bpsychiatric%252Bdisorders%26aulast%3DHuang%26aufirst%3DLumei%26date%3D2019%26volume%3D151%26spage%3D55%26epage%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erica L.  Fletcher</span>, <span class="hlFld-ContribAuthor ">Anna Y.  Wang</span>, <span class="hlFld-ContribAuthor ">Andrew I.  Jobling</span>, <span class="hlFld-ContribAuthor ">Matthew V.  Rutar</span>, <span class="hlFld-ContribAuthor ">Ursula  Greferath</span>, <span class="hlFld-ContribAuthor ">Ben  Gu</span>, <span class="hlFld-ContribAuthor ">Kirstan A.  Vessey</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting P2X7 receptors as a means for treating retinal disease. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (8)
                                     , 1598-1605. <a href="https://doi.org/10.1016/j.drudis.2019.03.029" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.03.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.03.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.03.029%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DTargeting%252BP2X7%252Breceptors%252Bas%252Ba%252Bmeans%252Bfor%252Btreating%252Bretinal%252Bdisease%26aulast%3DFletcher%26aufirst%3DErica%2BL.%26date%3D2019%26volume%3D24%26issue%3D8%26spage%3D1598%26epage%3D1605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hartmuth C.  Kolb</span>, <span class="hlFld-ContribAuthor ">Olivier  Barret</span>, <span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Gang  Chen</span>, <span class="hlFld-ContribAuthor ">Cristian  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Chaofeng  Huang</span>, <span class="hlFld-ContribAuthor ">Michael  Letavic</span>, <span class="hlFld-ContribAuthor ">Gilles  Tamagnan</span>, <span class="hlFld-ContribAuthor ">Chunfang A.  Xia</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Anna Katrin  Szardenings</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
              18
              F-JNJ-64413739, a PET Radioligand for P2X7 Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2019,</strong> <em>60 </em>
                                    (8)
                                     , 1154-1159. <a href="https://doi.org/10.2967/jnumed.118.212696" title="DOI URL">https://doi.org/10.2967/jnumed.118.212696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.212696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.212696%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DPreclinical%252BEvaluation%252Band%252BNonhuman%252BPrimate%252BReceptor%252BOccupancy%252BStudy%252Bof%252B18%252BF-JNJ-64413739%25252C%252Ba%252BPET%252BRadioligand%252Bfor%252BP2X7%252BReceptors%26aulast%3DKolb%26aufirst%3DHartmuth%2BC.%26date%3D2019%26date%3D2019%26volume%3D60%26issue%3D8%26spage%3D1154%26epage%3D1159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yufang  Xiao</span>, <span class="hlFld-ContribAuthor ">Srinivasa  Karra</span>, <span class="hlFld-ContribAuthor ">Andreas  Goutopoulos</span>, <span class="hlFld-ContribAuthor ">Noune Tahmassian  Morse</span>, <span class="hlFld-ContribAuthor ">Susan  Zhang</span>, <span class="hlFld-ContribAuthor ">Mohanraj  Dhanabal</span>, <span class="hlFld-ContribAuthor ">Hui  Tian</span>, <span class="hlFld-ContribAuthor ">Jeyaprakashnarayanan  Seenisamy</span>, <span class="hlFld-ContribAuthor ">Jayashankaran  Jayadevan</span>, <span class="hlFld-ContribAuthor ">Richard  Caldwell</span>, <span class="hlFld-ContribAuthor ">Justin  Potnick</span>, <span class="hlFld-ContribAuthor ">Matthew  Bleich</span>, <span class="hlFld-ContribAuthor ">Eugene  Chekler</span>, <span class="hlFld-ContribAuthor ">Brian  Sherer</span>, <span class="hlFld-ContribAuthor ">Venkataraman  Sriraman</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR development of quinoline analogs as novel P2X7 receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (13)
                                     , 1660-1664. <a href="https://doi.org/10.1016/j.bmcl.2019.04.033" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.033%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bdevelopment%252Bof%252Bquinoline%252Banalogs%252Bas%252Bnovel%252BP2X7%252Breceptor%252Bantagonists%26aulast%3DXiao%26aufirst%3DYufang%26date%3D2019%26volume%3D29%26issue%3D13%26spage%3D1660%26epage%3D1664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michel  Koole</span>, <span class="hlFld-ContribAuthor ">Mark E.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Anja  Hijzen</span>, <span class="hlFld-ContribAuthor ">Paulien  Ravenstijn</span>, <span class="hlFld-ContribAuthor ">Corinne  Vandermeulen</span>, <span class="hlFld-ContribAuthor ">Donatienne  Van Weehaeghe</span>, <span class="hlFld-ContribAuthor ">Kim  Serdons</span>, <span class="hlFld-ContribAuthor ">Sofie  Celen</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>, <span class="hlFld-ContribAuthor ">Marc  Ceusters</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Luc  Van Nueten</span>, <span class="hlFld-ContribAuthor ">Hartmuth  Kolb</span>, <span class="hlFld-ContribAuthor ">Jan  de Hoon</span>, <span class="hlFld-ContribAuthor ">Koen  Van Laere</span>. </span><span class="cited-content_cbyCitation_article-title">18
              F-JNJ-64413739, a Novel PET Ligand for the P2X7 Ion Channel: Radiation Dosimetry, Kinetic Modeling, Test-Retest Variability, and Occupancy of the P2X7 Antagonist JNJ-54175446. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2019,</strong> <em>60 </em>
                                    (5)
                                     , 683-690. <a href="https://doi.org/10.2967/jnumed.118.216747" title="DOI URL">https://doi.org/10.2967/jnumed.118.216747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.118.216747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.118.216747%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3D18%252BF-JNJ-64413739%25252C%252Ba%252BNovel%252BPET%252BLigand%252Bfor%252Bthe%252BP2X7%252BIon%252BChannel%25253A%252BRadiation%252BDosimetry%25252C%252BKinetic%252BModeling%25252C%252BTest-Retest%252BVariability%25252C%252Band%252BOccupancy%252Bof%252Bthe%252BP2X7%252BAntagonist%252BJNJ-54175446%26aulast%3DKoole%26aufirst%3DMichel%26date%3D2019%26date%3D2018%26volume%3D60%26issue%3D5%26spage%3D683%26epage%3D690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baban S.  Thawkar</span>, <span class="hlFld-ContribAuthor ">Ginpreet  Kaur</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroimmunology</span><span> <strong>2019,</strong> <em>326 </em>, 62-74. <a href="https://doi.org/10.1016/j.jneuroim.2018.11.010" title="DOI URL">https://doi.org/10.1016/j.jneuroim.2018.11.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jneuroim.2018.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jneuroim.2018.11.010%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroimmunology%26atitle%3DInhibitors%252Bof%252BNF-%2525CE%2525BAB%252Band%252BP2X7%25252FNLRP3%25252FCaspase%252B1%252Bpathway%252Bin%252Bmicroglia%25253A%252BNovel%252Btherapeutic%252Bopportunities%252Bin%252Bneuroinflammation%252Binduced%252Bearly-stage%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DThawkar%26aufirst%3DBaban%2BS.%26date%3D2019%26volume%3D326%26spage%3D62%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Declan N.C  Jones</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging role of the P2X7-NLRP3-IL1β pathway in mood disorders. </span><span class="cited-content_cbyCitation_journal-name">Psychoneuroendocrinology</span><span> <strong>2018,</strong> <em>98 </em>, 95-100. <a href="https://doi.org/10.1016/j.psyneuen.2018.08.015" title="DOI URL">https://doi.org/10.1016/j.psyneuen.2018.08.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.psyneuen.2018.08.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.psyneuen.2018.08.015%26sid%3Dliteratum%253Aachs%26jtitle%3DPsychoneuroendocrinology%26atitle%3DEmerging%252Brole%252Bof%252Bthe%252BP2X7-NLRP3-IL1%2525CE%2525B2%252Bpathway%252Bin%252Bmood%252Bdisorders%26aulast%3DBhattacharya%26aufirst%3DAnindya%26date%3D2018%26volume%3D98%26spage%3D95%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Brian  Lord</span>, <span class="hlFld-ContribAuthor ">Jan-Sebastian  Grigoleit</span>, <span class="hlFld-ContribAuthor ">Yingbo  He</span>, <span class="hlFld-ContribAuthor ">Ian  Fraser</span>, <span class="hlFld-ContribAuthor ">Shannon N.  Campbell</span>, <span class="hlFld-ContribAuthor ">Natalie  Taylor</span>, <span class="hlFld-ContribAuthor ">Leah  Aluisio</span>, <span class="hlFld-ContribAuthor ">Jason C.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Mariusz  Papp</span>, <span class="hlFld-ContribAuthor ">Christa  Chrovian</span>, <span class="hlFld-ContribAuthor ">Nicholas  Carruthers</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Lovenberg</span>, <span class="hlFld-ContribAuthor ">Michael A.  Letavic</span>. </span><span class="cited-content_cbyCitation_article-title">Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2018,</strong> <em>43 </em>
                                    (13)
                                     , 2586-2596. <a href="https://doi.org/10.1038/s41386-018-0141-6" title="DOI URL">https://doi.org/10.1038/s41386-018-0141-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-018-0141-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-018-0141-6%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DNeuropsychopharmacology%252Bof%252BJNJ-55308942%25253A%252Bevaluation%252Bof%252Ba%252Bclinical%252Bcandidate%252Btargeting%252BP2X7%252Bion%252Bchannels%252Bin%252Banimal%252Bmodels%252Bof%252Bneuroinflammation%252Band%252Banhedonia%26aulast%3DBhattacharya%26aufirst%3DAnindya%26date%3D2018%26date%3D2018%26volume%3D43%26issue%3D13%26spage%3D2586%26epage%3D2596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maarten  Timmers</span>, <span class="hlFld-ContribAuthor ">Paulien  Ravenstijn</span>, <span class="hlFld-ContribAuthor ">Liwen  Xi</span>, <span class="hlFld-ContribAuthor ">Gallen  Triana-Baltzer</span>, <span class="hlFld-ContribAuthor ">Maura  Furey</span>, <span class="hlFld-ContribAuthor ">Sandy  Van Hemelryck</span>, <span class="hlFld-ContribAuthor ">Jeike  Biewenga</span>, <span class="hlFld-ContribAuthor ">Marc  Ceusters</span>, <span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>, <span class="hlFld-ContribAuthor ">Maarten  van den Boer</span>, <span class="hlFld-ContribAuthor ">Luc  van Nueten</span>, <span class="hlFld-ContribAuthor ">Peter  de Boer</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Psychopharmacology</span><span> <strong>2018,</strong> <em>32 </em>
                                    (12)
                                     , 1341-1350. <a href="https://doi.org/10.1177/0269881118800067" title="DOI URL">https://doi.org/10.1177/0269881118800067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0269881118800067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0269881118800067%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Psychopharmacology%26atitle%3DClinical%252Bpharmacokinetics%25252C%252Bpharmacodynamics%25252C%252Bsafety%25252C%252Band%252Btolerability%252Bof%252BJNJ-54175446%25252C%252Ba%252Bbrain%252Bpermeable%252BP2X7%252Bantagonist%25252C%252Bin%252Ba%252Brandomised%252Bsingle-ascending%252Bdose%252Bstudy%252Bin%252Bhealthy%252Bparticipants%26aulast%3DTimmers%26aufirst%3DMaarten%26date%3D2018%26date%3D2018%26volume%3D32%26issue%3D12%26spage%3D1341%26epage%3D1350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linyu  Wei</span>, <span class="hlFld-ContribAuthor ">Sharifah A  Syed Mortadza</span>, <span class="hlFld-ContribAuthor ">Jing  Yan</span>, <span class="hlFld-ContribAuthor ">Libin  Zhang</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Yaling  Yin</span>, <span class="hlFld-ContribAuthor ">Chaokun  Li</span>, <span class="hlFld-ContribAuthor ">Sylvie  Chalon</span>, <span class="hlFld-ContribAuthor ">Patrick  Emond</span>, <span class="hlFld-ContribAuthor ">Catherine  Belzung</span>, <span class="hlFld-ContribAuthor ">Dongliang  Li</span>, <span class="hlFld-ContribAuthor ">Chengbiao  Lu</span>, <span class="hlFld-ContribAuthor ">Sebastien  Roger</span>, <span class="hlFld-ContribAuthor ">Lin-Hua  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">ATP-activated P2X7 receptor in the pathophysiology of mood disorders and as an emerging target for the development of novel antidepressant therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience & Biobehavioral Reviews</span><span> <strong>2018,</strong> <em>87 </em>, 192-205. <a href="https://doi.org/10.1016/j.neubiorev.2018.02.005" title="DOI URL">https://doi.org/10.1016/j.neubiorev.2018.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neubiorev.2018.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neubiorev.2018.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520%2526%2520Biobehavioral%2520Reviews%26atitle%3DATP-activated%252BP2X7%252Breceptor%252Bin%252Bthe%252Bpathophysiology%252Bof%252Bmood%252Bdisorders%252Band%252Bas%252Ban%252Bemerging%252Btarget%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bnovel%252Bantidepressant%252Btherapeutics%26aulast%3DWei%26aufirst%3DLinyu%26date%3D2018%26volume%3D87%26spage%3D192%26epage%3D205" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luiz E. B.  Savio</span>, <span class="hlFld-ContribAuthor ">Paola  de Andrade Mello</span>, <span class="hlFld-ContribAuthor ">Cleide Gonçalves  da Silva</span>, <span class="hlFld-ContribAuthor ">Robson  Coutinho-Silva</span>. </span><span class="cited-content_cbyCitation_article-title">The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphar.2018.00052" title="DOI URL">https://doi.org/10.3389/fphar.2018.00052</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2018.00052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2018.00052%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DThe%252BP2X7%252BReceptor%252Bin%252BInflammatory%252BDiseases%25253A%252BAngel%252Bor%252BDemon%25253F%26aulast%3DSavio%26aufirst%3DLuiz%2BE.%2BB.%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anindya  Bhattacharya</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in CNS P2X7 Physiology and Pharmacology: Focus on Neuropsychiatric Disorders. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2018,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphar.2018.00030" title="DOI URL">https://doi.org/10.3389/fphar.2018.00030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2018.00030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2018.00030%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DRecent%252BAdvances%252Bin%252BCNS%252BP2X7%252BPhysiology%252Band%252BPharmacology%25253A%252BFocus%252Bon%252BNeuropsychiatric%252BDisorders%26aulast%3DBhattacharya%26aufirst%3DAnindya%26date%3D2018%26date%3D2018%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Select P2X7 Antagonist Clinical Candidates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. CNS Penetrant Lead P2X7 Antagonists</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 3. Optimized CNS Active Lead Compounds</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=cht3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (A) Ex vivo P2X7 occupancy for compound <b>11</b> in rat brain: concentration–response after sc administration (data collected 60 min postdose (<i>n</i> = 3)). (B) Inhibition of IL-1β release in rat hippocampus. LLOQ = lower limit of quantitation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Ex vivo P2X7 occupancy for compound <b>12</b> in rat brain: concentration–response after po administration. Data were collected 60 min postdose (<i>n</i> = 6).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Plasma exposures in the rat multiple ascending dose study for compound <b>12</b> (administered po).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Ex vivo P2X7 occupancy for compound <b>14</b> in rat: concentration–response after po administration (<i>n</i> = 3) and time course for occupancy after a 10 mg/kg po dose in rat (<i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Specific binding of <b>14</b> to P2X7 receptors in rat and human brain sections: FCx = frontal cortex; SFG = superior frontal gyrus; <i>n</i> = 3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Inhibition of IL-1β release in rat hippocampus after oral administration of compound <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0010.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Central and peripheral target engagement study for <b>14</b> in dog (3 mg/kg po). Blood was used to determine IL-1β release by ex vivo stimulation of LPS and Bz-ATP. Brains were collected, and level of P2X7 receptor occupancy was measured by ex vivo receptor occupancy. Plasma and brain samples were also used to determine exposure of <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0011.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Plasma concentrations of <b>14</b> in a rat toleration study on day 1 and day 4 (oral administration, <i>n</i> = 3).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0013.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of 4-(<i>R</i>)-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-<i>c</i>]pyridines <b>10</b>–<b>14</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(OAc)<sub>2</sub>, BINAP, K<sub>2</sub>CO<sub>3</sub>, toluene, reflux, 38–90%; (b) H<sub>2</sub>, Pd/C, EtOH, rt, 80–99%; (c) <i>t</i>-BuONO, HOAc, THF, rt, 70–90%; (d) 2-chloro-3-(trifluoromethyl)benzoyl chloride, THF, rt, then methylmagnesium bromide, THF, −45 to −10 °C; (e) catalyst, H<sub>2</sub> or ammonium formate, MeOH or HOAc; (f) SFC; (g) methyl magnesium bromide, THF, 0–23 °C, then THF/H<sub>2</sub>O/HOAc, DDQ, 0–23 °C, 81%; (h) Pd(OAc)<sub>2</sub>, DINAP, 2-amino-4-fluoropyridine, K<sub>2</sub>CO<sub>3</sub>, toluene, 110 °C, 38%; (i) 10% Pd/C, H<sub>2</sub>, EtOH, HOAc, 88%; (j) 10% Pt/C, HOAc, H-Cube, 60 bar, 60 °C, 51%; (k) 2-chloro-3-(trifluoromethyl)benzoic acid, HATU, Et<sub>3</sub>N, DMF, 23 °C, 90%.</p></p></figure><figure data-id="fig9" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/medium/jm-2017-00408q_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0012.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Ball and stick diagram depicting the X-ray crystal structure of <b>14</b>. The asymmetric unit contains one fully ordered molecule of <b>14</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-11/acs.jmedchem.7b00408/20170602/images/large/jm-2017-00408q_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00408&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i46">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84883" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84883" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 30 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Walker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGee, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Druss, B. G.</span><span> </span><span class="NLM_article-title">Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis</span> <span class="citation_source-journal">JAMA Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">334</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span><span class="refDoi"> DOI: 10.1001/jamapsychiatry.2014.2502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1001%2Fjamapsychiatry.2014.2502" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2015&pages=334-341&issue=4&author=E.+Walkerauthor=R.+E.+McGeeauthor=B.+G.+Druss&title=Mortality+in+mental+disorders+and+global+disease+burden+implications%3A+A+systematic+review+and+meta-analysis&doi=10.1001%2Fjamapsychiatry.2014.2502"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Fjamapsychiatry.2014.2502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamapsychiatry.2014.2502%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DE.%26aulast%3DMcGee%26aufirst%3DR.%2BE.%26aulast%3DDruss%26aufirst%3DB.%2BG.%26atitle%3DMortality%2520in%2520mental%2520disorders%2520and%2520global%2520disease%2520burden%2520implications%253A%2520A%2520systematic%2520review%2520and%2520meta-analysis%26jtitle%3DJAMA%2520Psychiatry%26date%3D2015%26volume%3D72%26issue%3D4%26spage%3D334%26epage%3D341%26doi%3D10.1001%2Fjamapsychiatry.2014.2502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dowlati, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swardfager, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reim, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanctot, K. L.</span><span> </span><span class="NLM_article-title">A Meta-analysis of cytokines in major depression</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">446</span><span class="NLM_x">–</span> <span class="NLM_lpage">457</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2009.09.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.biopsych.2009.09.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=20015486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC3cXitV2rsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2010&pages=446-457&issue=5&author=Y.+Dowlatiauthor=N.+Herrmannauthor=W.+Swardfagerauthor=H.+Liuauthor=L.+Shamauthor=E.+K.+Reimauthor=K.+L.+Lanctot&title=A+Meta-analysis+of+cytokines+in+major+depression&doi=10.1016%2Fj.biopsych.2009.09.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">A Meta-Analysis of Cytokines in Major Depression</span></div><div class="casAuthors">Dowlati, Yekta; Herrmann, Nathan; Swardfager, Walter; Liu, Helena; Sham, Lauren; Reim, Elyse K.; Lanctot, Krista L.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">446-457</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Major depression occurs in 4.4% to 20% of the general population.  Studies suggest that major depression is accompanied by immune dysregulation and activation of the inflammatory response system (IRS).  Our objective was to quant. summarize the data on concns. of specific cytokines in patients diagnosed with a major depressive episode and controls.  We performed a meta-anal. of studies measuring cytokine concn. in patients with major depression, with a database search of the English literature (to August 2009) and a manual search of refs.  Twenty-four studies involving unstimulated measurements of cytokines in patients meeting DSM criteria for major depression were included in the meta-anal.; 13 for tumor necrosis factor (TNF)-α, 9 for interleukin (IL)-1β, 16 for IL-6, 5 for IL-4, 5 for IL-2, 4 for IL-8, 6 for IL-10, and 4 for interferon (IFN)-γ.  There were significantly higher concns. of TNF-α (p < .00001), weighted mean difference (WMD) (95% confidence interval) 3.97 pg/mL (2.24 to 5.71), in depressed subjects compared with control subjects (438 depressed/350 nondepressed).  Also, IL-6 concns. were significantly higher (p < .00001) in depressed subjects compared with control subjects (492 depressed/400 nondepressed) with an overall WMD of 1.78 pg/mL (1.23 to 2.33).  There were no significant differences among depressed and nondepressed subjects for the other cytokines studied.  This meta-anal. reports significantly higher concns. of the proinflammatory cytokines TNF-α and IL-6 in depressed subjects compared with control subjects.  While both pos. and neg. results have been reported in individual studies, this meta-analytic result strengthens evidence that depression is accompanied by activation of the IRS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOAN0dKQ7dBLVg90H21EOLACvtfcHk0lhxnDDx6bzl5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXitV2rsrw%253D&md5=d09e51e1298203434771c3f9c6a2b63a</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2009.09.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2009.09.033%26sid%3Dliteratum%253Aachs%26aulast%3DDowlati%26aufirst%3DY.%26aulast%3DHerrmann%26aufirst%3DN.%26aulast%3DSwardfager%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DSham%26aufirst%3DL.%26aulast%3DReim%26aufirst%3DE.%2BK.%26aulast%3DLanctot%26aufirst%3DK.%2BL.%26atitle%3DA%2520Meta-analysis%2520of%2520cytokines%2520in%2520major%2520depression%26jtitle%3DBiol.%2520Psychiatry%26date%3D2010%26volume%3D67%26issue%3D5%26spage%3D446%26epage%3D457%26doi%3D10.1016%2Fj.biopsych.2009.09.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Raison, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capuron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A. H.</span><span> </span><span class="NLM_article-title">Cytokines sing the blues: inflammation and the pathogenesis of depression</span> <span class="citation_source-journal">Trends Immunol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">24</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1016/j.it.2005.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.it.2005.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=16316783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BD28XmsVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2006&pages=24-31&issue=1&author=C.+L.+Raisonauthor=L.+Capuronauthor=A.+H.+Miller&title=Cytokines+sing+the+blues%3A+inflammation+and+the+pathogenesis+of+depression&doi=10.1016%2Fj.it.2005.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2bR"><div class="casContent"><span class="casTitleNuber">2b</span><div class="casTitle"><span class="NLM_cas:atitle">Cytokines sing the blues: inflammation and the pathogenesis of depression</span></div><div class="casAuthors">Raison, Charles L.; Capuron, Lucile; Miller, Andrew H.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-31</span>CODEN:
                <span class="NLM_cas:coden">TIRMAE</span>;
        ISSN:<span class="NLM_cas:issn">1471-4906</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Increasing amts. of data suggest that inflammatory responses have an important role in the pathophysiol. of depression.  Depressed patients have been found to have higher levels of proinflammatory cytokines, acute phase proteins, chemokines and cellular adhesion mols.  In addn., therapeutic administration of the cytokine interferon-α leads to depression in up to 50% of patients.  Moreover, proinflammatory cytokines have been found to interact with many of the pathophysiol. domains that characterize depression, including neurotransmitter metab., neuroendocrine function, synaptic plasticity and behavior.  Stress, which can ppt. depression, can also promote inflammatory responses through effects on sympathetic and parasympathetic nervous system pathways.  Finally, depression might be a behavioral byproduct of early adaptive advantages conferred by genes that promote inflammation.  These findings suggest that targeting proinflammatory cytokines and their signaling pathways might represent a novel strategy to treat depression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUQeAudNpT3rVg90H21EOLACvtfcHk0lhAaaoja4FL3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmsVylsg%253D%253D&md5=0d3c1631fe0d202ac8fd5ae4b251d1a8</span></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=10.1016%2Fj.it.2005.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.it.2005.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DRaison%26aufirst%3DC.%2BL.%26aulast%3DCapuron%26aufirst%3DL.%26aulast%3DMiller%26aufirst%3DA.%2BH.%26atitle%3DCytokines%2520sing%2520the%2520blues%253A%2520inflammation%2520and%2520the%2520pathogenesis%2520of%2520depression%26jtitle%3DTrends%2520Immunol.%26date%3D2006%26volume%3D27%26issue%3D1%26spage%3D24%26epage%3D31%26doi%3D10.1016%2Fj.it.2005.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derecki, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drevets, W. C.</span><span> </span><span class="NLM_article-title">Role of neuro-immunological factors in the pathophysiology of mood disorders</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">233</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">1623</span><span class="NLM_x">–</span> <span class="NLM_lpage">1636</span><span class="refDoi"> DOI: 10.1007/s00213-016-4214-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1007%2Fs00213-016-4214-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=26803500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKgs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2016&pages=1623-1636&issue=9&author=A.+Bhattacharyaauthor=N.+C.+Dereckiauthor=T.+W.+Lovenbergauthor=W.+C.+Drevets&title=Role+of+neuro-immunological+factors+in+the+pathophysiology+of+mood+disorders&doi=10.1007%2Fs00213-016-4214-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2cR"><div class="casContent"><span class="casTitleNuber">2c</span><div class="casTitle"><span class="NLM_cas:atitle">Role of neuro-immunological factors in the pathophysiology of mood disorders</span></div><div class="casAuthors">Bhattacharya, Anindya; Derecki, Noel C.; Lovenberg, Timothy W.; Drevets, Wayne C.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1623-1636</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Mood disorders, despite the widespread availability of monoamine-based antidepressant treatments, are assocd. with persistently high rates of disability, together with elevated rates of mortality due to suicide, cardiovascular disease, and other causes.  The development of more effective treatments has been hindered by the lack of knowledge about the etiol. and pathogenesis of mood disorders.  An emerging area of science that promises novel pathways to antidepressant and mood stabilizing therapies surrounds evidence that immune cells and their signaling play a major role in the pathophysiol. of major depressive disorder (MDD) and bipolar disorder (BD).  Here, we review evidence that the release of neuroactive cytokines, particularly interleukins such as IL-1β, IL-6, and TNF-α, is altered in these disorders and discuss mechanisms such as the ATP-gated ion channel P2X7, through which cytokine signaling can influence neuro-glial interactions.  Brain P2X7, an emerging target and antagonism of P2X7 holds promise as a novel mechanism for targeting treatment-resistant depression.  We further discuss the role of microglia and astroglia in central neuroinflammation and their interaction with the peripheral immune system.  We present extant clin. evidence that bolsters the role of neuroinflammation and neuroactive cytokines in mood disorders.  To that end, the role of clin. imaging by probing neuroinflammatory markers is also discussed briefly.  Finally, we present data using preclin. neuroinflammation models that produce depression-like behaviors in exptl. animals to identify neuroinflammatory mechanisms which may aid in novel neuroimmune target identification for the development of exciting pharmacol. interventions in mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3LHj0rffjabVg90H21EOLACvtfcHk0lhAaaoja4FL3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKgs7c%253D&md5=94cfc55223e0c7c21dad372c00e502cb</span></div><a href="/servlet/linkout?suffix=cit2c&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4214-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4214-0%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DDerecki%26aufirst%3DN.%2BC.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DDrevets%26aufirst%3DW.%2BC.%26atitle%3DRole%2520of%2520neuro-immunological%2520factors%2520in%2520the%2520pathophysiology%2520of%2520mood%2520disorders%26jtitle%3DPsychopharmacology%26date%3D2016%26volume%3D233%26issue%3D9%26spage%3D1623%26epage%3D1636%26doi%3D10.1007%2Fs00213-016-4214-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Goshen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreisel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Menachem-Zidon, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Licht, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weidenfeld, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ben-Hur, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yirmiya, R.</span><span> </span><span class="NLM_article-title">Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression</span> <span class="citation_source-journal">Mol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">717</span><span class="NLM_x">–</span> <span class="NLM_lpage">728</span><span class="refDoi"> DOI: 10.1038/sj.mp.4002055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1038%2Fsj.mp.4002055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=17700577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1alt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=717-728&issue=7&author=I.+Goshenauthor=T.+Kreiselauthor=O.+Ben-Menachem-Zidonauthor=T.+Lichtauthor=J.+Weidenfeldauthor=T.+Ben-Hurauthor=R.+Yirmiya&title=Brain+interleukin-1+mediates+chronic+stress-induced+depression+in+mice+via+adrenocortical+activation+and+hippocampal+neurogenesis+suppression&doi=10.1038%2Fsj.mp.4002055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression</span></div><div class="casAuthors">Goshen, I.; Kreisel, T.; Ben-Menachem-Zidon, O.; Licht, T.; Weidenfeld, J.; Ben-Hur, T.; Yirmiya, R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">717-728</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Several lines of evidence implicate the pro-inflammatory cytokine interleukin-1 (IL-1) in the etiol. and pathophysiol. of major depression.  To explore the role of IL-1 in chronic stress-induced depression and some of its underlying biol. mechanisms, we used the chronic mild stress (CMS) model of depression.  Mice subjected to CMS for 5 wk exhibited depressive-like symptoms, including decreased sucrose preference, reduced social exploration and adrenocortical activation, concomitantly with increased IL-1β levels in the hippocampus.  In contrast, mice with deletion of the IL-1 receptor type I (IL-1rKO) or mice with transgenic, brain-restricted overexpression of IL-1 receptor antagonist did not display CMS-induced behavioral or neuroendocrine changes.  Similarly, whereas in wild-type (WT) mice CMS significantly reduced hippocampal neurogenesis, measured by incorporation of bromodeoxyuridine (BrdU) and by doublecortin immunohistochem., no such decrease was obsd. IL-1rKO mice.  The blunting of the adrenocortical activation in IL-1rKO mice may play a causal role in their resistance to depression, because removal of endogenous glucocorticoids by adrenalectomy also abolished the depressive-like effects of CMS, whereas chronic administration of corticosterone for 4 wk produced depressive symptoms and reduced neurogenesis in both WT and IL-1rKO mice.  The effects of CMS on both behavioral depression and neurogenesis could be mimicked by exogenous s.c. administration of IL-1β via osmotic minipumps for 4 wk.  These findings indicate that elevation in brain IL-1 levels, which characterizes many medical conditions, is both necessary and sufficient for producing the high incidence of depression found in these conditions.  Thus, procedures aimed at reducing brain IL-1 levels may have potent antidepressive actions.  Mol. Psychiatry (2008) 13, 717-728; doi:10.1038/sj.mp.4002055; published online 14 August 2007.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPMCepUnKjv7Vg90H21EOLACvtfcHk0lhAaaoja4FL3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1alt7w%253D&md5=b7681e8cbc5837318e5f6163c606ee99</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1038%2Fsj.mp.4002055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.mp.4002055%26sid%3Dliteratum%253Aachs%26aulast%3DGoshen%26aufirst%3DI.%26aulast%3DKreisel%26aufirst%3DT.%26aulast%3DBen-Menachem-Zidon%26aufirst%3DO.%26aulast%3DLicht%26aufirst%3DT.%26aulast%3DWeidenfeld%26aufirst%3DJ.%26aulast%3DBen-Hur%26aufirst%3DT.%26aulast%3DYirmiya%26aufirst%3DR.%26atitle%3DBrain%2520interleukin-1%2520mediates%2520chronic%2520stress-induced%2520depression%2520in%2520mice%2520via%2520adrenocortical%2520activation%2520and%2520hippocampal%2520neurogenesis%2520suppression%26jtitle%3DMol.%2520Psychiatry%26date%3D2008%26volume%3D13%26issue%3D7%26spage%3D717%26epage%3D728%26doi%3D10.1038%2Fsj.mp.4002055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Koo, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">Interleukin-1 receptor null mutant mice show decreased anxiety-like behavior and enhanced fear memory</span> <span class="citation_source-journal">Neurosci. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">456</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">39</span><span class="NLM_x">–</span> <span class="NLM_lpage">43</span><span class="refDoi"> DOI: 10.1016/j.neulet.2009.03.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.neulet.2009.03.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=456&publication_year=2009&pages=39-43&issue=1&author=J.+W.+Kooauthor=R.+S.+Duman&title=Interleukin-1+receptor+null+mutant+mice+show+decreased+anxiety-like+behavior+and+enhanced+fear+memory&doi=10.1016%2Fj.neulet.2009.03.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2009.03.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2009.03.068%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DJ.%2BW.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DInterleukin-1%2520receptor%2520null%2520mutant%2520mice%2520show%2520decreased%2520anxiety-like%2520behavior%2520and%2520enhanced%2520fear%2520memory%26jtitle%3DNeurosci.%2520Lett.%26date%3D2009%26volume%3D456%26issue%3D1%26spage%3D39%26epage%3D43%26doi%3D10.1016%2Fj.neulet.2009.03.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Koo, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nestler, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2669</span><span class="NLM_x">–</span> <span class="NLM_lpage">2674</span><span class="refDoi"> DOI: 10.1073/pnas.0910658107</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1073%2Fpnas.0910658107" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=2669-2674&issue=6&author=J.+W.+Kooauthor=S.+J.+Russoauthor=D.+Fergusonauthor=E.+J.+Nestlerauthor=R.+S.+Duman&title=Nuclear+factor-kappaB+is+a+critical+mediator+of+stress-impaired+neurogenesis+and+depressive+behavior&doi=10.1073%2Fpnas.0910658107"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0910658107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0910658107%26sid%3Dliteratum%253Aachs%26aulast%3DKoo%26aufirst%3DJ.%2BW.%26aulast%3DRusso%26aufirst%3DS.%2BJ.%26aulast%3DFerguson%26aufirst%3DD.%26aulast%3DNestler%26aufirst%3DE.%2BJ.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DNuclear%2520factor-kappaB%2520is%2520a%2520critical%2520mediator%2520of%2520stress-impaired%2520neurogenesis%2520and%2520depressive%2520behavior%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2010%26volume%3D107%26issue%3D6%26spage%3D2669%26epage%3D2674%26doi%3D10.1073%2Fpnas.0910658107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Stokes, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuller, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluyter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skarratt, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiley, J. S.</span><span> </span><span class="NLM_article-title">Two haplotypes of the P2X7 receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1{beta} secretion</span> <span class="citation_source-journal">FASEB J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2916</span><span class="NLM_x">–</span> <span class="NLM_lpage">2927</span><span class="refDoi"> DOI: 10.1096/fj.09-150862</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1096%2Ffj.09-150862" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=2916-2927&issue=8&author=L.+Stokesauthor=S.+J.+Fullerauthor=R.+Sluyterauthor=K.+K.+Skarrattauthor=B.+J.+Guauthor=J.+S.+Wiley&title=Two+haplotypes+of+the+P2X7+receptor+containing+the+Ala-348+to+Thr+polymorphism+exhibit+a+gain-of-function+effect+and+enhanced+interleukin-1%7Bbeta%7D+secretion&doi=10.1096%2Ffj.09-150862"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=10.1096%2Ffj.09-150862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1096%252Ffj.09-150862%26sid%3Dliteratum%253Aachs%26aulast%3DStokes%26aufirst%3DL.%26aulast%3DFuller%26aufirst%3DS.%2BJ.%26aulast%3DSluyter%26aufirst%3DR.%26aulast%3DSkarratt%26aufirst%3DK.%2BK.%26aulast%3DGu%26aufirst%3DB.%2BJ.%26aulast%3DWiley%26aufirst%3DJ.%2BS.%26atitle%3DTwo%2520haplotypes%2520of%2520the%2520P2X7%2520receptor%2520containing%2520the%2520Ala-348%2520to%2520Thr%2520polymorphism%2520exhibit%2520a%2520gain-of-function%2520effect%2520and%2520enhanced%2520interleukin-1%257Bbeta%257D%2520secretion%26jtitle%3DFASEB%2520J.%26date%3D2010%26volume%3D24%26issue%3D8%26spage%3D2916%26epage%3D2927%26doi%3D10.1096%2Ffj.09-150862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Solle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stam, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petrushova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koller, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffiths, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span> </span><span class="NLM_article-title">Altered cytokine production in mice lacking P2X(7) receptors</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1074/jbc.M006781200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1074%2Fjbc.M006781200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=125-132&issue=1&author=M.+Solleauthor=J.+Labasiauthor=D.+G.+Perregauxauthor=E.+Stamauthor=N.+Petrushovaauthor=B.+H.+Kollerauthor=R.+J.+Griffithsauthor=C.+A.+Gabel&title=Altered+cytokine+production+in+mice+lacking+P2X%287%29+receptors&doi=10.1074%2Fjbc.M006781200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M006781200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M006781200%26sid%3Dliteratum%253Aachs%26aulast%3DSolle%26aufirst%3DM.%26aulast%3DLabasi%26aufirst%3DJ.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DStam%26aufirst%3DE.%26aulast%3DPetrushova%26aufirst%3DN.%26aulast%3DKoller%26aufirst%3DB.%2BH.%26aulast%3DGriffiths%26aufirst%3DR.%2BJ.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26atitle%3DAltered%2520cytokine%2520production%2520in%2520mice%2520lacking%2520P2X%25287%2529%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26issue%3D1%26spage%3D125%26epage%3D132%26doi%3D10.1074%2Fjbc.M006781200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biber, K.</span><span> </span><span class="NLM_article-title">The microglial ATP-gated ion channel P2X7 as a CNS drug target</span> <span class="citation_source-journal">Glia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1772</span><span class="NLM_x">–</span> <span class="NLM_lpage">1787</span><span class="refDoi"> DOI: 10.1002/glia.23001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1002%2Fglia.23001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2016&pages=1772-1787&issue=10&author=A.+Bhattacharyaauthor=K.+Biber&title=The+microglial+ATP-gated+ion+channel+P2X7+as+a+CNS+drug+target&doi=10.1002%2Fglia.23001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fglia.23001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fglia.23001%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DBiber%26aufirst%3DK.%26atitle%3DThe%2520microglial%2520ATP-gated%2520ion%2520channel%2520P2X7%2520as%2520a%2520CNS%2520drug%2520target%26jtitle%3DGlia%26date%3D2016%26volume%3D64%26issue%3D10%26spage%3D1772%26epage%3D1787%26doi%3D10.1002%2Fglia.23001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Csolle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ando, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kittel, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goloncser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baranyi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soproni, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zelena, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemeth, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocsai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperlagh, B.</span><span> </span><span class="NLM_article-title">The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">233</span><span class="refDoi"> DOI: 10.1017/S1461145711001933</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1017%2FS1461145711001933" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=22243662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A280%3ADC%252BC38vgtlGgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2013&pages=213-233&issue=1&author=C.+Csolleauthor=R.+D.+Andoauthor=A.+Kittelauthor=F.+Goloncserauthor=M.+Baranyiauthor=K.+Soproniauthor=D.+Zelenaauthor=J.+Hallerauthor=T.+Nemethauthor=A.+Mocsaiauthor=B.+Sperlagh&title=The+absence+of+P2X7+receptors+%28P2rx7%29+on+non-haematopoietic+cells+leads+to+selective+alteration+in+mood-related+behaviour+with+dysregulated+gene+expression+and+stress+reactivity+in+mice&doi=10.1017%2FS1461145711001933"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">The absence of P2X7 receptors (P2rx7) on non-haematopoietic cells leads to selective alteration in mood-related behaviour with dysregulated gene expression and stress reactivity in mice</span></div><div class="casAuthors">Csolle Cecilia; Ando Romeo D; Kittel Agnes; Goloncser Flora; Baranyi Maria; Soproni Krisztina; Zelena Dora; Haller Jozsef; Nemeth Tamas; Mocsai Attila; Sperlagh Beata</div><div class="citationInfo"><span class="NLM_cas:title">The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">213-33</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The purpose of this study was to explore how genetic deletion and pharmacological antagonism of the P2X7 receptor (P2rx7) alter mood-related behaviour, gene expression and stress reactivity in the brain.  The forced swim test (FST), tail suspension test (TST) and amphetamine-induced hyperlocomotion (AH) tests were used in wild-type (P2rx7(+/+)) and P2rx7-deficient (P2rx7(-/-)) mice.  Biogenic amine levels were analysed in the amygdala and striatum, adrenocorticotropic hormone (ACTH) and corticosterone levels were measured in the plasma and pituitary after restraint stress.  Chimeric mice were generated by bone marrow transplantation.  A whole genome microarray analysis with real-time polymerase chain reaction validation was performed on the amygdala.  In the absence of P2rx7s decreased behavioural despair in the FST, reduced immobility in the TST and attenuated amphetamine-induced hyperactivity were detected.  Basal norepinephrine levels were elevated in the amygdala, whereas stress-induced ACTH and corticosterone responses were alleviated in P2rx7(-/-) mice.  Sub-acute treatment with the selective P2rx7 antagonist, Brilliant Blue G, reproduced the effect of genetic deletion in the TST and AH test in P2rx7(+/+) but not P2rx7(-/-) mice.  No change in behavioural phenotype was observed in chimeras lacking the P2rx7 in their haematopoietic compartment.  Whole genome microarray analysis indicated a widespread up- and down-regulation of genes crucial for synaptic function and neuroplasticity by genetic deletion.  Here, we present evidence that the absence of P2rx7s on non-haematopoietic cells leads to a mood-stabilizing phenotype in several behavioural models and suggest a therapeutic potential of P2rx7 antagonists for the treatment of mood disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRhnfe6sBFWl9FxYDaSSP8XfW6udTcc2eal_cck8WAFrLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vgtlGgsA%253D%253D&md5=7acf270a1c234428ff37628d2b6a32dd</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1017%2FS1461145711001933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145711001933%26sid%3Dliteratum%253Aachs%26aulast%3DCsolle%26aufirst%3DC.%26aulast%3DAndo%26aufirst%3DR.%2BD.%26aulast%3DKittel%26aufirst%3DA.%26aulast%3DGoloncser%26aufirst%3DF.%26aulast%3DBaranyi%26aufirst%3DM.%26aulast%3DSoproni%26aufirst%3DK.%26aulast%3DZelena%26aufirst%3DD.%26aulast%3DHaller%26aufirst%3DJ.%26aulast%3DNemeth%26aufirst%3DT.%26aulast%3DMocsai%26aufirst%3DA.%26aulast%3DSperlagh%26aufirst%3DB.%26atitle%3DThe%2520absence%2520of%2520P2X7%2520receptors%2520%2528P2rx7%2529%2520on%2520non-haematopoietic%2520cells%2520leads%2520to%2520selective%2520alteration%2520in%2520mood-related%2520behaviour%2520with%2520dysregulated%2520gene%2520expression%2520and%2520stress%2520reactivity%2520in%2520mice%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2013%26volume%3D16%26issue%3D1%26spage%3D213%26epage%3D233%26doi%3D10.1017%2FS1461145711001933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses</span> <span class="citation_source-journal">Brain, Behav., Immun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">114</span><span class="refDoi"> DOI: 10.1016/j.bbi.2012.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.bbi.2012.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=23261775" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFWktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2013&pages=105-114&author=M.+Iwataauthor=K.+T.+Otaauthor=R.+S.+Duman&title=The+inflammasome%3A+Pathways+linking+psychological+stress%2C+depression%2C+and+systemic+illnesses&doi=10.1016%2Fj.bbi.2012.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">The inflammasome: Pathways linking psychological stress, depression, and systemic illnesses</span></div><div class="casAuthors">Iwata, Masaaki; Ota, Kristie T.; Duman, Ronald S.</div><div class="citationInfo"><span class="NLM_cas:title">Brain, Behavior, and Immunity</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">105-114</span>CODEN:
                <span class="NLM_cas:coden">BBIMEW</span>;
        ISSN:<span class="NLM_cas:issn">0889-1591</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Stress is a common occurrence in everyday life and repeated or traumatic stress can be a pptg. factor for illnesses of the central nervous system, as well as peripheral organ systems.  For example, severe or long-term psychol. stress can not only induce depression, a leading illness worldwide, but can also cause psychosomatic diseases such as asthma and rheumatoid arthritis.  Related key questions include how psychol. stress influences both brain and peripheral systems, and what detection mechanisms underlie these effects A clue is provided by the discovery of the pathways underlying the responses to host danger substances that cause systemic diseases, but can also contribute to depression.  The inflammasome is a protein complex that can detect diverse danger signals and produce the accompanying immune-inflammatory reactions.  Interestingly, the inflammasome can detect not only pathogen-assocd. mols., but also cell damage-assocd. mols. such as ATP.  Here, we propose a new inflammasome hypothesis of depression and related comorbid systemic illnesses.  According to this hypothesis, the inflammasome is a central mediator by which psychol. and phys. stressors can contribute to the development of depression, and as well as a bridge to systemic diseases.  This hypothesis includes an explanation for how psychol. stress can influence systemic diseases, and conversely how systemic diseases can lead to psychiatric illnesses.  The evidence suggests that the inflammasome may be a new target for the development of treatments for depression, as well as psychosomatic and somato-psycho diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFE-2qYPjgtLVg90H21EOLACvtfcHk0lipdJ8pSCTlNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFWktg%253D%253D&md5=64387d9412f24dd44e46b5d5b5bcd844</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.bbi.2012.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbi.2012.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DIwata%26aufirst%3DM.%26aulast%3DOta%26aufirst%3DK.%2BT.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DThe%2520inflammasome%253A%2520Pathways%2520linking%2520psychological%2520stress%252C%2520depression%252C%2520and%2520systemic%2520illnesses%26jtitle%3DBrain%252C%2520Behav.%252C%2520Immun.%26date%3D2013%26volume%3D31%26spage%3D105%26epage%3D114%26doi%3D10.1016%2Fj.bbi.2012.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Iwata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ota, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakaue, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutheil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banasr, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duric, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamanashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaneko, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasmussen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glasebrook, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koester, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smagin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duman, R. S.</span><span> </span><span class="NLM_article-title">Psychological stress activates the inflammasome via release of adenosine triphosphate and stimulation of the purinergic type 2X7 receptor</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">22</span><span class="refDoi"> DOI: 10.1016/j.biopsych.2015.11.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.biopsych.2015.11.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=26831917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhsl2murw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=12-22&author=M.+Iwataauthor=K.+T.+Otaauthor=X.+Y.+Liauthor=F.+Sakaueauthor=N.+Liauthor=S.+Dutheilauthor=M.+Banasrauthor=V.+Duricauthor=T.+Yamanashiauthor=K.+Kanekoauthor=K.+Rasmussenauthor=A.+Glasebrookauthor=A.+Koesterauthor=D.+Songauthor=K.+A.+Jonesauthor=S.+Zornauthor=G.+Smaginauthor=R.+S.+Duman&title=Psychological+stress+activates+the+inflammasome+via+release+of+adenosine+triphosphate+and+stimulation+of+the+purinergic+type+2X7+receptor&doi=10.1016%2Fj.biopsych.2015.11.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Psychological Stress Activates the Inflammasome via Release of Adenosine Triphosphate and Stimulation of the Purinergic Type 2X7 Receptor</span></div><div class="casAuthors">Iwata, Masaaki; Ota, Kristie T.; Li, Xiao-Yuan; Sakaue, Fumika; Li, Nanxin; Dutheil, Sophie; Banasr, Mounira; Duric, Vanja; Yamanashi, Takehiko; Kaneko, Koichi; Rasmussen, Kurt; Glasebrook, Andrew; Koester, Anja; Song, Dekun; Jones, Kenneth A.; Zorn, Stevin; Smagin, Gennady; Duman, Ronald S.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-22</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The mechanisms underlying stress-induced inflammation that contribute to major depressive disorder are unknown.  We examine the role of the ATP (ATP)/purinergic type 2X7 receptor (P2X7R) pathway and the NLRP3 (nucleotide-binding, leucine-rich repeat, pyrin domain contg. 3) inflammasome in interleukin (IL)-1β and depressive behavioral responses to stress.  The influence of acute restraint stress on extracellular ATP, glutamate, IL-1β, and tumor necrosis factor alpha in hippocampus was detd. by microdialysis, and the influence of acute restraint stress on the NLRP3 inflammasome was detd. by Western blot anal.  The influence of P2X7R antagonist administration on IL-1β and tumor necrosis factor alpha and on anxiety and depressive behaviors was detd. in the chronic unpredictable stress rodent model.  The role of the NLRP3 inflammasome was detd. by anal. of Nlrp3 null mice.  Acute restraint stress rapidly increased extracellular ATP, an endogenous agonist of P2X7R; the inflammatory cytokine IL-1β; and the active form of the NLRP3 inflammasome in the hippocampus.  Administration of a P2X7R antagonist completely blocked the release of IL-1β and tumor necrosis factor alpha, another stress-induced cytokine, and activated NLRP3.  Moreover, P2X7R antagonist administration reversed the anhedonic and anxiety behaviors caused by chronic unpredictable stress exposure, and deletion of the Nlrp3 gene rendered mice resistant to development of depressive behaviors caused by chronic unpredictable stress.  These findings demonstrate that psychol. "stress" is sensed by the innate immune system in the brain via the ATP/P2X7R-NLRP3 inflammasome cascade, and they identify novel therapeutic targets for the treatment of stress-related mood disorders and comorbid illnesses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPT4PeBplcG7Vg90H21EOLACvtfcHk0lipdJ8pSCTlNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhsl2murw%253D&md5=f17ad7ff32906696e07f3b9e52a7591e</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2015.11.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2015.11.026%26sid%3Dliteratum%253Aachs%26aulast%3DIwata%26aufirst%3DM.%26aulast%3DOta%26aufirst%3DK.%2BT.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DSakaue%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DDutheil%26aufirst%3DS.%26aulast%3DBanasr%26aufirst%3DM.%26aulast%3DDuric%26aufirst%3DV.%26aulast%3DYamanashi%26aufirst%3DT.%26aulast%3DKaneko%26aufirst%3DK.%26aulast%3DRasmussen%26aufirst%3DK.%26aulast%3DGlasebrook%26aufirst%3DA.%26aulast%3DKoester%26aufirst%3DA.%26aulast%3DSong%26aufirst%3DD.%26aulast%3DJones%26aufirst%3DK.%2BA.%26aulast%3DZorn%26aufirst%3DS.%26aulast%3DSmagin%26aufirst%3DG.%26aulast%3DDuman%26aufirst%3DR.%2BS.%26atitle%3DPsychological%2520stress%2520activates%2520the%2520inflammasome%2520via%2520release%2520of%2520adenosine%2520triphosphate%2520and%2520stimulation%2520of%2520the%2520purinergic%2520type%25202X7%2520receptor%26jtitle%3DBiol.%2520Psychiatry%26date%3D2016%26volume%3D80%26spage%3D12%26epage%3D22%26doi%3D10.1016%2Fj.biopsych.2015.11.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Keystone, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Layton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McInnes, I. B.</span><span> </span><span class="NLM_article-title">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span> <span class="citation_source-journal">Ann. Rheum. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1630</span><span class="NLM_x">–</span> <span class="NLM_lpage">1635</span><span class="refDoi"> DOI: 10.1136/annrheumdis-2011-143578</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1136%2Fannrheumdis-2011-143578" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=22966146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2012&pages=1630-1635&issue=10&author=E.+C.+Keystoneauthor=M.+M.+Wangauthor=M.+Laytonauthor=S.+Hollisauthor=I.+B.+McInnes&title=Clinical+evaluation+of+the+efficacy+of+the+P2X7+purinergic+receptor+antagonist+AZD9056+on+the+signs+and+symptoms+of+rheumatoid+arthritis+in+patients+with+active+disease+despite+treatment+with+methotrexate+or+sulphasalazine&doi=10.1136%2Fannrheumdis-2011-143578"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine</span></div><div class="casAuthors">Keystone, Edward C.; Wang, Millie M.; Layton, Mark; Hollis, Sally; McInnes, Iain B.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the Rheumatic Diseases</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1630-1635</span>CODEN:
                <span class="NLM_cas:coden">ARDIAO</span>;
        ISSN:<span class="NLM_cas:issn">0003-4967</span>.
    
            (<span class="NLM_cas:orgname">BMJ Publishing Group</span>)
        </div><div class="casAbstract">Objectives: The P2X7 purinergic receptor antagonist AZD9056 was evaluated in a phase IIa study and subsequently in a phase IIb study to assess the effects of orally administered AZD9056 on the signs/symptoms of rheumatoid arthritis (RA), with American College of Rheumatol. 20% response criteria (ACR20) as the primary outcome.  Methods: Both studies were randomized, double-blind, placebo-controlled, parallel-group studies in patients with RA receiving methotrexate or sulphasalazine.  Phase IIa was an ascending-dose trial in two cohorts (n=75) using AZD9056 administered daily over 4 wk.  Phase IIb included an open-label etanercept treatment group.  Patients were randomized to receive treatment for 6 mo with 50, 100, 200 or 400 mg AZD9056 (oral, once a day) or matching placebo (oral, once a day), or s.c. etanercept (50 mg once a week).  Results: In phase IIa, 65% of AZD9056 recipients at 400 mg/day responded at the ACR20 level compared with 27% of placebo-treated patients.  A significant redn. in swollen and tender joint count was obsd. in the actively treated group compared with placebo, whereas no effect on acute-phase response was obsd.  Of 385 randomized patients in the phase IIb study, 383 received treatment.  AZD9056 (all doses) had no clin. or statistically significant effect on RA relative to placebo as measured by the proportion of patients meeting the ACR20 criteria at 6 mo and further supported by secondary end points.  In both studies AZD9056 was well tolerated up to 400 mg/day.  Conclusions: AZD9056 does not have significant efficacy in the treatment of RA, and the P2X7 receptor does not appear to be a therapeutically useful target in RA.  Trial registration no. ClinicalTrials.gov NCT00520572.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzCebkc5d0gLVg90H21EOLACvtfcHk0lipdJ8pSCTlNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1SqurzL&md5=97ca48663327aa8578f11001fa96d8c0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1136%2Fannrheumdis-2011-143578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fannrheumdis-2011-143578%26sid%3Dliteratum%253Aachs%26aulast%3DKeystone%26aufirst%3DE.%2BC.%26aulast%3DWang%26aufirst%3DM.%2BM.%26aulast%3DLayton%26aufirst%3DM.%26aulast%3DHollis%26aufirst%3DS.%26aulast%3DMcInnes%26aufirst%3DI.%2BB.%26atitle%3DClinical%2520evaluation%2520of%2520the%2520efficacy%2520of%2520the%2520P2X7%2520purinergic%2520receptor%2520antagonist%2520AZD9056%2520on%2520the%2520signs%2520and%2520symptoms%2520of%2520rheumatoid%2520arthritis%2520in%2520patients%2520with%2520active%2520disease%2520despite%2520treatment%2520with%2520methotrexate%2520or%2520sulphasalazine%26jtitle%3DAnn.%2520Rheum.%2520Dis.%26date%3D2012%26volume%3D71%26issue%3D10%26spage%3D1630%26epage%3D1635%26doi%3D10.1136%2Fannrheumdis-2011-143578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Eser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombel, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutgeerts, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeire, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelsang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braddock, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Persson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reinisch, W.</span><span> </span><span class="NLM_article-title">Safety and efficacy of an oral inhibitor of the purinergic receptor P2X7 in adult patients with moderately to severely active Crohn’s disease: A randomized placebo-controlled, double-blind, Phase IIa study</span> <span class="citation_source-journal">Inflammatory Bowel Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2453</span><span class="refDoi"> DOI: 10.1097/MIB.0000000000000514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1097%2FMIB.0000000000000514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=26197451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FltVSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=2247-2453&issue=10&author=A.+Eserauthor=J.+F.+Colombelauthor=P.+Rutgeertsauthor=S.+Vermeireauthor=H.+Vogelsangauthor=M.+Braddockauthor=T.+Perssonauthor=W.+Reinisch&title=Safety+and+efficacy+of+an+oral+inhibitor+of+the+purinergic+receptor+P2X7+in+adult+patients+with+moderately+to+severely+active+Crohn%E2%80%99s+disease%3A+A+randomized+placebo-controlled%2C+double-blind%2C+Phase+IIa+study&doi=10.1097%2FMIB.0000000000000514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled, Double-blind, Phase IIa Study</span></div><div class="casAuthors">Eser Alexander; Colombel Jean-Frederic; Rutgeerts Paul; Vermeire Severine; Vogelsang Harald; Braddock Martin; Persson Tore; Reinisch Walter</div><div class="citationInfo"><span class="NLM_cas:title">Inflammatory bowel diseases</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2247-53</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  AZD9056 is a selective orally active inhibitor of the purinergic receptor P2X7, which is a key player in the generation and secretion of several proinflammatory cytokines involved in the pathogenesis of Crohn's disease (CD).  The aim of this phase IIa study was to assess the efficacy and safety of AZD9056 for the treatment of moderately to severely active CD.  METHODS:  We conducted a placebo-controlled, multicenter, double-blind phase IIa study in patients with moderately to severely active CD as defined by a CD Activity Index (CDAI) of at least 220.  Patients were randomized in a 2:1 mode either to 200 mg of AZD9056 administered orally as a tablet once daily for 28 days or matching placebo.  Primary endpoint was the change in CDAI from baseline at day 28, and secondary endpoints included clinical remission (CDAI < 150) and CDAI 70 response and improvement in the quality of life measures Short Form 36 and Inflammatory Bowel Disease Questionnaire.  Changes in serum C-reactive protein and fecal calprotectin were assessed.  RESULTS:  In total, 34 patients were enrolled, 24 to AZD9056 and 10 to placebo.  The CDAI dropped in AZD9056-treated subjects from a baseline mean of 311 to 242 and from 262 to 239 in placebo-treated subjects (P = 0.049).  Remission and response rates were numerically higher with AZD9056 versus placebo, (n = 5, 24% versus n = 1, 11%, P = 0.43 and n = 11, 52% versus n = 2, 22%, P = 0.13, respectively).  Marked decrease in disease activity was observed for the CDAI subcomponents, pain and general well-being.  Apart from a statistically significant improvement in the Mental Component Score of Short Form 36 for AZD9056 versus placebo (P = 0.017), no other differences in measurements of quality of life could be observed.  There was no decrease in concentrations of serum C-reactive protein and fecal calprotectin during treatment.  AZD9056 was well-tolerated, and no serious adverse events were reported.  CONCLUSIONS:  Our data suggest that the purinergic receptor P2X7 antagonist AZD9056 has the potential to improve symptoms in patients with moderate-to-severe CD combined with a beneficial risk profile.  Although the lack in change of inflammatory biomarkers questions its anti-inflammatory potential, the results obtained in this study rather suggest P2X7 antagonism for the treatment of chronic abdominal pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRHjK0qgS5fO0g6wdEZmT2rfW6udTcc2eZtoRcEXk_kwrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FltVSqtA%253D%253D&md5=8ade69d316c57adae49fb595e35ab2f7</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2FMIB.0000000000000514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMIB.0000000000000514%26sid%3Dliteratum%253Aachs%26aulast%3DEser%26aufirst%3DA.%26aulast%3DColombel%26aufirst%3DJ.%2BF.%26aulast%3DRutgeerts%26aufirst%3DP.%26aulast%3DVermeire%26aufirst%3DS.%26aulast%3DVogelsang%26aufirst%3DH.%26aulast%3DBraddock%26aufirst%3DM.%26aulast%3DPersson%26aufirst%3DT.%26aulast%3DReinisch%26aufirst%3DW.%26atitle%3DSafety%2520and%2520efficacy%2520of%2520an%2520oral%2520inhibitor%2520of%2520the%2520purinergic%2520receptor%2520P2X7%2520in%2520adult%2520patients%2520with%2520moderately%2520to%2520severely%2520active%2520Crohn%25E2%2580%2599s%2520disease%253A%2520A%2520randomized%2520placebo-controlled%252C%2520double-blind%252C%2520Phase%2520IIa%2520study%26jtitle%3DInflammatory%2520Bowel%2520Dis.%26date%3D2015%26volume%3D21%26issue%3D10%26spage%3D2247%26epage%3D2453%26doi%3D10.1097%2FMIB.0000000000000514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Duplantier, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dombroski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabel, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalgutkar, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraus, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labasi, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mussari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perregaux, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevena, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitney-Pickett, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, K.</span><span> </span><span class="NLM_article-title">Optimization of the physicochemical and pharmacokinetic attributes in a 6-azauracil series of P2X7 receptor antagonists leading to the discovery of the clinical candidate CE-224,535</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3708</span><span class="NLM_x">–</span> <span class="NLM_lpage">3711</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2011.04.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.bmcl.2011.04.077" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=3708-3711&issue=12&author=A.+J.+Duplantierauthor=M.+A.+Dombroskiauthor=C.+Subramanyamauthor=A.+M.+Beaulieuauthor=S.+P.+Changauthor=C.+A.+Gabelauthor=C.+Jordanauthor=A.+S.+Kalgutkarauthor=K.+G.+Krausauthor=J.+M.+Labasiauthor=C.+Mussariauthor=D.+G.+Perregauxauthor=R.+Shepardauthor=T.+J.+Taylorauthor=K.+A.+Trevenaauthor=C.+Whitney-Pickettauthor=K.+Yoon&title=Optimization+of+the+physicochemical+and+pharmacokinetic+attributes+in+a+6-azauracil+series+of+P2X7+receptor+antagonists+leading+to+the+discovery+of+the+clinical+candidate+CE-224%2C535&doi=10.1016%2Fj.bmcl.2011.04.077"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.04.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.04.077%26sid%3Dliteratum%253Aachs%26aulast%3DDuplantier%26aufirst%3DA.%2BJ.%26aulast%3DDombroski%26aufirst%3DM.%2BA.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DBeaulieu%26aufirst%3DA.%2BM.%26aulast%3DChang%26aufirst%3DS.%2BP.%26aulast%3DGabel%26aufirst%3DC.%2BA.%26aulast%3DJordan%26aufirst%3DC.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKraus%26aufirst%3DK.%2BG.%26aulast%3DLabasi%26aufirst%3DJ.%2BM.%26aulast%3DMussari%26aufirst%3DC.%26aulast%3DPerregaux%26aufirst%3DD.%2BG.%26aulast%3DShepard%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DT.%2BJ.%26aulast%3DTrevena%26aufirst%3DK.%2BA.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DYoon%26aufirst%3DK.%26atitle%3DOptimization%2520of%2520the%2520physicochemical%2520and%2520pharmacokinetic%2520attributes%2520in%2520a%25206-azauracil%2520series%2520of%2520P2X7%2520receptor%2520antagonists%2520leading%2520to%2520the%2520discovery%2520of%2520the%2520clinical%2520candidate%2520CE-224%252C535%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26issue%3D12%26spage%3D3708%26epage%3D3711%26doi%3D10.1016%2Fj.bmcl.2011.04.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Stock, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishaq, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mebus, C. A.</span><span> </span><span class="NLM_article-title">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span> <span class="citation_source-journal">J. Rheumatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">720</span><span class="NLM_x">–</span> <span class="NLM_lpage">727</span><span class="refDoi"> DOI: 10.3899/jrheum.110874</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.3899%2Fjrheum.110874" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=22382341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=720-727&issue=4&author=T.+C.+Stockauthor=B.+J.+Bloomauthor=N.+Weiauthor=S.+Ishaqauthor=W.+Parkauthor=X.+Wangauthor=P.+Guptaauthor=C.+A.+Mebus&title=Efficacy+and+safety+of+CE-224%2C535%2C+an+antagonist+of+P2X7+receptor%2C+in+treatment+of+patients+with+rheumatoid+arthritis+inadequately+controlled+by+methotrexate&doi=10.3899%2Fjrheum.110874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate</span></div><div class="casAuthors">Stock, Thomas C.; Bloom, Bradley J.; Wei, Nathan; Ishaq, Saliha; Park, Won; Wang, Xin; Gupta, Pankaj; Mebus, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Rheumatology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">720-727</span>CODEN:
                <span class="NLM_cas:coden">JRHUA9</span>;
        ISSN:<span class="NLM_cas:issn">0315-162X</span>.
    
            (<span class="NLM_cas:orgname">Journal of Rheumatology Publishing Co. Ltd.</span>)
        </div><div class="casAbstract">To evaluate efficacy and safety of CE-224,535, a selective P2X7 receptor antagonist, vs. placebo, in patients with active rheumatoid arthritis (RA) and inadequate response to methotrexate (MTX).  In our phase IIA study (ClinicalTrials.gov no. NCT00628095; A6341009), patients aged ≥ 18 years with active RA were randomized to receive either CE-224,535 (500 mg bid) or placebo for 12 wk; all patients continued a stable background dose of ≥ 7.5 mg MTX.  The American College of Rheumatol. 20% (ACR20) response rate (primary efficacy endpoint) was not significantly different from placebo for CE-224,535 (34.0% vs 36.2%; p = 0.591) at Week 12, or at any timepoint over the 12-wk treatment period.  There was no significant difference at Week 12 for the ACR20 response rate following subgroup analyses by age, sex, baseline disease activity, baseline duration of disease, geog. region, or concomitant use of steroids.  ACR50/ACR70 response rates and change from baseline in Disease Activity Score 28-joint C-reactive protein (DAS28-3-CRP) and Health Assessment Questionnaire-Disability Index for CE-224,535 were not significant at Week 12 vs. placebo.  Treatment-emergent adverse events (AE) were reported by 62.3% (CE-224,535) and 55.3% (placebo) of patients; the most common AE were nausea (11.3%, CE-224,535; 4.3%, placebo) and diarrhea (7.5%, CE-224,535; 4.3%, placebo).  The proportion of patients discontinuing due to an AE was 9.4% (CE-224,535) and 6.4% (placebo); no deaths were reported.  Serious AE occurred in 3.8% (CE-224,535) and 2.1% (placebo) of patients; none was considered treatment-related.  CE-224,535 was not efficacious, compared with placebo, for the treatment of RA in patients with an inadequate response to MTX.  CE-224,535 demonstrated an acceptable safety and tolerability profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorblWg-aNBNLVg90H21EOLACvtfcHk0ljlemhcyq3pkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XotVOnsro%253D&md5=dc919436c3c6e7f3f624c57b77c5dbb2</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3899%2Fjrheum.110874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3899%252Fjrheum.110874%26sid%3Dliteratum%253Aachs%26aulast%3DStock%26aufirst%3DT.%2BC.%26aulast%3DBloom%26aufirst%3DB.%2BJ.%26aulast%3DWei%26aufirst%3DN.%26aulast%3DIshaq%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DGupta%26aufirst%3DP.%26aulast%3DMebus%26aufirst%3DC.%2BA.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520CE-224%252C535%252C%2520an%2520antagonist%2520of%2520P2X7%2520receptor%252C%2520in%2520treatment%2520of%2520patients%2520with%2520rheumatoid%2520arthritis%2520inadequately%2520controlled%2520by%2520methotrexate%26jtitle%3DJ.%2520Rheumatol.%26date%3D2012%26volume%3D39%26issue%3D4%26spage%3D720%26epage%3D727%26doi%3D10.3899%2Fjrheum.110874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Ali, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurijssens, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostenfeld, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stylianou, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott-Stevens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosking, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewit, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span> </span><span class="NLM_article-title">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">197</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span><span class="refDoi"> DOI: 10.1111/j.1365-2125.2012.04320.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1111%2Fj.1365-2125.2012.04320.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=22568863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2013&pages=197-207&issue=1&author=Z.+Aliauthor=B.+Laurijssensauthor=T.+Ostenfeldauthor=S.+McHughauthor=A.+Stylianouauthor=P.+Scott-Stevensauthor=L.+Hoskingauthor=O.+Dewitauthor=J.+C.+Richardsonauthor=C.+Chen&title=Pharmacokinetic+and+pharmacodynamic+profiling+of+a+P2X7+receptor+allosteric+modulator+GSK1482160+in+healthy+human+subjects&doi=10.1111%2Fj.1365-2125.2012.04320.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects</span></div><div class="casAuthors">Ali, Zahid; Laurijssens, Bart; Ostenfeld, Thor; McHugh, Simon; Stylianou, Anastasia; Scott-Stevens, Paul; Hosking, Louise; Dewit, Odile; Richardson, Jill C.; Chen, Chao</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">197-207</span>CODEN:
                <span class="NLM_cas:coden">BCPHBM</span>;
        ISSN:<span class="NLM_cas:issn">0306-5251</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT • P2X7 receptors are involved in the prodn. of pro-inflammatory cytokines, such as Il-1β, by central and peripheral immune cells.  Il-1β has been implicated as an important mediator of inflammation.  Therefore, the P2X7 receptor is an attractive therapeutic target for inflammatory diseases.  WHAT THIS STUDY ADDS • Findings in pharmacokinetics, pharmacodynamics, safety and tolerability of a P2X7 receptor modulator, GSK1482160, from the first human study for the mol. are described.  A pharmacokinetic/pharmacodynamic model for LPS-stimulated ATP-induced Il-1β prodn. in blood allowed the integration of all relevant data and provided in vivo evidence of the nature of the drug-receptor interaction.  The model has the potential to be used to simulate future trials.  AIMS This paper describes findings from the first-in-human study for GSK1482160, an orally available allosteric P2X7 receptor modulator.  The study aimed to assess the pharmacokinetics (PK), pharmacodynamics (PD), safety and tolerability of the compd. in healthy subjects.  METHODS Escalating single doses of up to 1 g were administered to healthy subjects in a single-blind and placebo-controlled fashion.  Safety, tolerability, blood drug concns. and ex vivo Il-1β prodn. in blood were evaluated.  RESULTS. Drug concn. peaked within 3.5 h of dosing under fasting conditions and declined thereafter with a relatively short half-life of less than 4.5 h.  Exposure was proportional to dose with between subject variability of less than 60%.  A PK/PD model quantified Il-1β as a function of drug exposure.  The model allowed simulation of in vivo pharmacol. for various untested dose levels and regimens.  Furthermore, the mechanistic model supported the hypothesis that the compd. reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity.  No major safety or tolerability concerns were identified in this small study (n= 29), except for one case of asymptomatic accelerated idioventricular rhythm at the top dose.  CONCLUSION. The model-based approach maximized anal. power by integrating all biomarker data and revealed mechanistic insight into the pharmacol. of P2X7 modulation by GSK1482160.  Simulations by this model ultimately led to the discontinuation of the development of this compd.  The therapeutic relevance of the P2X7 receptor remains to be tested in patients.  The mechanistic-model-based approach can be applied widely to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr41Bz54gV-qLVg90H21EOLACvtfcHk0lhv2sLgOlfgXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVGmsbnF&md5=835023636e0c5b039245344c2a9a207a</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2012.04320.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2012.04320.x%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DZ.%26aulast%3DLaurijssens%26aufirst%3DB.%26aulast%3DOstenfeld%26aufirst%3DT.%26aulast%3DMcHugh%26aufirst%3DS.%26aulast%3DStylianou%26aufirst%3DA.%26aulast%3DScott-Stevens%26aufirst%3DP.%26aulast%3DHosking%26aufirst%3DL.%26aulast%3DDewit%26aufirst%3DO.%26aulast%3DRichardson%26aufirst%3DJ.%2BC.%26aulast%3DChen%26aufirst%3DC.%26atitle%3DPharmacokinetic%2520and%2520pharmacodynamic%2520profiling%2520of%2520a%2520P2X7%2520receptor%2520allosteric%2520modulator%2520GSK1482160%2520in%2520healthy%2520human%2520subjects%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2013%26volume%3D75%26issue%3D1%26spage%3D197%26epage%3D207%26doi%3D10.1111%2Fj.1365-2125.2012.04320.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Abdi, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beswick, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Billinton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collis, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonfria, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gleave, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lejeune, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livermore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michel, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moses, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slingsby, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steadman, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walter, D. S.</span><span> </span><span class="NLM_article-title">Discovery and structure-activity relationships of a series of pyroglutamic acid amide antagonists of the P2X7 receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5080</span><span class="NLM_x">–</span> <span class="NLM_lpage">5084</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2010.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.bmcl.2010.07.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5080-5084&issue=17&author=M.+H.+Abdiauthor=P.+J.+Beswickauthor=A.+Billintonauthor=L.+J.+Chambersauthor=A.+Charltonauthor=S.+D.+Collinsauthor=K.+L.+Collisauthor=D.+K.+Deanauthor=E.+Fonfriaauthor=R.+J.+Gleaveauthor=C.+L.+Lejeuneauthor=D.+G.+Livermoreauthor=S.+J.+Medhurstauthor=A.+D.+Michelauthor=A.+P.+Mosesauthor=L.+Pageauthor=S.+Patelauthor=S.+A.+Romanauthor=S.+Sengerauthor=B.+Slingsbyauthor=J.+G.+Steadmanauthor=A.+J.+Stevensauthor=D.+S.+Walter&title=Discovery+and+structure-activity+relationships+of+a+series+of+pyroglutamic+acid+amide+antagonists+of+the+P2X7+receptor&doi=10.1016%2Fj.bmcl.2010.07.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DAbdi%26aufirst%3DM.%2BH.%26aulast%3DBeswick%26aufirst%3DP.%2BJ.%26aulast%3DBillinton%26aufirst%3DA.%26aulast%3DChambers%26aufirst%3DL.%2BJ.%26aulast%3DCharlton%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DS.%2BD.%26aulast%3DCollis%26aufirst%3DK.%2BL.%26aulast%3DDean%26aufirst%3DD.%2BK.%26aulast%3DFonfria%26aufirst%3DE.%26aulast%3DGleave%26aufirst%3DR.%2BJ.%26aulast%3DLejeune%26aufirst%3DC.%2BL.%26aulast%3DLivermore%26aufirst%3DD.%2BG.%26aulast%3DMedhurst%26aufirst%3DS.%2BJ.%26aulast%3DMichel%26aufirst%3DA.%2BD.%26aulast%3DMoses%26aufirst%3DA.%2BP.%26aulast%3DPage%26aufirst%3DL.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRoman%26aufirst%3DS.%2BA.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DSlingsby%26aufirst%3DB.%26aulast%3DSteadman%26aufirst%3DJ.%2BG.%26aulast%3DStevens%26aufirst%3DA.%2BJ.%26aulast%3DWalter%26aufirst%3DD.%2BS.%26atitle%3DDiscovery%2520and%2520structure-activity%2520relationships%2520of%2520a%2520series%2520of%2520pyroglutamic%2520acid%2520amide%2520antagonists%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D17%26spage%3D5080%26epage%3D5084%26doi%3D10.1016%2Fj.bmcl.2010.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawryluk, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sales, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velter, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contreras, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morton, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickenden, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span> </span><span class="NLM_article-title">Synthesis and pharmacological characterization of two novel, brain penetrating P2X7 antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span><span class="refDoi"> DOI: 10.1021/ml400040v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml400040v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=419-422&issue=4&author=M.+A.+Letavicauthor=B.+Lordauthor=F.+Bischoffauthor=N.+A.+Hawrylukauthor=S.+Pietersauthor=J.+C.+Rechauthor=Z.+Salesauthor=A.+I.+Velterauthor=H.+Aoauthor=P.+Bonaventureauthor=V.+Contrerasauthor=X.+Jiangauthor=K.+L.+Mortonauthor=B.+Scottauthor=Q.+Wangauthor=A.+D.+Wickendenauthor=N.+I.+Carruthersauthor=A.+Bhattacharya&title=Synthesis+and+pharmacological+characterization+of+two+novel%2C+brain+penetrating+P2X7+antagonists&doi=10.1021%2Fml400040v"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fml400040v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400040v%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DHawryluk%26aufirst%3DN.%2BA.%26aulast%3DPieters%26aufirst%3DS.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DSales%26aufirst%3DZ.%26aulast%3DVelter%26aufirst%3DA.%2BI.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DContreras%26aufirst%3DV.%26aulast%3DJiang%26aufirst%3DX.%26aulast%3DMorton%26aufirst%3DK.%2BL.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520pharmacological%2520characterization%2520of%2520two%2520novel%252C%2520brain%2520penetrating%2520P2X7%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26issue%3D4%26spage%3D419%26epage%3D422%26doi%3D10.1021%2Fml400040v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoblock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraser, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nepomuceno, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neff, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickenden, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">170</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">624</span><span class="NLM_x">–</span> <span class="NLM_lpage">640</span><span class="refDoi"> DOI: 10.1111/bph.12314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1111%2Fbph.12314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=23889535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=170&publication_year=2013&pages=624-640&issue=3&author=A.+Bhattacharyaauthor=Q.+Wangauthor=H.+Aoauthor=J.+R.+Shoblockauthor=B.+Lordauthor=L.+Aluisioauthor=I.+Fraserauthor=D.+Nepomucenoauthor=R.+A.+Neffauthor=N.+Weltyauthor=T.+W.+Lovenbergauthor=P.+Bonaventureauthor=A.+D.+Wickendenauthor=M.+A.+Letavic&title=Pharmacological+characterization+of+a+novel+centrally+permeable+P2X7+receptor+antagonist%3A+JNJ-47965567&doi=10.1111%2Fbph.12314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567</span></div><div class="casAuthors">Bhattacharya, Anindya; Wang, Qi; Ao, Hong; Shoblock, James R.; Lord, Brian; Aluisio, Leah; Fraser, Ian; Nepomuceno, Diane; Neff, Robert A.; Welty, Natalie; Lovenberg, Timothy W.; Bonaventure, Pascal; Wickenden, Alan D.; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">170</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">624-640</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : An increasing body of evidence suggests that the purinergic receptor P2X, ligand-gated ion channel, 7 (P2X7) in the CNS may play a key role in neuropsychiatry, neurodegeneration and chronic pain.  In this study, we characterized JNJ-47965567, a centrally permeable, high-affinity, selective P2X7 antagonist.  Exptl. Approach : We have used a combination of in vitro assays (calcium flux, radioligand binding, electrophysiol., IL-1β release) in both recombinant and native systems.  Target engagement of JNJ-47965567 was demonstrated by ex vivo receptor binding autoradiog. and in vivo blockade of Bz-ATP induced IL-1β release in the rat brain.  Finally, the efficacy of JNJ-47965567 was tested in std. models of depression, mania and neuropathic pain.  Key Results : JNJ-47965567 is potent high affinity (pKi 7.9 ± 0.07), selective human P2X7 antagonist, with no significant obsd. speciation.  In native systems, the potency of the compd. to attenuate IL-1β release was 6.7 ± 0.07 (human blood), 7.5 ± 0.07 (human monocytes) and 7.1 ± 0.1 (rat microglia).  JNJ-47965567 exhibited target engagement in rat brain, with a brain EC50 of 78 ± 19 ng·mL-1 (P2X7 receptor autoradiog.) and functional block of Bz-ATP induced IL-1β release.  JNJ-47965567 (30 mg·kg-1) attenuated amphetamine-induced hyperactivity and exhibited modest, yet significant efficacy in the rat model of neuropathic pain.  No efficacy was obsd. in forced swim test.  Conclusion and Implications : JNJ-47965567 is centrally permeable, high affinity P2X7 antagonist that can be used to probe the role of central P2X7 in rodent models of CNS pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS_bU7fI8KzLVg90H21EOLACvtfcHk0lhv2sLgOlfgXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsV2ntrnI&md5=29d3bc1d3ecedda01f3d33b53d96c289</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2Fbph.12314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.12314%26sid%3Dliteratum%253Aachs%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DNepomuceno%26aufirst%3DD.%26aulast%3DNeff%26aufirst%3DR.%2BA.%26aulast%3DWelty%26aufirst%3DN.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPharmacological%2520characterization%2520of%2520a%2520novel%2520centrally%2520permeable%2520P2X7%2520receptor%2520antagonist%253A%2520JNJ-47965567%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2013%26volume%3D170%26issue%3D3%26spage%3D624%26epage%3D640%26doi%3D10.1111%2Fbph.12314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kovanyi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csolle, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calovi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanuska, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koles, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haller, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperlagh, B.</span><span> </span><span class="NLM_article-title">The role of P2X7 receptors in a rodent PCP-induced schizophrenia model</span> <span class="citation_source-journal">Sci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">36680</span><span class="refDoi"> DOI: 10.1038/srep36680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1038%2Fsrep36680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=27824163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVeht7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=36680&author=B.+Kovanyiauthor=C.+Csolleauthor=S.+Caloviauthor=A.+Hanuskaauthor=E.+Katoauthor=L.+Kolesauthor=A.+Bhattacharyaauthor=J.+Hallerauthor=B.+Sperlagh&title=The+role+of+P2X7+receptors+in+a+rodent+PCP-induced+schizophrenia+model&doi=10.1038%2Fsrep36680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The role of P2X7 receptors in a rodent PCP-induced schizophrenia model</span></div><div class="casAuthors">Kovanyi, Bence; Csolle, Cecilia; Calovi, Stefano; Hanuska, Adrienn; Kato, Erzsebet; Koles, Laszlo; Bhattacharya, Anindya; Haller, Jozsef; Sperlagh, Beata</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">36680</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">P2X7 receptors (P2X7Rs) are ligand-gated ion channels sensitive to extracellular ATP.  Here we examd. for the first time the role of P2X7R in an animal model of schizophrenia.  Using the PCP induced schizophrenia model we show that both genetic deletion and pharmacol. inhibition of P2X7Rs alleviate schizophrenia-like behavioral alterations.  In P2rx7+/+ mice, PCP induced hyperlocomotion, stereotype behavior, ataxia and social withdrawal.  In P2X7 receptor deficient mice (P2rx7-/-), the social interactions were increased, whereas the PCP induced hyperlocomotion and stereotype behavior were alleviated.  The selective P2X7 receptor antagonist JNJ-47965567 partly replicated the effect of gene deficiency on PCP-induced behavioral changes and counteracted PCP-induced social withdrawal.  We also show that PCP treatment upregulates and increases the functional responsiveness of P2X7Rs in the prefrontal cortex of young adult animals.  The amplitude of NMDA evoked currents recorded from layer V pyramidal neurons of cortical slices were slightly decreased by both genetic deletion of P2rx7 and by JNJ-47965567.  PCP induced alterations in mRNA expression encoding schizophrenia-related genes, such as NR2A, NR2B, neuregulin 1, NR1 and GABA α1 subunit were absent in the PFC of young adult P2rx7-/- animals.  Our findings point to P2X7R as a potential therapeutic target in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE7IvuTAwyvbVg90H21EOLACvtfcHk0lhXVg-v9kntLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVeht7fI&md5=336145e37b57f1d3a569afdc10dcdf70</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fsrep36680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep36680%26sid%3Dliteratum%253Aachs%26aulast%3DKovanyi%26aufirst%3DB.%26aulast%3DCsolle%26aufirst%3DC.%26aulast%3DCalovi%26aufirst%3DS.%26aulast%3DHanuska%26aufirst%3DA.%26aulast%3DKato%26aufirst%3DE.%26aulast%3DKoles%26aufirst%3DL.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DHaller%26aufirst%3DJ.%26aulast%3DSperlagh%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520P2X7%2520receptors%2520in%2520a%2520rodent%2520PCP-induced%2520schizophrenia%2520model%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D36680%26doi%3D10.1038%2Fsrep36680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Jimenez-Pacheco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Hernandez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arribas-Blazquez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz-Rodriguez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivos-Ore, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artalejo, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alves, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miras-Portugal, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conroy, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delanty, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrell, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henshall, D. C.</span><span> </span><span class="NLM_article-title">Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">22</span><span class="NLM_x">) </span> <span class="NLM_fpage">5920</span><span class="NLM_x">–</span> <span class="NLM_lpage">5932</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4009-15.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1523%2FJNEUROSCI.4009-15.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=27251615" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2lsbbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=5920-5932&issue=22&author=A.+Jimenez-Pachecoauthor=M.+Diaz-Hernandezauthor=M.+Arribas-Blazquezauthor=A.+Sanz-Rodriguezauthor=L.+A.+Olivos-Oreauthor=A.+R.+Artalejoauthor=M.+Alvesauthor=M.+Letavicauthor=M.+T.+Miras-Portugalauthor=R.+M.+Conroyauthor=N.+Delantyauthor=M.+A.+Farrellauthor=D.+F.+O%E2%80%99Brienauthor=A.+Bhattacharyaauthor=T.+Engelauthor=D.+C.+Henshall&title=Transient+P2X7+receptor+antagonism+produces+lasting+reductions+in+spontaneous+seizures+and+gliosis+in+experimental+temporal+lobe+epilepsy&doi=10.1523%2FJNEUROSCI.4009-15.2016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Transient P2X7 receptor antagonism produces lasting reductions in spontaneous seizures and gliosis in experimental temporal lobe epilepsy</span></div><div class="casAuthors">Jimenez-Pacheco, Alba; Diaz-Hernandez, Miguel; Arribas-Blazquez, Marina; Sanz-Rodriguez, Amaya; Olivos-Ore, Luis A.; Artalejo, Antonio R.; Alves, Mariana; Letavic, Michael; Miras-Portugal, M. Teresa; Conroy, Ronan M.; Delanty, Norman; Farrell, Michael A.; O'Brien, Donncha F.; Bhattacharya, Anindya; Engel, Tobias; Henshall, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5920-5932</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neuroinflammation is thought to contribute to the pathogenesis and maintenance of temporal lobe epilepsy, but the underlying cell and mol. mechanisms are not fully understood.  The P2X7 receptor is an ionotropic receptor predominantly expressed on the surface of microglia, although neuronal expression has also been reported.  The receptor is activated by the release of ATP from intracellular sources that occurs during neurodegeneration, leading to microglial activation and inflammasome-mediated interleukin 1β release that contributes to neuroinflammation.  Using a reporter mouse in which green fluorescent protein is induced in response to the transcription of P2rx7, we show that expression of the receptor is selectively increased in CA1 pyramidal and dentate granule neurons, as well as in microglia in mice that developed epilepsy after intra-amygdala kainic acid-induced status epilepticus.  P2X7 receptor levels were increased in hippocampal subfields in the mice and in resected hippocampus from patients with pharmacoresistant temporal lobe epilepsy.  Cells transcribing P2rx7 in hippocampal slices from epileptic mice displayed enhanced agonist-evoked P2X7 receptor currents, and synaptosomes from these animals showed increased P2X7 receptor levels and altered calcium responses.  A 5 d treatment of epileptic mice with systemic injections of the centrally available, potent, and specific P2X7 receptor antagonist JNJ-47965567 (30 mg/kg) significantly reduced spontaneous seizures during continuous video-EEG monitoring that persisted beyond the time of drug presence in the brain.  Hippocampal sections from JNJ-47965567-treated animals obtained >5 d after treatment ceased displayed strongly reduced microgliosis and astrogliosis.  The present study suggests that targeting the P2X7 receptor has anticonvulsant and possibly disease-modifying effects in exptl. epilepsy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKv2tFIlA_-7Vg90H21EOLACvtfcHk0lhXVg-v9kntLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2lsbbN&md5=2b57d7145b13968cea54920a6583de9a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4009-15.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4009-15.2016%26sid%3Dliteratum%253Aachs%26aulast%3DJimenez-Pacheco%26aufirst%3DA.%26aulast%3DDiaz-Hernandez%26aufirst%3DM.%26aulast%3DArribas-Blazquez%26aufirst%3DM.%26aulast%3DSanz-Rodriguez%26aufirst%3DA.%26aulast%3DOlivos-Ore%26aufirst%3DL.%2BA.%26aulast%3DArtalejo%26aufirst%3DA.%2BR.%26aulast%3DAlves%26aufirst%3DM.%26aulast%3DLetavic%26aufirst%3DM.%26aulast%3DMiras-Portugal%26aufirst%3DM.%2BT.%26aulast%3DConroy%26aufirst%3DR.%2BM.%26aulast%3DDelanty%26aufirst%3DN.%26aulast%3DFarrell%26aufirst%3DM.%2BA.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DD.%2BF.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DEngel%26aufirst%3DT.%26aulast%3DHenshall%26aufirst%3DD.%2BC.%26atitle%3DTransient%2520P2X7%2520receptor%2520antagonism%2520produces%2520lasting%2520reductions%2520in%2520spontaneous%2520seizures%2520and%2520gliosis%2520in%2520experimental%2520temporal%2520lobe%2520epilepsy%26jtitle%3DJ.%2520Neurosci.%26date%3D2016%26volume%3D36%26issue%3D22%26spage%3D5920%26epage%3D5932%26doi%3D10.1523%2FJNEUROSCI.4009-15.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Fischer, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franke, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krugel, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinkel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henshall, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engel, T.</span><span> </span><span class="NLM_article-title">Critical evaluation of P2X7 receptor antagonists in selected seizure models</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">e0156468</span><span class="refDoi"> DOI: 10.1371/journal.pone.0156468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1371%2Fjournal.pone.0156468" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0156468&issue=6&author=W.+Fischerauthor=H.+Frankeauthor=U.+Krugelauthor=H.+Mullerauthor=K.+Dinkelauthor=B.+Lordauthor=M.+A.+Letavicauthor=D.+C.+Henshallauthor=T.+Engel&title=Critical+evaluation+of+P2X7+receptor+antagonists+in+selected+seizure+models&doi=10.1371%2Fjournal.pone.0156468"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0156468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0156468%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DW.%26aulast%3DFranke%26aufirst%3DH.%26aulast%3DKrugel%26aufirst%3DU.%26aulast%3DMuller%26aufirst%3DH.%26aulast%3DDinkel%26aufirst%3DK.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DHenshall%26aufirst%3DD.%2BC.%26aulast%3DEngel%26aufirst%3DT.%26atitle%3DCritical%2520evaluation%2520of%2520P2X7%2520receptor%2520antagonists%2520in%2520selected%2520seizure%2520models%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3De0156468%26doi%3D10.1371%2Fjournal.pone.0156468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aluisio, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoblock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neff, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varlinskaya, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceusters, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drinkenburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span> </span><span class="NLM_article-title">Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">628</span><span class="NLM_x">–</span> <span class="NLM_lpage">641</span><span class="refDoi"> DOI: 10.1124/jpet.114.218487</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1124%2Fjpet.114.218487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=25271258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFWhu7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2014&pages=628-641&issue=3&author=B.+Lordauthor=L.+Aluisioauthor=J.+R.+Shoblockauthor=R.+A.+Neffauthor=E.+I.+Varlinskayaauthor=M.+Ceustersauthor=T.+W.+Lovenbergauthor=N.+Carruthersauthor=P.+Bonaventureauthor=M.+A.+Letavicauthor=T.+Deakauthor=W.+Drinkenburgauthor=A.+Bhattacharya&title=Pharmacology+of+a+novel+central+nervous+system-penetrant+P2X7+antagonist+JNJ-42253432&doi=10.1124%2Fjpet.114.218487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432</span></div><div class="casAuthors">Lord, Brian; Aluisio, Leah; Shoblock, James R.; Neff, Robert A.; Varlinskaya, Elena I.; Ceusters, Marc; Lovenberg, Timothy W.; Carruthers, Nicholas; Bonaventure, Pascal; Letavic, Michael A.; Deak, Terrence; Drinkenburg, Wilhelmus; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">628-641, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">In the central nervous system, the ATP-gated Purinergic receptor P2X ligand-gated ion channel 7 (P2X7) is expressed in glial cells and modulates neurophysiol. via release of gliotransmitters, including the proinflammatory cytokine interleukin (IL)-1β.  In this study, we characterized JNJ-42253432 [2-methyl-N-([1-(4-phenylpiperazin-1-yl)cyclohexyl]methyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide] as a centrally permeable (brain-to-plasma ratio of 1), high-affinity P2X7 antagonist with desirable pharmacokinetic and pharmacodynamic properties for in vivo testing in rodents.  JNJ-42253432 is a high-affinity antagonist for the rat (pKi 9.1 ± 0.07) and human (pKi 7.9 ± 0.08) P2X7 channel.  The compd. blocked the ATP-induced current and Bz-ATP [2'(3')-O-(4-benzoylbenzoyl)adenosine-5'-triphosphate tri(triethylammonium)]-induced release of IL-1β in a concn.-dependent manner.  When dosed in rats, JNJ-42253432 occupied the brain P2X7 channel with an ED50 of 0.3 mg/kg, corresponding to a mean plasma concn. of 42 ng/mL.  The compd. blocked the release of IL-1β induced by Bz-ATP in freely moving rat brain.  At higher doses/exposure, JNJ-42253432 also increased serotonin levels in the rat brain, which is due to antagonism of the serotonin transporter (SERT) resulting in an ED50 of 10 mg/kg for SERT occupancy.  JNJ-42253432 reduced electroencephalog. spectral power in the α-1 band in a dose-dependent manner; the compd. also attenuated amphetamine-induced hyperactivity.  JNJ-42253432 significantly increased both overall social interaction and social preference, an effect that was independent of stress induced by foot-shock.  Surprisingly, there was no effect of the compd. on either neuropathic pain or inflammatory pain behaviors.  In summary, in this study, we characterize JNJ-42253432 as a novel brain-penetrant P2X7 antagonist with high affinity and selectivity for the P2X7 channel.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU5MO_PDXIeLVg90H21EOLACvtfcHk0lhL6r_v_PtF2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFWhu7fN&md5=1ab23844891e251b37713c5cd80162a7</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.218487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.218487%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DShoblock%26aufirst%3DJ.%2BR.%26aulast%3DNeff%26aufirst%3DR.%2BA.%26aulast%3DVarlinskaya%26aufirst%3DE.%2BI.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DDeak%26aufirst%3DT.%26aulast%3DDrinkenburg%26aufirst%3DW.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DPharmacology%2520of%2520a%2520novel%2520central%2520nervous%2520system-penetrant%2520P2X7%2520antagonist%2520JNJ-42253432%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D351%26issue%3D3%26spage%3D628%26epage%3D641%26doi%3D10.1124%2Fjpet.114.218487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Dean, D. K.; Munoz-Muriedas, J.; Sime, M.; Steadman, J. G. A.; Thewlis, R. E. A.; Trani, G.; Walter, D. S.</span><span> </span><span class="NLM_article-title">Preparation of Tetrahydro[1,2,4]triazolo[4,3-a]pyrazine Derivatives for Use as P2X7 Modulators</span>. WO 2010125102 A1, November 4,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+K.+Dean&author=J.+Munoz-Muriedas&author=M.+Sime&author=J.+G.+A.+Steadman&author=R.+E.+A.+Thewlis&author=G.+Trani&author=D.+S.+Walter&title=Preparation+of+Tetrahydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazine+Derivatives+for+Use+as+P2X7+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DD.%2BK.%26atitle%3DPreparation%2520of%2520Tetrahydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazine%2520Derivatives%2520for%2520Use%2520as%2520P2X7%2520Modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anton, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chrovian, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andres, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Novel methyl substituted 1-(5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanones are P2X7 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">3157</span><span class="NLM_x">–</span> <span class="NLM_lpage">3163</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.bmcl.2015.06.004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3157-3163&issue=16&author=D.+A.+Rudolphauthor=J.+Alcazarauthor=M.+K.+Ameriksauthor=A.+B.+Antonauthor=H.+Aoauthor=P.+Bonaventureauthor=N.+I.+Carruthersauthor=C.+C.+Chrovianauthor=M.+De+Angelisauthor=B.+Lordauthor=J.+C.+Rechauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=J.+I.+Andresauthor=M.+A.+Letavic&title=Novel+methyl+substituted+1-%285%2C6-dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-7%288H%29-yl%29methanones+are+P2X7+antagonists&doi=10.1016%2Fj.bmcl.2015.06.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.004%26sid%3Dliteratum%253Aachs%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DAnton%26aufirst%3DA.%2BB.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520methyl%2520substituted%25201-%25285%252C6-dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-7%25288H%2529-yl%2529methanones%2520are%2520P2X7%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26issue%3D16%26spage%3D3157%26epage%3D3163%26doi%3D10.1016%2Fj.bmcl.2015.06.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Synthesis, SAR, and pharmacological characterization of brain penetrant P2X7 receptor antagonists</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span><span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00089</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00089" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=671-676&issue=6&author=B.+M.+Savallauthor=D.+Wuauthor=M.+De+Angelisauthor=N.+I.+Carruthersauthor=H.+Aoauthor=Q.+Wangauthor=B.+Lordauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Synthesis%2C+SAR%2C+and+pharmacological+characterization+of+brain+penetrant+P2X7+receptor+antagonists&doi=10.1021%2Facsmedchemlett.5b00089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00089%26sid%3Dliteratum%253Aachs%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%252C%2520SAR%252C%2520and%2520pharmacological%2520characterization%2520of%2520brain%2520penetrant%2520P2X7%2520receptor%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26issue%3D6%26spage%3D671%26epage%3D676%26doi%3D10.1021%2Facsmedchemlett.5b00089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Swanson, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coe, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schoetens, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaptason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepassi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-di hydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a small molecule antagonist of the P2X7 receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">8535</span><span class="NLM_x">–</span> <span class="NLM_lpage">8548</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00989</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00989" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8535-8548&issue=18&author=D.+M.+Swansonauthor=B.+M.+Savallauthor=K.+J.+Coeauthor=F.+Schoetensauthor=T.+Koudriakovaauthor=J.+Skaptasonauthor=J.+Wallauthor=J.+Rechauthor=X.+Dengauthor=M.+De+Angelisauthor=A.+Eversonauthor=B.+Lordauthor=Q.+Wangauthor=H.+Aoauthor=B.+Scottauthor=K.+Sepassiauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Identification+of+%28R%29-%282-Chloro-3-%28trifluoromethyl%29phenyl%29%281-%285-fluoropyridin-2-yl%29-4-methyl-6%2C7-di+hydro-1H-imidazo%5B4%2C5-c%5Dpyridin-5%284H%29-yl%29methanone+%28JNJ+54166060%29%2C+a+small+molecule+antagonist+of+the+P2X7+receptor&doi=10.1021%2Facs.jmedchem.6b00989"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00989%26sid%3Dliteratum%253Aachs%26aulast%3DSwanson%26aufirst%3DD.%2BM.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DSkaptason%26aufirst%3DJ.%26aulast%3DWall%26aufirst%3DJ.%26aulast%3DRech%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DEverson%26aufirst%3DA.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DIdentification%2520of%2520%2528R%2529-%25282-Chloro-3-%2528trifluoromethyl%2529phenyl%2529%25281-%25285-fluoropyridin-2-yl%2529-4-methyl-6%252C7-di%2520hydro-1H-imidazo%255B4%252C5-c%255Dpyridin-5%25284H%2529-yl%2529methanone%2520%2528JNJ%252054166060%2529%252C%2520a%2520small%2520molecule%2520antagonist%2520of%2520the%2520P2X7%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D18%26spage%3D8535%26epage%3D8548%26doi%3D10.1021%2Facs.jmedchem.6b00989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Preclinical characterization of substituted 6,7-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-8(5H)-one P2X7 receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">261</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.12.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.bmcl.2015.12.052" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=257-261&issue=2&author=M.+K.+Ameriksauthor=H.+Aoauthor=N.+I.+Carruthersauthor=B.+Lordauthor=S.+Ravulaauthor=J.+C.+Rechauthor=B.+M.+Savallauthor=J.+L.+Wallauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Preclinical+characterization+of+substituted+6%2C7-dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazin-8%285H%29-one+P2X7+receptor+antagonists&doi=10.1016%2Fj.bmcl.2015.12.052"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.12.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.12.052%26sid%3Dliteratum%253Aachs%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DRavula%26aufirst%3DS.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWall%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DPreclinical%2520characterization%2520of%2520substituted%25206%252C7-dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazin-8%25285H%2529-one%2520P2X7%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26issue%3D2%26spage%3D257%26epage%3D261%26doi%3D10.1016%2Fj.bmcl.2015.12.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ziff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudolph, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stenne, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koudriakova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shireman, B. T.</span><span> </span><span class="NLM_article-title">Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 antagonists</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">498</span><span class="NLM_x">–</span> <span class="NLM_lpage">504</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00304</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00304" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28XlvVemsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=498-504&issue=4&author=J.+Ziffauthor=D.+A.+Rudolphauthor=B.+Stenneauthor=T.+Koudriakovaauthor=B.+Lordauthor=P.+Bonaventureauthor=T.+W.+Lovenbergauthor=N.+I.+Carruthersauthor=A.+Bhattacharyaauthor=M.+A.+Letavicauthor=B.+T.+Shireman&title=Substituted+5%2C6-%28Dihydropyrido%5B3%2C4-d%5Dpyrimidin-7%288H%29-yl%29-methanones+as+P2X7+antagonists&doi=10.1021%2Facschemneuro.5b00304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25aR"><div class="casContent"><span class="casTitleNuber">25a</span><div class="casTitle"><span class="NLM_cas:atitle">Substituted 5,6-(Dihydropyrido[3,4-d]pyrimidin-7(8H)-yl)-methanones as P2X7 Antagonists</span></div><div class="casAuthors">Ziff, Jeannie; Rudolph, Dale A.; Stenne, Brice; Koudriakova, Tatiana; Lord, Brian; Bonaventure, Pascal; Lovenberg, Timothy W.; Carruthers, Nicholas I.; Bhattacharya, Anindya; Letavic, Michael A.; Shireman, Brock T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">498-504</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe the synthesis of a novel class of brain penetrating P2X7 antagonists with high potency at both the rat and human P2X7 receptors.  Disclosed herein are druglike mols. with demonstrated target engagement of the rat P2X7 receptors after an oral dose.  Specifically, compd. 20 occupied the P2X7 receptors >80% over the 6 h time course as measured by an ex vivo radioligand binding expt.  In a dose-response assay, this mol. has a plasma EC50 of 8 ng/mL.  Overall, 20 has suitable druglike properties and pharmacokinetics in rat and dog.  This mol. and others disclosed herein will serve as addnl. tools to elucidate the role of the P2X7 receptor in neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX4iuRhC8lPbVg90H21EOLACvtfcHk0lj3LwjZo6sHwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlvVemsA%253D%253D&md5=7f3f1afa4dad4db259189b98d97c8ae9</span></div><a href="/servlet/linkout?suffix=cit25a&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00304%26sid%3Dliteratum%253Aachs%26aulast%3DZiff%26aufirst%3DJ.%26aulast%3DRudolph%26aufirst%3DD.%2BA.%26aulast%3DStenne%26aufirst%3DB.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DShireman%26aufirst%3DB.%2BT.%26atitle%3DSubstituted%25205%252C6-%2528Dihydropyrido%255B3%252C4-d%255Dpyrimidin-7%25288H%2529-yl%2529-methanones%2520as%2520P2X7%2520antagonists%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D498%26epage%3D504%26doi%3D10.1021%2Facschemneuro.5b00304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit25b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chrovian, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soyode-Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacani, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rech, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span> </span><span class="NLM_article-title">Novel phenyl-substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 antagonists with robust target engagement in rat brain</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">497</span><span class="refDoi"> DOI: 10.1021/acschemneuro.5b00303</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00303" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlGmsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=490-497&issue=4&author=C.+C.+Chrovianauthor=A.+Soyode-Johnsonauthor=H.+Aoauthor=G.+M.+Bacaniauthor=N.+I.+Carruthersauthor=B.+Lordauthor=L.+Nguyenauthor=J.+C.+Rechauthor=Q.+Wangauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Novel+phenyl-substituted+5%2C6-Dihydro-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazine+P2X7+antagonists+with+robust+target+engagement+in+rat+brain&doi=10.1021%2Facschemneuro.5b00303"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25bR"><div class="casContent"><span class="casTitleNuber">25b</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Phenyl-Substituted 5,6-Dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 Antagonists with Robust Target Engagement in Rat Brain</span></div><div class="casAuthors">Chrovian, Christa C.; Soyode-Johnson, Akinola; Ao, Hong; Bacani, Genesis M.; Carruthers, Nicholas I.; Lord, Brian; Nguyen, Leslie; Rech, Jason C.; Wang, Qi; Bhattacharya, Anindya; Letavic, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">490-497</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel 5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine P2X7 antagonists were optimized to allow for good blood-brain barrier permeability and high P2X7 target engagement in the brain of rats.  Compd. I (huP2X7 IC50 = 9 nM; rat P2X7 IC50 = 42 nM) achieved 80% receptor occupancy for 6 h when dosed orally at 10 mg/kg in rats as measured by ex vivo radioligand binding autoradiog.  Structure-activity relationships within this series are described, as well as in vitro ADME results.  In vivo pharmacokinetic data for key compds. is also included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFc11o0pApUbVg90H21EOLACvtfcHk0lgrGJHWtyr1_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlGmsA%253D%253D&md5=a51ac05ebd3115489ddbabecf0cd1170</span></div><a href="/servlet/linkout?suffix=cit25b&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00303%26sid%3Dliteratum%253Aachs%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DSoyode-Johnson%26aufirst%3DA.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBacani%26aufirst%3DG.%2BM.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DNovel%2520phenyl-substituted%25205%252C6-Dihydro-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazine%2520P2X7%2520antagonists%2520with%2520robust%2520target%2520engagement%2520in%2520rat%2520brain%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2016%26volume%3D7%26issue%3D4%26spage%3D490%26epage%3D497%26doi%3D10.1021%2Facschemneuro.5b00303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Lord, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ameriks, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fourgeaud, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vliegen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verluyten, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haspeslagh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carruthers, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovenberg, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonaventure, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letavic, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, A.</span><span> </span><span class="NLM_article-title">A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">765</span><span class="NLM_x">, </span> <span class="NLM_fpage">551</span><span class="NLM_x">–</span> <span class="NLM_lpage">559</span><span class="refDoi"> DOI: 10.1016/j.ejphar.2015.09.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2Fj.ejphar.2015.09.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=26386289" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFOrs7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=765&publication_year=2015&pages=551-559&author=B.+Lordauthor=M.+K.+Ameriksauthor=Q.+Wangauthor=L.+Fourgeaudauthor=M.+Vliegenauthor=W.+Verluytenauthor=P.+Haspeslaghauthor=N.+I.+Carruthersauthor=T.+W.+Lovenbergauthor=P.+Bonaventureauthor=M.+A.+Letavicauthor=A.+Bhattacharya&title=A+novel+radioligand+for+the+ATP-gated+ion+channel+P2X7%3A+%5B3H%5D+JNJ-54232334&doi=10.1016%2Fj.ejphar.2015.09.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334</span></div><div class="casAuthors">Lord, Brian; Ameriks, Michael K.; Wang, Qi; Fourgeaud, Lawrence; Vliegen, Maarten; Verluyten, Willy; Haspeslagh, Pieter; Carruthers, Nicholas I.; Lovenberg, Timothy W.; Bonaventure, Pascal; Letavic, Michael A.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">765</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">551-559</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The ATP-gated ion channel P2X7 has emerged as a potential central nervous system (CNS) drug target based on the hypotheses that pro-inflammatory cytokines such as IL-1β that are released by microglia, may contribute to the etiol. of various disorders of the CNS including depression.  In this study, we identified two closely related P2X7 antagonists, JNJ-54232334 and JNJ-54140515, and then tritium labeled the former to produce a new radioligand for P2X7.  JNJ-54232334 is a high affinity ligand for the rat P2X7 with a pKi of 9.3±0.1.  In rat cortical membranes, [3H] JNJ-54232334 reached saturable binding with equil. dissocn. (Kd) const. of 4.9±1.3 nM.  The compd. displayed monophasic assocn. and dissocn. kinetics with fast on and off rates.  In rat brain sections, specific binding of [3H] JNJ-54232334 was markedly improved compared to the previously described P2X7 radioligand, [3H] A-804598.  In P2X7 knockout mouse brain sections, [3H] A-804598 bound to non-P2X7 binding sites in contrast to [3H] JNJ-54232334.  In rat or wild type mouse brain sections [3H] JNJ-54232334 bound in a more homogenous and region independent manner.  The ubiquitous expression of P2X7 receptors was confirmed with immunohistochem. in rat brain sections.  The partial displacement of [3H] A-804598 binding resulted in the underestimation of the level of ex vivo P2X7 occupancy for JNJ-54140515.  Higher levels of P2X7 ex vivo occupancy were measured using [3H] JNJ-54232334 due to less non-specific binding.  In summary, we describe [3H] JNJ-54232334 as a novel P2X7 radioligand, with improved properties over [3H] A-804598.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqr6Nqq14QSLVg90H21EOLACvtfcHk0lgrGJHWtyr1_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFOrs7zP&md5=b7d9da772882fa3d9e405fa54444d0f3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2015.09.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2015.09.026%26sid%3Dliteratum%253Aachs%26aulast%3DLord%26aufirst%3DB.%26aulast%3DAmeriks%26aufirst%3DM.%2BK.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DFourgeaud%26aufirst%3DL.%26aulast%3DVliegen%26aufirst%3DM.%26aulast%3DVerluyten%26aufirst%3DW.%26aulast%3DHaspeslagh%26aufirst%3DP.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3DA%2520novel%2520radioligand%2520for%2520the%2520ATP-gated%2520ion%2520channel%2520P2X7%253A%2520%255B3H%255D%2520JNJ-54232334%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2015%26volume%3D765%26spage%3D551%26epage%3D559%26doi%3D10.1016%2Fj.ejphar.2015.09.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Altman, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koval, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Copper-catalyzed N-arylation of imidazoles and benzimidazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">16</span><span class="NLM_x">) </span> <span class="NLM_fpage">6190</span><span class="NLM_x">–</span> <span class="NLM_lpage">6199</span><span class="refDoi"> DOI: 10.1021/jo070807a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo070807a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=6190-6199&issue=16&author=R.+A.+Altmanauthor=E.+D.+Kovalauthor=S.+L.+Buchwald&title=Copper-catalyzed+N-arylation+of+imidazoles+and+benzimidazoles&doi=10.1021%2Fjo070807a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27a&amp;dbid=16384&amp;doi=10.1021%2Fjo070807a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo070807a%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DR.%2BA.%26aulast%3DKoval%26aufirst%3DE.%2BD.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DCopper-catalyzed%2520N-arylation%2520of%2520imidazoles%2520and%2520benzimidazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26issue%3D16%26spage%3D6190%26epage%3D6199%26doi%3D10.1021%2Fjo070807a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit27b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Antilla, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baskin, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barder, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Copper–diamine-catalyzed N-arylation of pyrroles, pyrazoles, indazoles, imidazoles, and triazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">5578</span><span class="NLM_x">–</span> <span class="NLM_lpage">5587</span><span class="refDoi"> DOI: 10.1021/jo049658b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo049658b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=5578-5587&issue=17&author=J.+C.+Antillaauthor=J.+M.+Baskinauthor=T.+E.+Barderauthor=S.+L.+Buchwald&title=Copper%E2%80%93diamine-catalyzed+N-arylation+of+pyrroles%2C+pyrazoles%2C+indazoles%2C+imidazoles%2C+and+triazoles&doi=10.1021%2Fjo049658b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27b&amp;dbid=16384&amp;doi=10.1021%2Fjo049658b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo049658b%26sid%3Dliteratum%253Aachs%26aulast%3DAntilla%26aufirst%3DJ.%2BC.%26aulast%3DBaskin%26aufirst%3DJ.%2BM.%26aulast%3DBarder%26aufirst%3DT.%2BE.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DCopper%25E2%2580%2593diamine-catalyzed%2520N-arylation%2520of%2520pyrroles%252C%2520pyrazoles%252C%2520indazoles%252C%2520imidazoles%252C%2520and%2520triazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26issue%3D17%26spage%3D5578%26epage%3D5587%26doi%3D10.1021%2Fjo049658b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Khanna, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weier, R. M.</span><span> </span><span class="NLM_article-title">Regiospecific addition of Grignard reagents to the 4-position of activated imidazo[4,5-c]pyridine. A convenient method fot the synthesisof 4-alkylarylimidazopyrazines</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1885</span><span class="NLM_x">–</span> <span class="NLM_lpage">1888</span><span class="refDoi"> DOI: 10.1016/S0040-4039(00)91954-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;key=10.1016%2FS0040-4039%2800%2991954-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=1885-1888&issue=12&author=I.+K.+Khannaauthor=R.+M.+Weier&title=Regiospecific+addition+of+Grignard+reagents+to+the+4-position+of+activated+imidazo%5B4%2C5-c%5Dpyridine.+A+convenient+method+fot+the+synthesisof+4-alkylarylimidazopyrazines&doi=10.1016%2FS0040-4039%2800%2991954-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2800%2991954-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252800%252991954-3%26sid%3Dliteratum%253Aachs%26aulast%3DKhanna%26aufirst%3DI.%2BK.%26aulast%3DWeier%26aufirst%3DR.%2BM.%26atitle%3DRegiospecific%2520addition%2520of%2520Grignard%2520reagents%2520to%2520the%25204-position%2520of%2520activated%2520imidazo%255B4%252C5-c%255Dpyridine.%2520A%2520convenient%2520method%2520fot%2520the%2520synthesisof%25204-alkylarylimidazopyrazines%26jtitle%3DTetrahedron%2520Lett.%26date%3D1993%26volume%3D34%26issue%3D12%26spage%3D1885%26epage%3D1888%26doi%3D10.1016%2FS0040-4039%2800%2991954-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Deng, X. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allison, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAllister, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savall, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mani, N. S.</span><span> </span><span class="NLM_article-title">Allyl-assisted, Cu(I)-catalyzed azide-alkyne cycloaddition/allylation reaction: Assembly of the [1,2,3]triazolo-4,5,6,7-tetrahydropyridine core structure</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">80</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">11003</span><span class="NLM_x">–</span> <span class="NLM_lpage">11012</span><span class="refDoi"> DOI: 10.1021/acs.joc.5b02174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.joc.5b02174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2015&pages=11003-11012&issue=21&author=X.+H.+Dengauthor=J.+Liangauthor=B.+B.+Allisonauthor=C.+Dvorakauthor=H.+McAllisterauthor=B.+M.+Savallauthor=N.+S.+Mani&title=Allyl-assisted%2C+Cu%28I%29-catalyzed+azide-alkyne+cycloaddition%2Fallylation+reaction%3A+Assembly+of+the+%5B1%2C2%2C3%5Dtriazolo-4%2C5%2C6%2C7-tetrahydropyridine+core+structure&doi=10.1021%2Facs.joc.5b02174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.joc.5b02174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.joc.5b02174%26sid%3Dliteratum%253Aachs%26aulast%3DDeng%26aufirst%3DX.%2BH.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DAllison%26aufirst%3DB.%2BB.%26aulast%3DDvorak%26aufirst%3DC.%26aulast%3DMcAllister%26aufirst%3DH.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DMani%26aufirst%3DN.%2BS.%26atitle%3DAllyl-assisted%252C%2520Cu%2528I%2529-catalyzed%2520azide-alkyne%2520cycloaddition%252Fallylation%2520reaction%253A%2520Assembly%2520of%2520the%2520%255B1%252C2%252C3%255Dtriazolo-4%252C5%252C6%252C7-tetrahydropyridine%2520core%2520structure%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2015%26volume%3D80%26issue%3D21%26spage%3D11003%26epage%3D11012%26doi%3D10.1021%2Facs.joc.5b02174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Alcazar Vaca, M. J.; Andres Gil, J. I.; Chrovian, C. C.; Coate, H. R.; De Angelis, M.; Gelin, C. F.; Letavic, M. A.; Savall, B. M.; Soyode-Johnson, A.; Stenne, B. M.; Swanson, D. M.</span><span> </span><span class="NLM_article-title">Preparation of Imidazo[4,5-c]pyridines and 1,2,3-Triazolopyridines as P2X7 Modulators for Therapy</span>. US 2014 0275015 A1 September 18,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=M.+J.+Alcazar+Vaca&author=J.+I.+Andres+Gil&author=C.+C.+Chrovian&author=H.+R.+Coate&author=M.+De+Angelis&author=C.+F.+Gelin&author=M.+A.+Letavic&author=B.+M.+Savall&author=A.+Soyode-Johnson&author=B.+M.+Stenne&author=D.+M.+Swanson&title=Preparation+of+Imidazo%5B4%2C5-c%5Dpyridines+and+1%2C2%2C3-Triazolopyridines+as+P2X7+Modulators+for+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAlcazar%2BVaca%26aufirst%3DM.%2BJ.%26atitle%3DPreparation%2520of%2520Imidazo%255B4%252C5-c%255Dpyridines%2520and%25201%252C2%252C3-Triazolopyridines%2520as%2520P2X7%2520Modulators%2520for%2520Therapy%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00408">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_34270"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00408">10.1021/acs.jmedchem.7b00408</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Coordinates for the crystal structure of compound <b>14</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00408/suppl_file/jm7b00408_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00408/suppl_file/jm7b00408_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00408/suppl_file/jm7b00408_si_001.pdf">jm7b00408_si_001.pdf (107.91 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00408/suppl_file/jm7b00408_si_002.csv">jm7b00408_si_002.csv (0.88 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-11%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00408%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00408" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67999440cb4f3cca","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
